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ABSTRACT  
   
Genomic structural variation (SV) is defined as gross alterations in the 
genome broadly classified as insertions/duplications, deletions inversions and 
translocations. DNA sequencing ushered structural variant discovery beyond 
laboratory detection techniques to high resolution informatics approaches. 
Bioinformatics tools for computational discovery of SVs however are still missing 
variants in the complex cancer genome. This study aimed to define genomic context 
leading to tool failure and design novel algorithm addressing this context. Methods: 
The study tested the widely held but unproven hypothesis that tools fail to detect 
variants which lie in repeat regions. Publicly available 1000-Genomes dataset with 
experimentally validated variants was tested with SVDetect-tool for presence of true 
positives (TP) SVs versus false negative (FN) SVs, expecting that FNs would be 
overrepresented in repeat regions. Further, the novel algorithm designed to 
informatically capture the biological etiology of translocations (non-allelic 
homologous recombination and 3-D placement of chromosomes in cells-context) 
was tested using simulated dataset. Translocations were created in known 
translocation hotspots and the novel-algorithm tool compared with SVDetect and 
BreakDancer. Results: 53% of false negative (FN) deletions were within repeat 
structure compared to 81% true positive (TP) deletions. Similarly, 33% FN insertions 
versus 42% TP, 26% FN duplication versus 57% TP and 54% FN novel sequences 
versus 62% TP were within repeats. Repeat structure was not driving the tool’s 
inability to detect variants and could not be used as context. The novel algorithm  
with a redefined context, when tested against SVDetect and BreakDancer was able to 
detect 10/10 simulated translocations with 30X coverage dataset and 100% allele 
frequency, while SVDetect captured 4/10 and BreakDancer detected 6/10. For 15X 
coverage dataset with 100% allele frequency, novel algorithm was able to detect all 
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ten translocations albeit with fewer reads supporting the same. BreakDancer 
detected 4/10 and SVDetect detected 2/10 Conclusion: This study showed that 
presence of repetitive elements in general within a structural variant did not 
influence the tool’s ability to capture it. This context-based algorithm proved 
better than current tools even with half the genome coverage than accepted protocol 
and provides an important first step for novel translocation discovery in cancer 
genome.  
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1. INTRODUCTION 
Identifying differences at the genome level between a diseased and healthy 
individual has been the cornerstone of current medical genetic research with the 
purpose of identifying and targeting disease causing variants.  
1.1 Overview  
Structural variations in the human genome are changes in the genome, when 
compared to the reference human genome, that lead to gross aberrations in the 
physical structure of the genome. These typically include insertions, deletions, 
inversions, and translocations. Structural variations are typically studied by 
comparing the target DNA to the consensus reference genome. Insertions represent 
the inclusion of a segment of DNA sequence inserted into the target genome. 
Similarly a deletion represents a deleted segment, duplication represents a 
duplicated or repeat segment, and an inversion is a change in the orientation of the 
segment. A translocation is a change in the physical location of a segment of DNA 
normally present on the reference chromosome to another chromosomal location in 
the donor. Structural variations play a very important role in cancer development. 
Translocations were the earliest identified variants in cancer with the identification of 
Philadelphia chromosome (translocation between chromosomes 9 and 22 [t(9;22)]) 
as a hallmark of chronic myeloid leukemia (CML) (Nowell & Hungerford, 1960; 
Rowley, 1973). These gross variants in cancer produce fusion genes as BCR-ABL1, 
between a breakpoint cluster region on chromosome 22 and tyrosine kinase receptor 
gene chromosome 9 that is a recurrent phenomenon in CML and one of the 
diagnostic criteria for this disease. Another commonly occurring fusion gene between 
a transmembrane protease gene (TMPRSS2) and one of two transcription factors 
(ETV1 or ERG) was first reported in 23 of 29 prostate cancers (Tomlins et al., 2005). 
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These commonly occurring fusion genes are fast becoming the hallmark of cancer 
diagnostics with researchers now aiming to define the etiology of this recurrence.  
1.2 Significance of the Problem 
Detecting structural variations in the cancer genome is the first step towards 
extracting disease causing mutations. Current tools using well-examined 
bioinformatics approaches to variant detection are still missing variants in the cancer 
genome. The reasons for this could be due to allele frequency of the mutant genome 
captured in an experiment, due to tumor heterogeneity, mapping algorithm flaws or 
structural variant detection algorithm flaws. In addition, these tools have been 
designed without accounting for the very special case of cancer genome complexity. 
Understanding the biological processes leading to structural variation generation in 
the cancer genome and using this context to define the algorithm for variant 
detection is an overlooked novel approach explored in this study, specifically in the 
study of translocations. 
Chromosomal translocations are the most obvious signature for many cancers and 
serve as a very important biomarker. Cancer genomes have inherent genetic 
instability either due to various micro-environmental factors leading to somatic 
mutations or inherent predisposition in the genome leading to germline mutations. 
Normal cellular machinery has checks to curb such major overhauls using DNA repair 
mechanism. The cancer genome however has circumvented this repair mechanism; 
most evident in the resulting fusion-genes which produce protein products which 
further disrupt the repair infrastructure.  
DNA sequencing technologies aim to identify these variants at a faster rate and with 
more accuracy based on the sheer volume of data exiting the machines. Clinical 
translation of this information helps to design specific drug targets for these specific 
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translocation fusion gene products. Two major hurdles to achieve this purpose, 
namely the presence of the human reference genome and the reducing cost of 
sequencing the patient genome have now been surmounted. Bioinformatics 
challenges to map and align this large amount of data, though not fully conquered, 
have made significant progress. The challenge now facing the scientific community is 
how to make sense of the data by designing better algorithms for detecting variants.  
Every approach available in the literature has used some form of 
statistical/mathematical modeling or computational algorithm to solve this issue of 
detecting structural variants without paying much attention to the biology driving 
these variants. Computational methods to detect structural variants (SV) utilize a 
consistent algorithm (Tuzun et al., 2005) including: 1) creating a distribution of the 
reads length (insert size) to derive a mean and standard deviation (s.d) 2) defining 
SV signatures (e.g. insertion = reads mapping 3 s.d. outside the mean length), and 
3) clustering all reads which support the same SV.  The current study used a 
different approach using biological domain information which is already known and 
well documented in literature to help design a more effective and biologically 
plausible algorithm to detect translocations in the cancer genome.  
1.3 Theoretical basis for the study 
Cancer occurs due to genomic instability that leads to disruption of normal cell 
functions. These mutations and structural alterations can be germline or somatic.  
Genomic mutations in germline cells lead to their transmission to the next generation 
as a cancer susceptibility gene like BRCA1 (P. Kent et al., 1995). Mutations in 
somatic cells can cause cancer due to abnormal proliferation of somatic cells with 
aberrant genomic structure. Identifying these gross structural changes has been 
done traditionally using experimental technique like karyotyping. Karyotyping uses 
stains (Giemsa stains) to color the chromosome during mitosis and studying the 
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banding patterns (G-banding) to define structural abnormalities like duplication of a 
region of chromosome or presence or absence of chromosomes (McNeil, Montagna, 
Difilippantonio, & Ried, 2012). However the primary issue with karyotyping remains 
to be the resolution of the abnormal chromosomal region, which is 5-10 million base 
pairs (Mbps). A successful experiment is also dependent on quality of cell division 
rates in metaphase, which is when these chromosomes are captured (Bridge & 
Cushman-Vokoun, 2011).  
One of the major advances in cytogenetic diagnosis was development of fluorescent 
in-situ hybridization (FISH) techniques and its various offshoots (Volpi & Bridger, 
2008). The principle was based on hybridization of complementary DNA to specific 
fluorescent probes, designed for specific regions on the genome, and viewed through 
special cameras for detecting structural abnormalities (McNeil et al., 2012). These 
technologies have far reaching applications from pre-natal detection of structural 
abnormalities (Hastings, Nisbet, Waters, Spencer, & Chitty, 1999), profiling gene 
expression during meiosis in mammalian cells (Mahadevaiah, Costa, & Turner, 2009) 
to identifying novel fusion genes in leukemias (H. Lee et al., 2013). Further these 
techniques have been seminal in identifying specific recurrent translocations in 
tumors leading to targeted therapy for fusion genes (Buchdunger et al., 1996; 
Druker et al., 1996; Inokuchi, 2006; Lynch et al., 2004; Mathews et al., 2010; Niu et 
al., 1999; Paez et al., 2004). However the resolution of these methods can be about 
1 kbps depending on the size of the probe, the target locus and type of FISH being 
used. A subsequent development, also based on hybridization, known as 
comparative genomic hybridization (CGH) (Kallioniemi et al., 1992) uses tumor and 
normal control samples to compare copy number variation between normal and 
tumor tissue and even detect gene fusions (Przybytkowski, Ferrario, & Basik, 2011). 
These methods have higher resolution of 500 bps to even 50 bps but can be 
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extremely sensitive to the quality of tumor samples and therefore have a high rate of 
errors (Fragouli et al., 2011). These methods are thus dependent on the quality of 
the probes and the genomic distance between the probes on the array.  
Furthermore, they can only detect aberrations that alter copy number; copy-number 
neutral events are missed. 
With the advent of massively parallel high throughput sequencing technologies 
gaining ground due to reduction in cost, mutation definition is getting higher and 
higher resolution with the number of implicated oncogenes growing from 291 in 2004 
(Futreal et al., 2004) to 384 in 2010 (Santarius, Shipley, Brewer, Stratton, & Cooper, 
2010) and the most recent database of cancer mutations, ‘Mitelmans Database of 
Gene Chromosome Aberrations and Gene Fusions in cancer’, a National Cancer 
Institute (NCI) resource showing 2038 gene fusions(Mitelman, Johansson, & 
Mertens, 2014). These next generation sequencing methods have provided 
enormous amount of data and with it daunting bioinformatics challenges. Even with 
obvious computational challenges of analyzing large data, sequencing has identified 
novel causative mutations that were experimentally validated in diseases like mental 
retardation where there was no familial history (Vissers et al., 2010). Similar success 
was also seen in autism which is characterized as a multi spectrum disease. Exome-
sequencing of 928 autistic individuals identified 279 novel coding mutations (Sanders 
et al., 2012), a feat if not unachievable would be highly labor intensive in an 
experimental procedure.  
Sequencing methods currently produce paired-end, short reads (30 -100 base-pairs) 
such that both ends of a sequence segment are read with an intervening region of 
unread sequence in the middle. The two reads are paired such that they have the 
same identifier linking the two reads. Sequencing technologies today have adopted 
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paired end short read sequencing as the preferred method due to the relative low 
cost. The bioinformatics challenge is to map these short sequences correctly to the 
reference human genome and be able to discern variants. The algorithm developed 
for detecting variants was first laid down by Tuzun et al. (Tuzun et al., 2005) as: 
• mapping the subject genome to the reference genome 
• defining signatures for structural variation using the distribution based 
on size of the short reads (inserts) 
• identifying the reads which support the structural variant as described 
by the signature and clustering all reads which support the same 
variant together, and finally 
• removing false positives based on percent identity of the variants read 
with the reference genomes 
Current tools use this basic model for defining structural variation with statistical 
adjustments for calculating sensitivity and specificity, and sometimes expanding the 
signatures for calling structural variants. These work very well in normal genomes 
and reasonably well in cancer genomes. However, cancer genomes are more 
complex as samples represent an admixture of normal and abnormal cells, the latter 
of which may differ genomically. The ability to detect somatic mutations in a given 
sample depends on tissue type, type of mutation (i.e. germline versus somatic), 
amount of intercellular heterogeneity in the tumor, the sequencing technology itself, 
and most importantly the algorithm used to detect variants. The choice of 
sequencing technology/platform also depends on the goal of the study. The 
comparison of sequencing platforms in metagenomic studies revealed that the use of 
short-read generating technology was better due to significantly increased number of 
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reads and therefore greater coverage of genomic regions (Mende et al., 2012). In 
contrast, a comparison of these sequencing technologies for low-coverage 
experiments in clinical setting to detect major copy number changes as part of 
prenatal diagnosis found that increased number of reads produced in one 
technological platform also made it more prone to GC-content bias due to greater 
number of PCR-cycles (S. Chen et al., 2014). After choosing the right platform for 
the study, the next challenge is to determine the appropriate tools to analyze the 
data and call variants. All major bioinformatics development has been open source, 
and tools such as National Center for Biotechnology Information, NCBI’s BLAST 
(Basic Local Alignment Search Tool), University of California Santa Cruz, UCSC’s 
Genome Browser, and Burrow-Wheeler aligner (BWA) have become the de-facto 
standards for alignment and graphical viewing of the genome. However, new variant 
detection algorithms are constantly being designed to address specific problems. For 
example, a study comparing 12 algorithms for quantifying somatic copy number 
variation using whole genome sequencing data (WGS) found that there were 
significant differences in sensitivity and specificity of these algorithms (Alkodsi, 
Louhimo, & Hautaniemi, 2014). Sensitivity depended on the size of the variant being 
detected, while breakpoint detection accuracy was determined by the algorithmic 
approach of the tools. These studies demonstrate the bioinformatics challenges of 
analyzing DNA sequencing data, specifically variant detection. The multitude of data 
being generated by next generation sequencing and the analogous growth in 
bioinformatics tools to deal with this data shows the nascent state of the field in 
terms of standardized methodologies to analyze this data.  
1.4 Variables used in the study 
Taking the computational modeling for detection of SVs first presented by Tuzun et 
al. (Tuzun et al., 2005) further, Lee et al. (S. Lee, Cheran, & Brudno, 2008) 
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proposed a probabilistic method for variant calling and controlling the false discovery 
rates. Many currently popular tools use this methodology with modifications. For 
example, SVDetect (Zeitouni et al., 2010) uses a windowing strategy in the paired 
end library together with the clustering mechanism explained above to define 
variants. BreakDancer (K. Chen et al., 2009) uses a more stringent method for 
defining probabilities and therefore reducing the output of false positives. CREST 
(Wang et al., 2011) on the other hand used another signature called soft clipping1 to 
extract anomalous reads, build contigs2 of soft-clipped reads and subsequently 
define variants based on similar probability calculations discussed above. Thus, all of 
these tools work off the alignments produced by the mapping tool. However, this can 
be a problem when there are multiple mapping regions with similar identity in the 
BWA mapping tool algorithm (Li & Durbin, 2009). During these instances the tool will 
randomly assign the read to any location. This is a characteristic of the human 
genome: there are regions with considerable sequence homology and repeats such 
that the mapping tool fails to align sequences at a unique region on the genome. The 
variant detection tools completely ignore the fact that the alignment reported by the 
mapping tool may be a random position.  
These repeat regions comprise up to 50% of the human genome (Smit, Hubley, & 
Green, 2014) and play a very significant role in development of these structural 
variants due to errors in the DNA repair process (G. McVean, 2010). McVean has 
reviewed these recombination events that lead to mutation and identified hotspots in 
the genome that were more prone to rearrangement breakages. Further, these 
                                           
1 Soft clipping: Paired end read mapped to the reference genome where one end 
mapped globally an d the other mapped partially, may need the unaligned ends of 
the read ‘clipped’ to achieve mapping. The read is labeled as ‘S’ in its CIGAR string 
(Section 4.2.1). 
 
2 Contig: Creating a longer sequence of DNA from overlapping smaller subsequences.  
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regions tended to be closer to promotor regions but not in the transcribed regions 
and were driven by a particular class of repair system called non-allelic homologous 
recombination (G. A. McVean et al., 2004). Non-allelic homologous recombination 
events (NAHR) are the result of errors in DNA repair involving large chromosomal 
regions characterized by low copy repeats and up to 95% sequence identity 
(Stankiewicz & Lupski, 2002), (Colnaghi, Carpenter, Volker, & O'Driscoll, 2011a). 
Thus, there was information within the genome with a specific signature that was 
leading to error prone repair. Further, Ou et al. (Ou et al., 2011) were able to 
specifically prove NAHR as the cause of same unbalanced translocation in four 
unrelated families. The group was also able to map these ‘NAHR’ regions on the 
human genome based on the signature of low copy repeat regions with greater than 
94% sequence identity. They were also able to find validated translocations in the 
database in these predicted rearrangement hotspots.  
Current tools ignore this very relevant information driving these structural variation 
events in the genome. There is a general consensus in the scientific community that 
variant calling tools fail in repetitive regions (non-unique regions) of the genome 
because the mapping algorithms cannot reliably map these regions. This leads to a 
decrease in the signal-to-noise ratio, and thus the number of reads supportive of an 
aberration. While this is true, there is enough information known about these regions 
to account for them algorithmically in a variant detection tool.  
DNA damage is acquired primarily during replication process of the cell. Cells have 
checks and balances to control for errors during repair and a breakdown of these 
repair mechanism leads to non-allelic homologous regions of the genome undergoing 
recombination and going unchecked. A low copy repeat region will share homology to 
many regions on the genome and even share significant identity with these regions. 
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The 3-D structural organization of the genome within the cell, as studied by Hi-C 
experiments showed that regions of chromosome within close proximity to each 
other were more likely to interact compared to regions that were far away 
(Lieberman-Aiden et al., 2009). Another study probing the effect of DNA replication 
timing on generation of copy number variations in the cancer genome also found the 
correlation of spatial organization of the chromosomes within the genome affecting 
the occurrence of mutations at specific locations (De & Michor, 2011). They went 
further with the hypothesis proving that those regions that were closer to each other 
spatially in the cell were also likely to have similar replication timing during cell 
division. 
1.5 Problem Statement 
The purpose of this research was to use the known genomic context driving the 
formation of chromosomal aberrations, both in terms of repeat structure and 3D 
spatial organization, to design a biologically sound computational algorithm to detect 
translocations in the cancer genome. 
1.6 Research Question and Hypothesis 
1. Are the tools able to detect validated structural variants from a known 
dataset? 
2. Will the tools fail in regions of repeats? 
3. Is the ability of the tool to detect variants driven primarily by the presence of 
these variants in high complexity (unique) regions? 
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Research Hypothesis 
1. Tools fail when the variants fall in the repeat regions. Variants in unique regions 
are more likely to be detected by the tools compared to variants in repeat 
regions. 
2. A novel algorithm designed to take into account the genomic context that drives 
the formation of chromosomal alterations (De & Michor, 2011; Lieberman-Aiden 
et al., 2009) as well as the genomic architecture of cancers (regions of the 
genome more susceptible to structural variant formation as seen in recurrent 
cancers) is likely to perform better than current tools that do not include this 
information. 
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2. BACKGROUND 
 
 
2.1 DNA Sequencing 
DNA sequencing is the decoding of genetic information locked in the DNA and is the 
machine translation of the nucleotide sequence that makes up the three billion bases 
of human genetic code. Fred Sanger introduced the chain-termination method for 
base determination (Sanger, Nicklen, & Coulson, 1977) (Figure 2.1 (Estevezj., 
2012)) which gained wide acceptance as the preferred method for sequencing. 
Although another method by Maxam-Gilbert (Maxam & Gilbert, 1977) was introduced 
at the same time and used base-specific chemical degradation, the Sanger method 
became more popular due to its ease of use (Nunnally, 2005).  
DNA sequencing can be broadly divided into four steps (Nunnally, 2005): 
• Reaction 
• Separation 
• Detection 
• Data analysis 
The reaction step is specific to the type of method being used. Broadly, double-
stranded DNA is broken mechanically or chemically into single-stranded DNA, mixed 
with a DNA polymerase3, DNA primer4, the four deoxynucleotide bases (adenine, 
guanine, tyrosine and cytosine) and one dideoxynucleotide (ddNTP) corresponding 
each of the bases that when incorporated during the polymerase reaction stops the 
lengthening of the DNA chain.  Thus, the reaction yields a multiplicity of different 
                                           
3 Polymerase: Enzyme present in the cells, used during DNA replication process for 
synthesizing a new strand of DNA from a copy/template.    
 
4 Primer: Short DNA segment of known sequence which attached to the DNA strand 
at its end 
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sized fragments where the length of the fragment depends on the chance 
incorporation of a ddNTP into the chain.  Each type of radioactively or fluorescently 
labeled ddNTP (ddATP, ddTTP, ddCTP, ddGTP) is aliquotted into a separate reaction, 
and all four reactions are required to generate a sequence.  
The separation step involves separating the DNA fragments obtained from the 
reaction step based on size. Earlier methods used polyacrylamide gel electrophoresis, 
in which the DNA fragments travelled vertically through the gel under a steady 
current for a set period of time.  The distance traveled was dependent on size, with 
smaller fragments migrating more quickly than larger ones.  Thus sequence was read 
from the bottom of the gel up. Currently, this process is done by the capillary based 
system where the sample are run through a very fine capillary and can be read 
simultaneously by the detector as the DNA sample is travelling through the capillary. 
The detection of the separated fragments involves exposing the separated sample to 
X-ray film for radioactive labeling.  Once the film was developed, the sequence of the 
DNA could be read from the bottom up by recording in which lane the smallest 
fragment appeared, followed by the next smallest, and so on.  However, this method 
is not routinely used anymore. It has been replaced by the use of fluorescently 
labeled ddNTPs exposed to laser light that is simultaneously detected by the 
detecting machine. In the analysis step, all the data is compiled into a single 
continuous sequence.  
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Figure 2.1. Sanger DNA sequencing method. This figure explains the steps in modern 
Sanger technology. Adapted from Sanger Sequencing, by Estevezj, Retrieved March 
27, 2009, from http://commons.wikimedia.org/wiki/File:Sanger-sequencing.svg. 
Copyright 2012 by Estevezj. Reprinted under Creative Commons Attribution-Share 
Alike 3.0 Unported license.  
 
The automation of the Sanger-sequencing method led to the human genome project 
with the aim of sequencing the entire human genome and was completed in 2001 
(Venter et al., 2001). The project was completed much earlier than expected using 
the above method together with shotgun assembly. In shotgun assembly process the 
entire genome is broken into random smaller pieces, these pieces are amplified by 
first cloning in bacterial cell (plasmids/bacterial artificial clones) and then through 
PCR5. These amplified PCR products have known fragment sizes (also known as 
insert size). The major contribution of this group was the development of mate-pair 
                                           
5 PCR: Polychromase chain reaction, a procedure to create multiple copies of the 
DNA using DNA polymerase 
  15 
reading methods. Different sized libraries of these inserts were created such that 
multiple clonally amplified fragments of circularized DNA sequences from each library 
are cut into linear pieces and read from both ends, put together to form contigs with 
unread gaps and finally contigs assembled together bioinformatically into scaffolds in 
the analysis step (Istrail et al., 2004). The size of the gap can be estimated with 
reasonable confidence based on the segment length (i.e. insert size) of the DNA 
library. This mate-pair sequencing and assembling method was a major step in the 
direction of high throughput analysis. The completion of the human genome 
assembly was a significant achievement as the scientific community now had the 
entire human genome decoded and publicly available through NCBI.  
Technology for faster sequencing has improved over the years with a corresponding 
decrease in the cost due to the development of these new sequencing methods. 
These newer-generation sequencing technologies are now collectively called next-
generation (next-gen) sequencing. The most commonly used next-gen applications 
include Roche/454, Illumina/Solexa, Life/APG and Helicos BioSciences (Metzker, 
2010). The flow of steps more or less is the same as Sanger sequencing, including 
template preparation, sequencing, viewing and data analysis, with major 
improvements in template preparation and sequencing.  
Template preparation has seen major advances in next generation sequencing 
methods with shift from bacterial artificial chromosomes (BACs) (Monaco & Larin, 
1994) (Shizuya & Kouros-Mehr, 2001) due to inherent problems with BAC 
procedures, including loss of genomic material in the BAC during cell replication and 
introduction of replication errors as human errors during the mapping process. The 
two major types of template preparation in NGS technology are:  
1. Clonally amplified templates 
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2. Single-molecule templates (Metzker, 2010) 
Clonally amplified templates use single stranded DNA molecule with universal primer 
attached to beads (Figure 2.2) 
 
Figure 2.2. Emulsion bead template preparation for next generation sequencing 
technology. Adapted by permission from Macmillan Publishers Ltd, “Sequencing 
technologies - the next generation”, by M.L.Metzker, 2010, Nature reviews.Genetics, 
11, p.33, copyright 2010.  
 
These PCR-amplified beads can then be placed on a glass slide for the NGS sequence 
reading to be performed. 
Solid phase amplification or bridge amplification can also be performed (Figure 2.3), 
where the primers are attached to glass slide and DNA fragments along with 
polymerase are added to the glass slide to produce spatially-separated clones of 
amplified DNA fragments.  
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Figure 2.3. Bridge amplification template preparation for next generation sequencing 
technology. Adapted by permission from Macmillan Publishers Ltd, “Sequencing 
technologies - the next generation”, by M.L.Metzker, 2010, Nature reviews.Genetics, 
11, p.33, copyright 2010.  
 
A single molecule template has a major advantage of not requiring PCR amplification 
and therefore reducing errors. Thus there is no need for clonal amplification in this 
method and it is believed to be more representative of the original sample. This is 
achieved by either attaching primers to the glass slide and adding single-stranded 
DNA molecules to these immobilized primers (Figure 2.4) or attaching the single-
stranded DNA molecules to the glass slide and then adding the primers to these 
immobilized DNA strands (Figure 2.4). A new approach uses the DNA polymerase 
bound to a glass slide and the single-stranded DNA template can be introduced to 
this polymerase and read in real-time (Figure 2.5).  
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Figure 2.4. Single molecule template preparation for next generation sequencing 
technology. Adapted by permission from Macmillan Publishers Ltd, “Sequencing 
technologies - the next generation”, by M.L.Metzker, 2010, Nature reviews.Genetics, 
11, p.33, copyright 2010. 
 
 
 
Figure 2.5. Real-time template preparation for next generation sequencing 
technology. Adapted by permission from Macmillan Publishers Ltd, “Sequencing 
technologies - the next generation”, by M.L.Metzker, 2010, Nature reviews.Genetics, 
11, p.33, copyright 2010. 
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The next step in the process is sequencing the single-stranded DNA and reading it 
using imaging of fluorescence probes attached to the nucleotides. Currently there are 
four methods used for sequencing (Metzker, 2010): 
1. Cyclic reversible termination 
2. Sequencing by ligation 
3. Single-nucleotide addition/ pyrosequencing 
4. Real-time sequencing 
Cyclic reversible termination (Figure 2.6) uses the cyclical process of 
incorporating fluorescent nucleotides, imaging, and termination using ddNTPs. Each 
step of a single nucleotide incorporation, termination, imaging, and washing is 
repeated until the entire template is read. This is most commonly used in clonally 
amplified templates. The method relies on the use of modified ddNTPs with more 
efficient cleavage of the fluorescent labels compared to Sanger sequencing.  
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Figure 2.6. Cyclic reversible termination method in next generation sequencing 
technology. Adapted by permission from Macmillan Publishers Ltd, “Sequencing 
technologies - the next generation”, by M.L.Metzker, 2010, Nature reviews.Genetics, 
11, p.36, copyright 2010. 
 
Sequencing by ligation uses DNA ligase6 to attach to a fluorescent dye-labeled 
probe, washing extra probes away and read by imaging in a cyclical way (Figure 
2.7). Pyrosequencing uses sulphurylase and luciferase to detect bioluminescence 
(Figure 2.7) instead of fluorescently labeled nucleotides. Real-time sequencing is the 
                                           
6 Ligase: cellular enzyme which catalyzes the formation of bonds between two DNA 
strands. 
  21 
most advanced of these technologies not requiring any terminators to stop the 
process of sequencing. DNA polymerases are attached to the glass slides and 
therefore sequencing can be performed without the need to terminate and the 
release of fluorescence from the nucleotide read in real-time by imaging.  
 
Figure 2.7. Sequencing by ligation and pyrosequencing method in next generation 
sequencing technology. Adapted by permission from Macmillan Publishers Ltd, 
“Sequencing technologies - the next generation”, by M.L.Metzker, 2010, Nature 
reviews.Genetics, 11, p.36, copyright 2010. 
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Technological advances will continue to improve these NGS technologies with the 
purpose of reducing sequencing errors. One of the first challenges of parallel 
sequencing was developing efficient algorithms for fast and accurate mapping of this 
data to the reference genome. Big data however brought with itself bioinformatics 
analysis challenges, the first being mapping the target genome to the reference. 
2.2 Mapping Algorithms 
The earliest efforts in algorithm development for mapping was done for discovering 
sequence homology that examines the relatedness of two sequences (protein-coding 
DNA sequences) in different species in order to understand its function (Pevsner, 
2009). Understanding homology was important to define relatedness of proteins 
through evolution and define changes that occurred through speciation. The same 
principles were applied to DNA sequence mapping. Reads to be compared are placed 
along the x-axis and y-axis and scored +1 for each match, -2 for each mismatch and 
gap. This method was first developed by Needleman and Wunsch and is known as 
the Needleman-Wunsch algorithm (Needleman & Wunsch, 1970). At the heart of this 
algorithm is dynamic programming (Eddy, 2004) which starts with laying out the 
matrix, deciding on scoring method and finally recursively finding the best path with 
the best optimal score. This algorithm is dynamic because it finds the best optimal 
score and keeps it in memory in order to avoid recalculation of scores that happens 
in a recursive process (Figure 2.8).  
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Figure 2.8. Dynamic programming matrix. Reprinted by permission from Macmillan 
Publishers Ltd, “What is dynamic programming”, by S.R.Eddy, 2004, Nature 
biotechnology, 22, p.909, copyright 2004. 
 
The Needleman-Wunsch algorithm was used for global alignment and when adapted 
to local alignment as done by Smith-Waterman algorithm (Smith, Waterman, & 
Fitch, 1981), proved even more useful in finding DNA sequences of local identity 
(Pevsner, 2009). The Smith-Waterman method uses one more row (m+1) and 
column (n+1) for two sequences of length m and n and each subsequent score in the 
matrix is incremented from the value in the preceding diagonal cell, with a match 
getting a score of +1, -0.3 for a mismatch, and -1.3 for a gap. The Smith-Waterman 
algorithm does not allow for any negative scores. The highest score in the matrix 
signifies the end of alignment. This method allows for getting local alignments from a 
long sequence instead of global alignment of Needleman-Wunsch that is 
computationally intensive due to its recursive calculations. Local alignment is often 
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used for quick database searches and serves as the foundation for most population 
database search mapping tools like BLAST and BLAT.  
 
2.3 Structural Variant Detection Tools 
 
Tuzun et al. were the first to describe a computational framework for structural 
variant (SV) detection (Tuzun et al., 2005). The most gain in information while 
defining SVs comes from alignment of paired end reads i.e. single fragment of DNA 
read from both ends with an unread segment in between. The length of the original 
fragment is known and can further be empirically determined based on the insert 
size distribution of the experiment. Their approach is still the basic framework for SV 
detection and is as follows: 1) define probability distribution of insert sizes (length of 
fragment of DNA sequenced), 2) define discordant reads as those which lie at least 
2-4 standard deviations outside this distribution, 3) cluster all reads that support the 
same SV such that at least 2 discordant reads identify the same SV, 4) identify the 
SV at the location using percent identity of the discordant reads and number of 
supporting reads. 
Lee et al. proposed a more robust probabilistic method for SV detection (S. Lee et 
al., 2008).  The key methodology proposed was: 
1. Defining a probabilistic framework: All reads generated (paired end reads: 
short fragments of DNA sequenced from both sides with an area of un-
sequenced portion in between) are assumed to be independent of each other. 
The set of same type of structural variants is represented by C. Using the 
independence assumption  each mapped read A and B which are part of the 
same cluster and therefore explaining the same SV will have a joined 
probability of belonging to the same cluster C defined as P(A,B|C)=P(A|C). 
P(B|C). The mean insert size length s is known from library generation for 
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sequencing experiment and also can be derived computationally from 
experiment output. The probability distribution gives the standard deviation of 
insert size. The signature for insertions and deletions is as follows: a length of 
r represents the length of insertion or deletion and s represents the correct 
mapping length of the insert in the reference. Therefore an insertion event is 
s+r and deletion event is s-r. Using this signature we define the probability of 
read A and read B being in the insert size distribution of s+r (or s-r) paired-
end reads by using a maximizing function of the joint probability of A and B 
belonging to the same variant cluster. It thus calculated the probability that a 
read is produced from the genome sequenced. Similarly, in defining the 
signature for inversion and translocation we determine the joint probability of 
observing the 2 mate pairs in the same cluster. The higher this probability the 
more likely a read belongs to the cluster.  
 
2. Defining the SV: The structural variant is defined using three features 
i. Percent similarity of the mate pair sequence to the reference 
ii. Product of the probabilities calculated above for a cluster. The 
larger the probability of a cluster the more it is reliable. 
iii. Number of mate pairs in a cluster 
Each SV can map to various clusters and therefore using the above three features we 
need to find the configuration which maximizes each of the features mentioned 
above. Using this configuration we can assign each SV to just a single cluster. 
The primary challenge of the probabilistic model is that the distributions are based 
on insert sizes and are dependent on intrinsic information output by the mapping 
tool. If the mapping tool does not know where to place the read, the read can be 
either disregarded or placed randomly based on all possible best matches. Lee et al. 
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assigned confidence scores (p-values) to insertion/deletion signatures, but this could 
not be done to inversions and translocations. If there were systematic errors in 
sequencing or in alignment algorithms, these will not be picked up using the 
probability calculation for inversions and translocations and will therefore be ignored. 
However with the current NGS platforms these errors have been considerably 
reduced due to higher coverage. Current tools built up on this method with 
SVDetect, BreakDancer and CREST discussed below. 
The BreakDancerMax (K. Chen et al., 2009) algorithm uses the distance and 
alignment of paired end reads along with the distribution of reads which map to a 
certain location on the reference to define a SV. Using the SV signature, the program 
then searches for regions on the reference genome which anchor more SV’s than 
expected.  These regions form the putative breakpoints. For a particular region, 
whichever is the ‘dominant’ SV signature is used to identify the SV at the location i.e. 
clustering of all SV’s for a particular location and choosing the SV. Further, it uses a 
confidence score to assign the probability of observing a SV at the location which is 
higher than chance using a chi-squared statistic with the cutoff p-value <0.0001. 
This tool assumes a Poisson distribution for the clustered variants. Using an 
analytical model for detecting true positive SV rate in a simulated dataset, they 
estimated that with an average insert size of 200 bps, insertions and deletions 
shorter than 40 bps would be difficult to detect.  
BreakDancerMini tries to overcome the dependence on the insert size by using a 
sliding window test. The algorithm defines a window for the reference that is the 
mean of the insert library of a confidently mapped region+3 s.d - 2(average length 
of read). Using this window, the frame is shifted 1 bp at a time and the probability 
that the read lies in this window is calculated. Once again this method works well for 
insertions and deletions. BreakDancer Max and Mini together did a better job at indel 
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detection (experimentally validated 110 of 167 indels called by BreakDancer) and to 
some extent inversions (validated 4 of 13 inversions) but did not do so well with 
intra-chromosomal events (validated 2 of 6 intra-chromosomal translocations). This 
is primarily because it uses only paired end data where both read ends map within a 
defined distance. If only one end of the pair maps then this read is not considered. 
Translocations will show this pattern where one end of a paired end read mapped to 
one chromosome and the other end mapped on another chromosome. This 
information may be lost in the alignment process as the aligner aligned just one end 
of the read and information on the paired end is lost. Therefore, this tool is most 
likely to miss this inter-chromosomal event. Thus BreakDancer performs well with 
indels but does not have a very strong method for detecting translocations. 
SVDetect (Zeitouni et al., 2010) on the other hand uses a simplified strategy for 
clustering which is non-probabilistic. Clusters are formed from paired end reads 
which had incorrect distance (2-3 s.d.) and/or orientation from the reference 
genome. SVDetect then divides the reference genome into overlapping windows of 
fixed size and groups all the paired end reads which map to the same overlapping 
reference. SVDetect also uses clustering parameters like minimum number of reads 
supporting a SV, filtering those reads whose orientation is different from the majority 
in a cluster. The filtering process is user defined and the thresholds for filtering can 
be changed. 
Another important feature added to SVDetect is the ability to predict copy number 
variations/duplication events. The algorithm does this by finding the ratio of depth of 
coverage of sample to a control dataset in a sliding window along the genome, 
though they do not define the length of the window.  However, the detection of 
duplications needs a control dataset that has not been well defined in the paper. 
Thus SVDetect is able to identify insertions, deletions, inter-chromosomal events, 
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duplications and translocations using a clustering pattern and filtering process. 
However, SVDetect will also miss reads which were the alignment tool failed to 
assign a read unambiguously.  
CREST (Wang et al., 2011), unlike other applications, does not use the concept of 
discordant paired reads. Instead it uses direct mapping of reads to the reference to 
identify the breakpoints. The Burrow Wheeler alignment tool soft clips reads during 
alignment, i.e. when there is partial alignment or when one end of the pair aligns 
perfectly and the other end is partially aligned the tool clips the sequence at the 
point of partial alignment. CREST collects all these soft clipped reads together, 
creates longer contigs of these reads using an assembly algorithm (CAP3) and 
realigns these contigs using BLAT (BLAST Like Alignment Tool) alignment algorithm. 
Thus, the identification of first soft clipped region defines the first breakpoint at 
location 1. All the soft clipped reads are collected and assembled into contigs using 
CAP3 algorithm and aligned using BLAT. Wherever these soft clipped contigs map to 
the genome is the second breakpoint, which will have soft clipped regions mapping 
to location 1. CREST requires the second contig generated from soft clipped regions 
at location 1 to be within a certain distance (user-defined) of the second location.  
The final call of variants includes only those reads with >97% sequence similarity 
and a BLAT score >30 and defines the probability of observing at least c soft clipped 
reads with sequence coverage C (at that location) to be less than or equal to 0.05  
The signatures defined by CREST use the same basic signature of all the SVs but do 
not use the mapping distance of 2-3 s.d. It uses direct alignment information and 
therefore is able to identify the SVs at breakpoint coordinate level. In experiments 
comparing the platform it performed better than BreakDancer in detecting insertions, 
deletions, and inversions. CREST is more apt for inter-chromosomal event detection 
and therefore performs better in translocation events seen in cancer genomes. 
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However due to the alignment heavy algorithm, it performs badly in regions of 
repeats as the tool will perform only as good as the assembly/alignment tool.  
All of the above methods use the mapping tool output as the input and derive 
possible anomalous reads based on either the insert size distribution or flags set by 
the mapping tool. Thus the ability of the tools to detect variants depends entirely on 
the robustness of the alignment.  In regions where the aligner cannot reliably map 
sequence, such as repetitive regions, it is assumed that the ability of the tools to 
detect variants is compromised.  This study aimed to test this theory and to design a 
more effective approach to variant detection by utilizing the known biology driving 
variant formation, focusing specifically on translocations.  
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3. TESTING CONTEXT: REPEAT STRUCTURE OF GENOME 
3.1 Overview 
The overall approach for this study was three pronged: first, test the currently 
available tools against an experimentally validated dataset; second, develop an 
algorithm for translocation detection based on known biological information; and 
finally test our algorithm against the known tools. The first step was essentially to 
identify and define the reason why tools would fail to detect experimentally validated 
variants. Our hypothesis was that the tools would fail to recognize variants that were 
in genomic regions of repeat due to low complexity of these regions and therefore 
the inability of the aligner to map these regions uniquely. Thus stated differently, 
variants in repeat regions were less likely to be detected by the tool compared to 
variants in unique regions.  
  
 
 
3.2 Testing Current Tools 
The first step for proof of concept was to test the available structural variant 
detection tool on an experimentally validated dataset. The 1000-Genomes project 
was designed to use extensive sequencing of many individuals around the world with 
different ethnicities in order to characterize all types of variants found in these 
individuals and to relate it to the phenotype (1000 genomes project). This project is 
a major international collaboration between universities around the world providing 
samples, sequencing data, and bioinformatics analysis in order to map the entire 
spectrum of genetic variation in the human population. The data has been made 
Test current tools to 
understand “context” of 
the structural variants 
failing to be detected 
by the tools 
Develop novel 
algorithm based on 
this “context” 
Test the novel 
algorithm against 
known tools for 
sensitivity 
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publicly available on the website (www.1000genomes.org) (1000 Genomes Project 
Consortium, Abecasis, Altshuler, Auton, Brooks, Durbin, Gibbs, Hurles, & McVean, 
2010b). The project had low-coverage whole genome  sequencing, exome 
sequencing, and high-coverage sequencing of trio-subjects (mother-father-child) 
from different ethnic populations around the world. For purpose of testing we used 
deep sequencing data of the trio subject from Nigeria (YRI: NA19238, NA19239, 
NA19240).  
3.2.1 FASTQ file format 
Most sequencing machine output the data in a widely accepted format known as the 
Sanger-FASTQ (Cock, Fields, Goto, Heuer, & Rice, 2010). This is a text file with 
information about the sequence read and quality score of each base of the sequence 
read. Each read starts with a ‘@’ followed by the identifier and description of the 
sequence which may be platform specific. The next line is a string of ‘ATCGs’, which 
is the actual read from the sequencing machine. The next line is a + sign which may 
be followed by a repeat of the sequence identifier and description line. The last line 
represents quality scores for each of the bases in the read sequence (Figure 3.1).  
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Figure 3.1. Sanger FASTQ format. Reprinted by permission from Oxford University 
Press, “The Sanger FASTQ file format for sequences with quality scores, and the 
Solexa/Illumina FASTQ variants”, by P.J.Cock et al., 2010, Nucleic Acids Research, 
38, p.1769, copyright 2010. 
 
 
The last line equates quality values for each base read by the sequencing machine. 
This is a PHRED-based quality score converted to ASCII characters. PHRED was a 
computation tool developed by Ewing et al. (Ewing & Green, 1998; Ewing, Hillier, 
Wendl, & Green, 1998) to automatically assign quality values to sequencing trace 
files such as chromatograms that are generated by the sequencing machines. This is 
defined in the equation below. 
q = -10 X log10 (p) ----------( Ewing et al.) 
q= quality score of the base 
p=estimated error probability for the base 
 
According to this formula, a base having a 1/1000  probability of being erroneous will 
have a quality score q of 30. The lower the probability score, the higher the quality.  
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3.2.2 1000-Genomes data analysis 
The files obtained from 1000-Genomes website were in FASTQ format. This study 
used Yoruba subject data (YRI: NA19238, NA19239, NA19240). The FASTQ files 
were downloaded from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/pilot_data/data/. 
Datasets for each subject had sequencing files of various insert sizes. To maintain 
consistency we only used deep sequencing high coverage paired end library of insert 
size 260. Briefly, experiment ID-SRX001106 with 8 billion reads was used for 
NA19238, experiment ID-SRX000654 with 7.4 billion reads was used for NA19239 
and experiment ID-SRX001102 with 6.1 billion reads was used for NA19240. 
Appendix A lists the files used for this analysis. 
Sequencing reads from these files listed in Appendix A Table 1.1 were aligned to the 
reference genome NCBI build 36.1/ UCSC hg18. The reference human genome is 
assembled and maintained by the Genome Reference Consortium (GRC) 
(http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/human/) which 
includes NCBI, Wellcome Trust, Sanger Institute, Genome Institute at Washington 
University and European Bioinformatics Institute (EBI) at NCBI. The complete 
genome and chromosome level FASTA files are stored at UCSC website which can be 
downloaded at (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/chromosomes). 
The GRC, which is an extension of the Human Genome project 
(http://www.genome.gov/10001772), produces overlapping segments of high 
quality, longer length DNA sequence from a group of volunteers. Using in-house 
tools they release a comprehensive and rigorous representative of a consensus 
normal human reference genome for use in the public domain. The builds are 
constantly getting updated as more data becomes available on previously un-
sequenced regions of the human genome or improved on currently sequences 
regions.  
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Data for these various builds are stored in the FASTA format, which is a text file with 
a header line starting with ‘>’ containing information about the sequence followed on 
the next line by the longest continuous available sequence data as shown in Figure 
3.2. Standard codes to represent amino acid sequences and nucleotides are used 
and can also have lower case letters representing the same nucleotide/amino acid. 
 
 
Figure 3.2. FASTA format example. First line starts with “>” followed by information 
about the sequence and next line contains actual sequence  
 
 
Fastq files for the same insert size and same library were downloaded from the ftp 
site7 for each of the trio subjects; NA19238, NA19239, NA19240. These were aligned 
to the reference genome UCSC hg18 using a popular tool for short read alignment, 
BWA-0.5.9 (Li & Durbin, 2009).8 Briefly, BWA uses the Burrow-Wheeler 
transformation algorithm to compresses the data such that repetitive information is 
stored in a compressed format in prefix and suffix arrays in order to perform 
searches on the entire human genome. The output of the mapping tool is in SAM 
format described in Section 4.2.1. SAM is then converted to BAM, which is the binary 
representation of a SAM file using ‘samtools’ suite.9  
The output from BWA mapping was used to further detect structural variants using 
an open-source toolkit. SVDetect (Zeitouni et al., 2010) is one such toolkit which 
uses paired-end mapping data to identify reads which occur at a distance greater 
than expected insert size and/or are in the incorrect orientation with respect to each 
                                           
7 1000 genomes data download:ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/data/ 
8 BWA sourceforge page: http://bio-bwa.sourceforge.net/bwa.shtml 
9 SAMTools sourceforge page: http://samtools.sourceforge.net/ 
 
>gi|12345|ref|NM_12345.01|Homo sapiens XYZ 
ATTTCGATTAATCGAGAAAAAAAATATTTTAGGGGGCCATTTATATACCCCCCCC
TACACCCACAC 
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other. It then breaks the genome to create overlapping windows. Each anomalous 
paired-end read can anchor to these windows such that the two windows where the 
two paired-end reads map form a link. A filtering process removes links that has less 
than a certain number of reads supporting a link and other features defined in the 
tool. Structural variants are called based on mapping signatures for a particular type 
of variant. This tool has a tendency to output many false positives as it only uses a 
clustering method to call variants. Thus, any variant with 2 or more reads supporting 
it is called as a variant without using the underlying variants distribution to calculate 
confidence scores of calling a variant as done in BreakDancer. We therefore used this 
tool which reports all possible variants in order to test our hypothesis that tools fail 
to detect variants because these variants lie in the repeat regions.  
Experimentally validated structural variants detected in the same trio subjects were 
used as the validation standard. The variant dataset was downloaded from the ftp 
site.10 
Variants were detected computationally using various algorithms developed in-house 
by 1000-Genomes team (1000 Genomes Project Consortium, Abecasis, Altshuler, 
Auton, Brooks, Durbin, Gibbs, Hurles, & McVean, 2010a). The variants were defined 
as mobile element insertions, tandem duplication, deletions, and novel sequences. 
We extracted only those variants from the variant files that were experimentally 
validated as indicated in the Description field of the file.  
 
                                           
10 1000-Genomes structural variation data page: 
ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/pilot_data/paper_data_sets/a_map_of_hu
man_variation/trio/sv/ 
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3.2.3 SVDetect Analysis 
SVDetect defines its set of variants as described in the Table 3.1. 
Table 3.1: SVDetect defined structural variants 
NORMAL_SENSE  Correct ends orientation using <mates_orientation> as reference 
REVERSE_SENSE  One of the ends has an incorrect orientation 
DELETION  Deletion (NORMAL_SENSE & mean insert size > µ+threshold*σ) 
INSERTION  Insertion (NORMAL_SENSE & mean insert size < µ-threshold*σ) 
INVERSION  Inversion (REVERSE_SENSE) 
INV_FRAGMT  Inversion of a genomic fragment, defined by balanced signatures 
(BAL) 
INS_FRAGMT  Insertion of a genomic fragment, defined by balanced signatures 
(BAL) 
INV_INS_FRAGMT  Inverted INS_FRAGMT (BAL) 
LARGE_DUPLI  Large duplication 
DUPLICATION  Duplication, medium size 
SMALL_DUPLI  Small duplication (mean insert size < µ-threshold*σ & overlap 
between subgroups) 
INV_DUPLI  Inverted duplication (REVERSE_SENSE & mean insert size < µ-
threshold*σ & UNBAL) 
TRANSLOC  Translocation 
INV_TRANSLOC  Inverted translocation 
COAMPLICON  Co-amplicons, two different fragments repeated in the same 
strand sense (BAL) 
INV_COAMPLICON  Inverted co-amplicons, two different fragments repeated in the 
opposite strand sense (BAL) 
SINGLETON  Singleton (mean insert size < µ-threshold*σ), for Illumina mate-
pairs only 
UNDEFINED  Undefined inter/intra-chromosomal SV type 
 
The purpose of this analysis was to see if the variants detected by SVDetect had 
some overlap in the same genomic region as those in the 1000-Genomes 
experimentally-validated variant dataset. To further characterize these variants, we 
looked for overlap of the variants with mapped repeat structure in the human 
genome (Smit et al., 2014)11. We used the RepeatMasker mapped repeat regions on 
the hg18 build human genome to identify the repeat regions in the human genome. 
The repeat elements in RepeatMasker database have been classified as LINEs: Long 
                                           
11 RepeatMasker webpage: http://www.repeatmasker.org 
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interspersed nuclear elements; SINEs: Short interspersed nuclear elements; LTR: 
Long terminal repeats; DNA repeats and other.  
3.3 Extracting Overlapping Regions 
SVDetect-0.7f was used on the mapped BAM files to detect variants. Each variant file 
from 1000-Genomes classified as ‘Deletion’, ‘Novel Sequences’, ‘Mobile Element 
Insertion’ and ‘Tandem Duplications’ was used separately to extract overlapping 
variants detected by SVDetect. 1000-Genomes variant files did not have subject 
identifier in file and thus had structural variants detected in all three trio subjects 
combined. SVDetect was run on each BAM file separately and then combined. We 
were only looking for regions of the genome that showed an overlap irrespective of 
the type of variant as defined in SVDetect. Overlap was defined as at least 10 
percent of the insert size. In this case the insert size library chosen for download was 
260 and therefore 10 percent overlap was at least 26 basepairs on either side of the 
read as represented in the Figure 3.3. Ten percent of insert size was used as an 
arbitrary cutoff. 
    
Figure 3.3: Overlap definition for SVDetect; a: left overlap; b: right overlap; c: 
SVDetect variant completely within; d: 1000-genome variant completely within  
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A perl script was used to do the overlap extraction. Similarly, since the purpose was 
to define the context of the genomic region that is causing the tools to fail, 
RepeatMasker mapped repeat regions was used to do a similar overlap of with 1000-
genome variants. However in order to identify the overlapping regions with repeat 
structure within, the entire repeat region had to be present within the variant as 
shown in Figure 1.1. 
 
Figure 3.4: Overlap definition for repeat; Blue arrows: 1000 genomes, Black arrows: 
repeat elements in RepeatMasker.   
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3.3.1 Results: SVDetect performance  
The result from extraction analysis showed that SVDetect did poorly in detecting 
insertion elements (17%) while it did very well in identifying validated novel 
sequences high in detection percent (67%) (Table 3.2).  
Table 3.2: Overlap results for SVDetect 
Type of Event 1000-
Genomes 
events 
Events detected by 
SV-Detect: True 
Positive 
Events not detected 
by SV-Detect: False 
Negative 
Deletion 9695 4657 (48%) 5038 
Mobile Element 
Insertion 
492 85 (17%) 407 
Tandem 
Duplication 
65 23 (35%) 42 
Novel 
Sequences 
66 42 (67%) 24 
 
SVDetect is known to give many false positives and thus is a highly sensitive tool for 
detection of structural variants. However, even with such a highly sensitive tool, less 
than 50% of the variants detected by SVDetect were in the same region as deletions 
events identified by 1000-Genomes. SVDetect was in the true variants regions 
anywhere from 17 to 67 percent of the time depending on the type of variant. Even 
a highly sensitive tool was clearly not able to detect many of the validated variants.  
3.3.2 Understanding context: Repeat 
We therefore tried to understand if the underlying repeat structure within these 
variants was driving the ability of the tool to detect a variant. If a variant is in a 
repeat region, the mapping tool will not be able to definitively place the read 
representing the variant in a specific region due to low complexity of the repeat 
region. We hypothesized that validated variants that were not detected by the tool 
were more likely to have repeat elements within them than variants that were 
detected by the tool. As shown in Figure 3.4, we extracted those reads that had the 
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repeat element completely contained within the variants or variant completely 
contained within the repeat. The results are shown in Table 3.3, 3.4.  
Table 3.3: Repeat elements within undetected events 
Type of Event 1000-
Genomes 
events 
Events not detected by 
SV-Detect: False-
Negatives (a) 
Events with repeat 
structure within (b) 
(a/b%) 
Deletion 9695 5038 2678 (53%) 
Mobile Element 
Insertion 
492 407 134 (33%) 
Tandem 
Duplication 
65 42 11 (26%) 
Novel 
Sequences 
66 24 13 (54%) 
 
Table 3.4: Repeat elements within detected events 
Type of Event 1000-
Genomes 
events 
Events detected by 
SV-Detect: True-
Positives(a) 
Events with any repeat 
structure within (b) 
(a/b%) 
Deletion 9695 4657 3754 (81%) 
Mobile Element 
Insertion 
492 85  36 (42%) 
Tandem 
Duplication 
65 23  13 (57%) 
Novel Sequences 66 42  26 (62%) 
 
Although 53% of deletion events that were not detected by the tool showed some 
form of repeat structure, 81% of deletion events which were detected also showed a 
repeat structure. A similar pattern was seen with all other variant types where the 
events which were detected by the tool had a greater percent of repeat elements 
compared with those which were not detected by the tool. A chi-squared analysis 
(Tables 3.5, 3.6, 3.7, 3.8) showed a significant association between repeat structure 
and the ability of the tool to detect the variant for deletions and tandem duplication 
events but not significant for novel sequences and mobile element insertion events 
at p<0.05 level. Thus if there was a repeat structure within the variant, the tool was 
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more likely to detect it, which was contrary to our hypothesis. We therefore failed to 
reject the null of no association between repeat structure and ability of the tool to 
detect the variant.  
Table 3.5: Chi-squared test: Relation of deletion events with repeat 
Deletion Events Repeat structure 
within 
No Repeat structure 
within 
Total 
Detected by tool (True 
positives) 
3754 903 4657 
Not detected by tool (False 
Negatives) 
2678 2360 5038 
Note: Table tests if ability of the tool to detect deletion events is influenced by the 
repeat structure within it. The Chi-square statistic is 816.873 with p-value of 0. This 
result is significant at p < 0.05. 
Table 3.6: Chi-squared test: Relation of insertion events with repeat 
Insertion Events Repeat structure 
within 
No Repeat structure 
within 
Total 
Detected by tool (True 
positives) 
36 49 85 
Not detected by tool (False 
Negatives) 
134 273 407 
Note: Table tests if ability of the tool to detect insertion events is influenced by the 
repeat structure within it The Chi-square statistic is 2.764 with p-value of p=0.096. 
This result is not significant at p<0.05.  
Table 3.7: Chi-squared test: Relation of duplication events with repeat 
Duplication Events Repeat structure 
within 
No Repeat structure 
within 
Total 
Detected by tool (True 
positives) 
13 10 23 
Not detected by tool (False 
Negatives) 
11 31 42 
Note: Table tests if ability of the tool to detect duplication events is influenced by the 
repeat structure within it The Chi-square statistic is 5.871 with p-value of 0.015. This 
result is significant at p<0.05.  
Table 3.8: Chi-squared test: Relation of novel sequences events with repeat 
Novel Sequence Events Repeat structure 
within 
No Repeat structure 
within 
Total 
Detected by tool (True 
positives) 
26 16 42 
Not detected by tool (False 
Negatives) 
13 11 24 
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Note: Table tests if ability of the tool to detect novel sequences events is influenced 
by the repeat structure within it The Chi-square statistic is 0.378 with p-value of 
0.538. This result is not significant at p<0.05.  
Since defining genomic context was the goal of the analysis, we further broke down 
the detected and undetected events by type of repeat structure as classified by 
RepeatMasker. Note, however, that the same variants can have more than one type 
of repeat structure. This breakdown also showed similar results. While LINEs and 
SINEs were more abundant of the repeat structure, undetected events (false-
negatives) showed a lower percentage of these events than detected events (true-
positives) (Tables 3.9, 3.10, 3.11, 3.12). 
Table 3.9: Repeats structure by type: Deletion  
1000 
genome 
events 
DNA_repeats  LINEs SINEs LTR Other 
Yes No Yes No Yes No yes No Yes No 
Un-
detected 
(5038) 
245 
(5%) 
4793 825 
(16%) 
4213 1096 
(22%) 
3942 423 
(8%) 
4615 1113 
(22%) 
3925 
Detected 
(4657) 
1560 
(34%) 
3097 2480 
(53%) 
2177 2710 
(58%) 
1947 1954 
(42%) 
2703 2549 
(55%) 
2108 
Note: LINEs: Long interspersed nuclear elements; SINEs: Short interspersed nuclear 
elements; LTR: Long terminal repeats; Undetected: False negative events; Detected: 
True positive events (1000-Genomes event) 
 
Table 3.10: Repeats structure by type: Mobile element insertion 
1000 
genome 
events 
DNA_repeats  LINEs SINEs LTR Other 
Yes No Yes No Yes No yes No Yes No 
Undetected 
(407) 
11 
(3%) 
396 69 
(17%) 
338 20 
(5%) 
387 24 
(6%) 
383 31 
(8%) 
376 
Detected 
(85) 
12 
(14%) 
73 15 
(18%) 
70 18 
(21%) 
67 12 
(14%) 
73 14 
(16%) 
71 
Note: LINEs: Long interspersed nuclear elements; SINEs: Short interspersed nuclear 
elements; LTR: Long terminal repeats; Undetected: False negative events; Detected: 
True positive events (1000-Genomes event) 
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Table 3.11: Repeats structure by type: Tandem duplication 
1000 
genome 
events 
DNA_repeats  LINES SINES LTR Other 
Yes No Yes No Yes No yes No Yes No 
Undetected 
(24) 
1 
(4%) 
23 3 
(13%) 
21 6 
(25%) 
18 2 
(8%) 
22 5 
(21%) 
19 
Detected 
(42) 
3 
(7%) 
39 7 
(17%) 
35 9 
(21%) 
33 4 
(10%) 
38 13 
(31%) 
29 
Note: LINEs: Long interspersed nuclear elements; SINEs: Short interspersed nuclear 
elements; LTR: Long terminal repeats; Undetected: False negative events; Detected: 
True positive events (1000-Genomes event) 
 
Table 3.12: Repeats structure by type: Novel sequences 
1000 
genome 
events 
DNA_repeats  LINES SINES LTR Other 
Yes No Yes No Yes No yes No Yes No 
Undetected 
(42) 
1 
(2%) 
41 5 
(12%) 
37 2 
(5%) 
40 3 
(7%) 
39 1 
(2%) 
41 
Detected 
(23) 
6 
(26%) 
17 10 
(43%) 
13 8 
(34%) 
15 9 
(39%) 
14 9 
(39%) 
14 
Note: LINEs: Long interspersed nuclear elements; SINEs: Short interspersed nuclear 
elements; LTR: Long terminal repeats; Undetected: False negative events; Detected: 
True positive events (1000-Genomes event) 
Since presence of repeat elements was not driving the ability of the tool to detect 
variants, we decided that we had to be even more specific in defining the “context” 
of these variants. Repeat element in general, (including every type of repeat) within 
or around these variants was not the “context” causing these variants to go 
undetected.   
Our goal was to design a tool to detect translocations, and thus the design step 
started from defining the context for translocations occurring in the genome i.e. 
understand how translocations occur in the genome (Bunting & Nussenzweig, 2013) 
and build the context using this information. When we looked at the overlap between 
the NAHR regions and the genomic location of the variants missed by SVDetect, we 
observed a pileup in the regions where the tools failed to detect variants and the 
NAHR regions (Figure 3.5).  Thus, we used NAHR as one part of the biological 
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context for the novel algorithm. However, there are multiple substrates for NAHR in 
the human genome. The likelihood of any two regions of NAHR taking part in 
exchange of genomic material (translocation) depends in part on the probability of 
these regions being in close proximity in 3-dimensional space. Therefore, the second 
part of our biological context was to incorporate information about the distribution of 
the genome in 3-dimensional space as derived from Hi-C data.  
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Figure 3.5: NAHR overlap with 1000-Genomes variants. Pile-up of false negative 
deletion ebents (middle grey bar plot) shows concordant spike with pile-up of NAHR 
(non-allelic homologous recombination) regions (inner red bar plot). Outermost grey 
and red dot plot shows count of number of LINE elements (long interspersed nuclear 
elements) in 1Kbps windows. 
  
NAHR  
LINES repeat 
distribution  
False Negative 
variants  
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4. ALGORITHM DESIGN AND DEVELOPMENT 
4.1 A Context Definition for Translocations 
The purpose of defining “context” for detecting translocation in the genome was to 
effectively use information on mechanism of translocation formation in designing the 
tool. Earlier held belief that cancer occurs due to random genomic events is being 
proven ineffective due to studies which show non-random patterns to breakage sites, 
also called ‘hotspots’ (Jeffreys, Kauppi, & Neumann, 2001). Recombination event is a 
process by the cellular machinery to create diversity through evolution. These events 
occur through double stranded breaks and the aberrant repair of these breakpoints 
leads to structural variations. However these breakpoint regions have specific 
signatures of low copy number variations which share significant homology 
(Colnaghi, Carpenter, Volker, & O'Driscoll, 2011b). The breakpoint acting as 
substrates for anomalous repair (non-allelic homologous recombination, NAHR) lead 
to translocations and cause phenotypic changes (Deininger & Batzer, 1999), (Ou et 
al., 2011), (Gu, Zhang, & Lupski, 2008). Using this information for the purpose of 
designing a structural variant has not been done so far by any of the current tools. 
There is sufficient evidence to define these regions bioinformatically (Ou et al., 2011) 
and thus be able to use the signature of NAHR programmatically in tool design which 
was attempted in this study. The novelty of this approach is the use of inherent 
biologically processes driving these variants formation and is the first such attempt 
to program this information in a tool. This study tried to capture 3-D packing of the 
genome within a cell bioinformatically, thus taking the concept of “context” one step 
further.  Translocations occurring from double-stranded breaks also do not occur 
randomly. Chromosomes which are more close to each other and with similar 
replication timings are more likely to interact and exchange genomic material 
through NAHR (Yaffe & Tanay, 2011), (De & Michor, 2011), (Wijchers, 2011). 
Instead of using empirical distribution of reads and variants in the data to derive 
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confidence score, this study attempted to use probability distribution of two regions 
in the genome interacting due to physical proximity. This study has thus introduced 
the concept of context-based evaluation of structural variation in the human genome 
as a novel approach.  
4.2 Designing the Algorithm 
The algorithm for the tool is shown in Figure 4.1. Broadly the tool could be divided 
into 3 major steps:  
1. Extraction of anomalous reads from the bam file 
2. Re-alignment using BLAT 
3. Identifying potential translocations and defining probabilities using Hi-C data 
Figure 4.1: Novel algorithm flowchart  
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4.2.1 Read extraction overview  
Sequence Alignment Format: There are many tools available for mapping reads to 
the reference genome like BWA, Bowtie, MAQ. These tools give the output in a 
common format known as SAM format (Sequence Alignment/Map Format), which 
had been widely accepted as the default format for generating output files. Briefly 
the alignment output has a header section and an alignment section. All headers 
start with @ (eg. @HD) and contain general information about the experimental 
process used to generate the sequencing reads. Alignment sections contain 11 
mandatory fields as listed in Table 4.1.  
Table 4.1: SAM format fields: alignment section 
Field  Type  Regexp/Range  Brief description 
QNAME String [!-?A-~]{1,255}  Query template NAME 
FLAG Int [0,216 -1] bitwise FLAG 
RNAME String \*|[!-()+-<>-~][!-~]* Reference sequence NAME 
POS Int [0,229-1] 1-based leftmost mapping POSition 
MAPQ Int [0,28-1] MAPping Quality 
CIGAR String \*|([0-
9]+[MIDNSHPX=])+ 
CIGAR string 
RNEXT String \*|=|[!-()+-<>-~][!-
~]* 
Ref. name of the mate/next read 
PNEXT Int [0,229-1] Position of the mate/next read 
TLEN Int [-229+1,229-1] observed Template LENgth 
SEQ String \*|[A-Za-z=.]+ segment SEQuence 
QUAL String [!-~]+ ASCII of Phred-scaled base 
QUALity+33 
The purpose of the extraction algorithm is to retrieve reads which were assigned by 
the aligner as improperly mapped. This information is coded in the bitwise ‘FLAG’ 
field of the SAM file as shown in Table 4.2.  
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Table 4.2: Bitwise FLAG of SAM file 
Bit Description 
0x1 template having multiple segments in sequencing 
0x2 each segment properly aligned according to the aligner 
0x4 segment unmapped 
0x8 next segment in the template unmapped 
0x10 SEQ being reverse complemented 
0x20 SEQ of the next segment in the template being reversed 
0x40 the first segment in the template 
0x80 the last segment in the template 
0x100 secondary alignment 
0x200 not passing quality controls 
0x400 PCR or optical duplicate 
0x800 supplementary alignment 
 
The above table is represented in the hexadecimal system. The corresponding binary 
and decimal conversion is shown in Table 4.3.  
Table 4.3: Bitwise Flag of SAM FLAG- binary to decimal conversion 
Bit Binary Decimal 
0x1 1 1 
0x2 10 2 
0x4 100 4 
0x8 1000 8 
0x10 100000 16 
0x20 1000000 32 
0x40 10000000 64 
0x80 100000000 128 
0x100 1000000000 256 
0x200 10000000000 512 
0x400 100000000000 1024 
0x800 1000000000000 2048 
 
The value for each bit is set to 0 or 1 based on the description, with 0 being no and 1 
being yes. Thus if a sequencing segment which has been mapped has a value of 64, 
it is the first segment in the template (Table 4.1, Table 4.2). Each mapped segment 
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will have a value as represented in the decimal system in the SAM file. Thus a value 
of 99 equals 64+32+2+1. The corresponding natural language interpretation based 
on the tables 4.1 and 4.2 will be as below: 
FLAG Bit Description 
64  0x40 the first segment in the template 
32 0x20 SEQ of the next segment in the template 
being reversed 
2 0x2 each segment properly aligned according to 
the aligner 
1 0x1 template having multiple segments in 
sequencing 
Thus the read with a SAM flag of 99 meant it mapped correctly. The conversion of 
SAM flag values to the corresponding interpretation can be done using one of the 
utilities of PICARD tool suite.12  
CIGAR String: The sixth field in a SAM file is represented by the ‘CIGAR’ string. Just 
as ‘FLAG’ is used to describe the overall information of sequence read in terms of 
mapping to the reference genome, ‘CIGAR’ string explains similar information in 
terms of mapping at the base-pair level. Thus each base in a sequence read will have 
any one of the CIGAR values listed in Table 4.4. 
Table 4.4: CIGAR String 
Operation BAM  Description 
M 0 alignment match (can be a sequence match or 
mismatch) 
I 1 insertion to the reference 
D 2 deletion from the reference 
N 3 skipped region from the reference 
S 4 soft clipping (clipped sequences present in SEQ) 
H 5 hard clipping (clipped sequences NOT present in 
SEQ) 
P 6 padding (silent deletion from padded reference) 
= 7 sequence match 
X 8 sequence mismatch 
                                           
12 PICARD tool webpage: http://picard.sourceforge.net/index.shtml, 
http://picard.sourceforge.net/explain-flags.html 
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An example of a sequence read mapped to the reference genome can be represented 
as: 
Reference Genome Sequence:  A T T T G C A T C C C G     T A T T G G C A  
Query Read Sequence:               A T T T G C   T C C C G A T A T T G G C A 
CIGAR String: 6M1D5M1I5M 6 Match, 1 Deletion, 5 Match, 1 Insertion, 8 Match 
Reference Genome Sequence: A T T T G C A T C C C  G T A T T G G C A  
Query Read Sequence:              A T T T    C A T C C C G T A g g g g g 
CIGAR String: 4M1D9M5S 4 Match, 1 Deletion, 9 Match, 5 Soft clipped 
The CIGAR string informs about how many insertions and deletions of base pairs is 
needed to be done in the query sequence for the mapping tool to align the read to a 
given location on the reference genome.  
FLAGs for read extraction: All mapping tools will give the output in SAM format with 
a FLAG assigned. The purpose of read extraction is to identify those reads that did 
not have enough information contained in the sequence for the mapping tool to align 
it at the correct location. This information is extracted using the FLAG field and 
‘CIGAR’ string explained in Section 4.2.1. The FLAG fields used for extraction are 
shown in Table 4.5. 
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Table 4.5: FLAGs for read extraction 
Flag Fields set to derive 
Flag 
Description of fields for Flag 
UNMAPPED READS 
101 64+32+4+1 first in pair, mate reverse strand, read 
unmapped, read paired 
89 64+16+8+1 first in pair,  read reverse strand, mate 
unmapped, read paired 
117 64+32+16+4+1 first in pair, mate reverse strand, read 
reverse strand, read unmapped, read 
paired 
121 64+32+16+8+1 first in pair, mate reverse strand,  read 
reverse strand, mate unmapped, read 
paired 
165 128+32+4+1 second in pair, mate reverse strand, read 
unmapped, read paired  
153 128+16+8+1 second in pair, read reverse strand, mate 
unmapped, read paired 
185 128+32+16+4+1 second in pair, mate reverse strand, read 
reverse strand, read unmapped, read 
paired 
181 128+32+16+8+1 second in pair, mate reverse strand,  read 
reverse strand, mate unmapped, read 
paired 
69 64+4+1 first in pair, read unmapped, read paired 
73 64+8+1 first in pair, mate unmapped, read paired 
133 128+4+1 second in pair, read unmapped, read 
paired 
137 128+8+1 second in pair, mate unmapped, read 
paired 
77 64+8+4+1 first in pair, mate unmapped, read 
unmapped, read paired 
141 128+8+4+1 second in pair, mate unmapped, read 
unmapped, read paired 
 
READS WITH NO INFORMATION ON MAPPING 
65 64+1 first in pair, read paired 
129 128+1 second in pair, read paired 
81 64+16+1 first in pair, read reverse strand, read paired 
97 64+32+1 first in pair, mate reverse strand, read 
paired 
145 128+16+1 second in pair,  read reverse strand, read 
paired 
161 128+32+1 second in pair, mate reverse strand, read 
paired 
113 64+32+16+1 first in pair, mate reverse strand,  read 
reverse strand, read paired  
177 128+32+16+1 second in pair, mate reverse strand,  read 
reverse strand, read paired 
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Flag Fields set to derive 
Flag 
Description of fields for Flag 
READS WITH IMPROPER ORIENTATION 
115 64+32+16+2+1 first in pair, mate reverse strand,  read 
reverse strand, read mapped in proper pair, 
read paired 
179 128+32+16+2+1 second in pair, mate reverse strand,  read 
reverse strand, read mapped in proper pair, 
read paired 
67 64+2+1 first in pair, read mapped in proper pair, 
read paired 
131 128+2+1 second in pair, read mapped in proper pair, 
read paired 
 
4.2.2 Read extraction algorithm 
Perl script algorithm to extract the reads using the ‘Flag’ field and ‘CIGAR’ string was 
used as described in Table 4.6. 
Table 4.6: Read_Extract Algorithm 
Assumption: The input file has to be in BAM/SAM 
format. 
Creating FASTA 
file from BAM 
output of mapping 
tool 
Input Arguments for file name; 
 if (file is in SAM/BAM format) 
      { Create output files, both FASTA and SAM;} 
  Else 
    {output error to screen} 
Matchlist array=(List of FLAGs) 
Creates input 
argument array 
and array of 
FLAGs to be used, 
output files with 
.fa and .sam 
extension 
While {  
           Read each line of SAM/BAM file; 
           Split into fields based on delimiter; 
           Set fields 0: Read Identifier 
                          1: FLAG 
                          5: CIGAR 
                          8: TLEN 
                          9: SEQUENCE as variables;             
 
Variables identified 
for read extraction  
   If (readcounter==1) 
             {Calculate 30% of read length 
                Create pattern for longest continuous  
                 ‘N’s which equals 30% of read length 
                Increment readcounter} 
 
Creates ‘NNNN’ 
pattern which is 
30% of read 
length to search 
for in SEQUENCE; 
pattern created 
just once 
   If (currentReadIdentifier==previousReadIdentifier Matches FLAG 
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       AND 
        (currentReadIdentifier OR  previousReadIdentifier 
          == matchlist array)) 
      {  if (‘N’ pattern not found) 
         {print to output FASTA file with <RID1>/ 
           <RID2> as suffix to identify two reads of a pair  
           and also entire line to SAM file} 
      } 
} END OF WHILE LOOP 
 
Close all files 
 
array and extracts 
only those reads 
where both reads 
of a pair are 
present and did 
not have more 
than 30% ‘N’s. It 
further adds 
identifier <RID1>, 
<RID2> to keep 
paired end reads 
information 
 
The output from the extraction process is saved in both FASTA and SAM format. The 
FASTA file serves as the input for BLAT mapping tool. Both reads of a pair now have 
a unique identifier (RID1, RID2) which is an important addition in this step. 
4.3 Re-alignment Using BLAT 
4.3.1 The need for BLAT 
BLAT which stands for BLAST-like alignment tool was developed in 2001 by James 
Kent at University of California, Santa Cruz. The popular alignment tool BLAST 
(Altschul, Gish, Miller, Myers, & Lipman, 1990) developed by the NCBI uses the 
Smith-Waterman algorithm (Smith et al., 1981) to do local alignment of a defined 
length. The extension is done such that further extension of the segment will not 
improve the score.  
BLAT (Kent, 2002) was used primarily because of its speed and comparable output 
to BLAST. For example a sample output from the simulated data of translocations 
had FLAGs set as 117 and 153 such that the first read was unmapped and the 
second read mapped to a region with 100% match (Figure 4.2). The output from 
BLAST and BLAT are shown in Figures 1 and 2. BLAT is very similar to BLAST in 
terms of its search algorithm but differs in the fact that BLAST builds an index of the 
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query to search through its database, while BLAT used the database to build its index 
and search through the query which significantly affects search time. 
Figure 4.2: Sample paired-end read of simulated dataset: SAM format 
BLAST output for the first segment of the pair (with FLAG=117) showed a match 
with 56 regions in the ‘Human plus Transcript’ database and MegaBLAST algorithm 
(Figure 4.3). The corresponding mate segment of the pair (with FLAG=153) showed 
match with 200 regions in the same database and same algorithm (Figures 4.4). 
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Figure 4.3. MegaBLAST output with defaults for query sequence pair1 
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Figure 4.4: MegaBLAST output with defaults for query sequence pair2 
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For the same two query sequences, BLAT output is represented below (Figures 4.5, 
4.6).  
 
Figure 4.5: BLAT output with defaults for query sequence pair1 
 
Figure 4.6: BLAT output with defaults for query sequence pair2 
The BLAT output was comparable with BLAST and took less time even with a web 
interface. BLAT had 200+ entries for each query pair and showed significant identity 
with chromosome 12 for sequence pair 1 (Figure 1 and 2) and chromosome 4 for 
sequence pair 2. More importantly, BLAST did not show any output if the option for 
filtering in repeat regions was turned on. BLAT does not have such an option and 
gives all possible hits.  
4.3.2 BLAT alignment method used in tool 
We used the FASTA output from the read extraction as the input for BLAT tool. BLAT 
can be run as server-client interface where the user creates a server (gfServer) that 
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keeps the genome index in memory while the client (gfClient) is used to input query 
sequences that are sent to the gfServer. The server-client program has also been 
combined into a single standalone program such that the database and query are 
sent as arguments to the program. Instructions on setting up the client and options 
used by BLAT are provided in Appendix B. A perl script was written that allows the 
user to set up the server-client interface in a single step. A pre-requisite for this was 
that the 2-bit file for the genome needs to be made using a BLAT-faToTwoBit 
program. This program converts a FASTA file into “.2bit” format that is then used by 
gfServer to create the reference genome index file. In order to speed up the process, 
the reference genome was split by chromosome, and the query was run against each 
database in parallel.  
We used BLAT-version 35.1 to run the queries with minimum tile match of 4 and 
minimum identity of 95%. These queries were run in parallel, one for each 
chromosome. Output from BLAT is presented in the psl format (Appendix B, BLAT 
specification) which has the fields as defined in Table 1.1. The output from each 
chromosome mapping was finally merged together and sorted by ‘Identifier’ (field 
10), ‘Chromosome’ (field 14) and ‘Start position’ (field 16) to get the sorted psl 
output file. 
  
  
  60 
Table 4.7: BLAT output file format: psl 
Field 
# 
Field Names 
(Type) 
Description 
1 Matches 
(int unsigned) 
 Number of bases that match that aren't repeats 
2 Mismatches 
(int unsigned) 
 Number of bases that don't match 
3 repMatches 
(int unsigned) 
 Number of bases that match but are part of repeats 
4 nCount  
(int unsigned) 
 Number of 'N' bases 
5 qNumInsert  
(int unsigned) 
 Number of inserts in query 
6 qBaseInsert  
(int unsigned ) 
 Number of bases inserted in query 
7 tNumInsert  
(int unsigned) 
 Number of inserts in target 
8 tBaseInsert  
(int unsigned) 
 Number of bases inserted in target 
9 Strand 
(char(2)) 
 + or - for query strand  optionally followed by + or – 
for target strand 
10 qName  
(varchar(255)) 
 Query sequence name 
11 qSize  
(int unsigned) 
 Query sequence size 
12 qStart  
(int unsigned) 
 Alignment start position in query 
13 qEnd  
(int unsigned) 
 Alignment end position in query 
14 tName 
(varchar(255)) 
 Target sequence name 
15 tSize  
(int unsigned) 
 Target sequence size 
16 tStart 
(int unsigned) 
 Alignment start position in target 
17 tEnd 
(int unsigned) 
 Alignment end position in target 
18 blockCount  
(int unsigned) 
 Number of blocks in alignment. A block contains no 
gaps. 
19 blockSizes  
(longblob) 
 Size of each block in a comma separated list 
20 qStarts  
(longblob) 
 Start of each block in query in a comma separated list 
21 tStarts  
(longblob) 
 Start of each block in target in a comma separated 
list 
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4.4 De-Duplication Algorithm  
The de-duplication algorithm essentially checks for rows with the same ‘Identifier’ 
and ‘Chromosome’ and bins it into buckets of 1000 basepairs windows. The output 
for this algorithm produces an SML file, an in-house defined format (Table 4.8).  
Table 4.8: De-Duplication Algorithm 
Assumption: The input file is in psl format which has 
been sorted by ‘Read identifier’, ‘Chromosome’ and 
‘Start Position’ 
Creating sml file 
from psl file 
Input Arguments for file name; 
 if (file is in sorted psl format) 
      { Create output file with sml extension;} 
  Else 
    {output error to screen} 
 
Creates output file 
with .sml 
extension 
While {  
           Read each line of psl file; 
           Split into fields based on delimiter; 
           Set fields 9:Identifier 
                         13:Chromosome 
                         15:Start position 
                         16:End position 
                         17:BlockCount as variables; 
      Define variables current-range and previous- 
      range using GetRange() function return value 
 
Sets variables and 
defines new 
variables current-
range and 
previous-range 
If (Prev Identifier not equal Curr Identifier) 
    {Insert Read(to output file)} 
Else  
  if (Prev Chr not equal Curr Chr) 
    {if (BlockSize==1) 
       {Insert Read(to output file)} 
     Else  
       if (current-range not equals previous-range) 
         {if (BlockSize==1) 
           {Insert Read(to output file)} 
          } 
     } 
} END OF WHILE LOOP 
 
Close all files 
 
Bins data in 1000 
basepair regions. 
If identifiers and 
chromosomes are 
same, compress 
the rows into 1000 
basepair bins, 
finally filtered on 
BlockSize; de-
duplication of rows 
Sub GetRange{ 
  rangeSpan=1000; 
  midpoint=(StartPosition+EndPosition)/2 
  if (midpoint < rangeSpan) 
 { 
GetRange function 
defines the 1000 
base-pair blocks 
into which the 
consecutive rows 
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  grange = 1; 
 } 
 else 
 { 
     grange = int(midpoint/rangespan) + 1; 
 } 
 return grange ; 
} 
 
with same 
identifier and 
chromosome are 
compressed i.e. 
de-duplicated. 
Mid-point of length 
of mapping region 
is used to check 
for range span. 
The return value 
of the function is 
the offset for 
each bin starting 
from 1 for 1-1000 
bp bin 
Sub InsertRead{ 
 print ‘Identifier’, ‘Chromosome’, ‘Start position’, 
 ‘Start position’, ‘current-range’ 
} 
Output format for 
the sml file 
defined 
 
Table 4.9: Example sml file from de-duplication algorithm 
Identifier Chromo some 
Start  
Position 
End  
Position 
Offset  
for 
Range 
4_103112562_103113055 
_5:1:0_2:0:0_dedbba<RID>1 4 950 1010 1 
4_14019666_14020194 
_6:0:0_1:0:0_17f93b6<RID>1 8 999 1010 2 
4_4086095_4086615 
_3:0:0_2:0:0_a6acbd<RID>1 4 4086515 4086615 4087 
4_4086106_4086642 
_3:0:0_2:0:0_5cdfa1<RID>1 4 4086105 4086205 4087 
4_4086106_4086642 
_3:0:0_2:0:0_5cdfa1<RID>2 4 4086542 4086642 4087 
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4.5 Create_Matrix Algorithm  
The SML file created from de-duplication algorithm serves as input file for matrix 
creation. The SML file essentially contains all the possible mapping locations for the 
queries in PSL file on the reference genome based on BLAT mapping algorithm in 
1000 base pair windows.  
The Create_Matrix algorithm creates all possible combinations of the read pair (RID1 
and RID2), such that each row in output file is the location where readpair1 maps 
and the corresponding location where readpair2 maps on the human genome. The 
algorithm is defined in Table 4.10. The Create_Matrix algorithm essentially defines 
how to capture the NAHR regions and can be represented in the Figure 4.7a, 4.7b. 
Output is a MAT file with an example in Table 4.11.  
Table 4.10: Create_Matrix Algorithm 
Assumption: The input file is in sml format and is 
sorted by ‘Read Identifier’ and ‘Chromosome’ 
Creating mat file from 
sml file 
Input Arguments for file name; 
 if (file is in sorted sml format) 
      { Create output files with mat extension;} 
  Else 
    {output error to screen} 
 
Creates output files 
with .mat extension 
While {  
           Read each line of psl file; 
           Split into fields based on delimiter; 
           Set fields 1:Identifier 
                         2:Chromosome 
                         3:Start position 
                         4:End position 
                         5:Range offset; 
       
Sets variables 
  If (previous Identifier==current Identifier) 
    {Insert Read(to output file)} 
    Else 
     { Create_Matrix() 
        Insert Read() 
      } 
 If first line of file 
   {Insert Read(to output file} 
} END OF WHILE LOOP 
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Close all files 
Do UNIX sort on Read1,Read2, Range Offset1, 
Range Offset2 
 
Sub Create_Matrix{ 
 Foreach read1 
  { 
    Foreach read2 
    { 
     If (Chromosome and Range offset is same) 
        {do not print} 
     Else 
         {  
            If (swapFunction==False) 
            {print to outfile read1, read2} 
             Else 
             {print to outfile read2, read1} 
          } 
    } 
  } 
For (read1) 
 { 
  For ( next read1) 
   { 
    If (Chromosome and Range offset is same) 
        {do not print} 
     Else 
         {  
            If (swapFunction==False) 
            {print to outfile read1, next read1} 
             Else 
             {print to outfile nextread1, read1} 
          } 
 
    } 
  } 
} 
 
For (read2) 
 { 
  For ( next read2) 
   { 
    If (Chromosome and Range offset is same) 
        {do not print} 
     Else 
         {  
            If (swapFunction==False) 
            {print to outfile read2, next read2} 
             Else 
             {print to outfile nextread2, read2} 
          } 
    } 
Matrix is created based 
on conditions; if both 
read pairs map to the 
same region we do not 
print the output as 
these do not suggest a 
translocation. Else if 
read1 and read2 go on 
different locations then 
print to outfile. 
 
 
 
 
 
 
Second condition 
checks for read1 going 
to different locations 
i.e. the same read 
mapping to different 
locations and creating a 
matrix of these 
combinations. Printing 
of values is such that 
Chromosome field1 is 
always less than 
Chromosome field2 and 
Chromosome X is 
always less than 
Chromosome Y 
 
 
 
Third condition checks 
for read2 going to 
different locations i.e. 
the same read mapping 
to different locations 
and creating a matrix of 
these combinations. 
Printing of values is 
such that Chromosome 
field1 is always less 
than Chromosome 
field2 and Chromosome 
X is always less than 
Chromosome Y. 
  65 
  } 
} 
 
Sub InsertRead { 
 If (Identifier==Read1) 
 { write array for Read1;Chromosome and Offset}
  
If (Identifier==Read2) 
 { write array for Read2;Chromosome and Offset} 
} 
Creates array for read1 
and read 2 and pushes 
each read into the 
respective array based 
on Identifier 
Sub SwapFunction{ 
  Set default SwapFunction return-value==No; 
   Create arg1: Chromosome read1 
              arg2: Chromosome read2 
              arg3: Offset read1 
              arg4: Offset read2 
 If (Chromosome read1 ==Y and Chromosome  
            read2==X ) 
   { swap return value==Yes} 
Else 
 If (Chromosomes read1 and 2 are integers and  
      Chromosome read1>Chromosome read2) 
   { swap return value==Yes } 
 Return swap return-value; 
} 
This function returns a 
value of “Yes” if 
Chromosome on field1 
is greater than 
Chromosome in field2. 
Y is greater than X as 
defined.  
 
Table 4.11: Example ‘mat’ file from create_matrix algorithm 
Chromosome1 Offset1 Chromosome2 Offset2 
1 1001 4 2021 
1 1004 4 5036 
1 2385 8 6236 
1 5321 8 8288 
4 4087 8 6974 
4 4087 8 6974 
4 4087 8 6974 
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Figure 4.7a: Create_Matrix Algorithm: Matrix creation with all possible combinations 
of read1 and read2 excluding reads where both go to same chromosome. 
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Figure 4.7b: Create_Matrix Algorithm: Swapping reads such that lower number 
chromosome is always on the left which makes the counting process efficient.  
Non-allelic homologous recombination regions are defined by their sequence identity 
(>95%) with different regions of the genome and greater than 5kb in size such that 
these form substrates for anomalous pairing during repair. BLAT identifies all 
possible regions such that read-pair1 maps to one region and read-pair2 maps to 
another region which will therefore identify potential NAHR regions. The 
Create_Matrix algorithm, in creating the matrix, identifies potential NAHR pairs and 
therefore potential translocation breakpoints. Further support is added if read1 also 
maps to both locations on different chromosomes identified as potential breakpoint 
regions (e.g. Read1 mapping to chromosome 4 and chromosome 8) suggesting that 
these regions could be homologous and share significant identity. The purpose of 
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swapping the reads is to sort the reads for easier counting. This finally gives the 
number of reads supporting a translocation identified by the matrix.   
4.6 Write_Count Algorithm  
Output from matrix creation is a sorted MAT file and is the input for the write_count 
algorithm. The output for the write_count algorithm is a CHR file as shown in 
example Table 4.12. 
Table 4.12: Write_count Algorithm 
Assumption: The input file is in mat format and is 
sorted by field1, field3, field2 and field4 in that 
order, i.e. Chromosome1, Chromosome2, Offset1, 
Offset2 
Creating chr file from 
mat file 
Input Arguments for file name; 
 if (file is in sorted .mat format) 
      { Create output files with .chr extension;} 
  Else 
    {output error to screen} 
 
Creates output files 
with .chr extension 
While  (Read each line of mat file) 
  { 
    If (previous record==current record) 
      {Count=1; Increment count} 
    Else 
      {WriteCount(to output file)} 
  } END OF WHILE LOOP 
 
Close all files 
                  
Counts number of 
records which are same 
Sub WriteCount{ 
  Print each unique row with count; 
} 
Creates ‘.chr’ output file 
format 
 
Table 4.13: Example ‘chr’ file from write_count algorithm 
Chromosome1 Offset1 Chromosome2 Offset2 Count 
1 1001 4 2021 1 
1 1004 4 5036 1 
1 2385 8 6236 1 
1 5321 8 8288 1 
4 4087 8 6974 3 
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4.7 Get_HiC-Score Algorithm  
The last step in the process was to define the probability of calling a translocation as 
not false. We did not used distribution of insert size within the dataset to define this 
probability as is done by other variant calling programs (SVDetect, BreakDancer, 
PEMer). The cancer genome is highly heterogeneous with various clonal populations 
showing different types of variation signatures. Even with a 30X coverage of 
sequencing experiment, the likelihood of picking a variant in the heterogeneous 
cancer sample cannot be defined based on the distribution of reads in the current 
sample. We therefore wanted to capture as many variants as we could define using 
our algorithm and assign the probability based on an informative prior. This was 
determined using Hi-C experiments (Lieberman-Aiden et al., 2009) which takes into 
account the three dimensional positioning of the genomes within a cell and defines 
the probability of two regions of the genome interacting based on their physical 
proximity to each other, as determined experimentally. For the purpose of this 
analysis we used the database created by Lieberman-Aiden’s groups at 
BROAD/MIT.13 The datasets contain Pearson’s correlation coefficient for each 
combination of chromosome in one million base-pair (1Mbps) windows. This is the 
highest level of resolution for these experiments, and we had our variants defined in 
1000 basepair windows. We had to accept this as a limitation of the study.   
 
 
 
 
                                           
13 Hi-C database webpage: http://hic.umassmed.edu/welcome/welcome.php 
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Table 4.14: Get_HiC-Score Algorithm 
Assumption: The input file is in chr format and is 
sorted by field1(chr1), field3(chr2), field2(Offset1) 
and field4(Offset2) in that order 
Creating FASTA file 
from BAM output of 
mapping tool 
Input Arguments for file name, path to Hi-C file; 
 if (file is in sorted .chr format) 
      { Create output files with .score extension;} 
  Else 
    {output error to screen} 
 
Creates output files 
with .score extension 
While  (Read each line of chr file) 
  { 
    Split into fields based on delimiter; 
    Set fields 1: Chromosome1 
                 2: Offset1 
                 3: Chromosome2 
                 4: Offset2 
                 5: Chromosome Count 
                 6: Current Hi-C filename  
Create Hi-C filename by dynamically setting  
values of chromosome1 and chromosome2 on Hi-C 
filename template 
 
If (current Hi-C filename not equals previous Hi-C 
filename) 
    { 
     Open Hi-C file () 
    } 
row-midrange= CalcMidPosition(offset1) 
column-midrange=CalcMidPosition(offset2) 
rowposition=GetFilePosition(row-midrange); 
colposition=GetFilePosition(column-midrange); 
score = GetHi-CScore() 
CalcRange(Offset1,Offset2) 
If (score>0) 
  { 
   Print to outfile chr1,start1,end1,chr2,start2,end2 
    numberOfReads, scorefrom Hi-C 
  } 
} END OF WHILE LOOP 
 
Close all files 
 
Open each Hi-C file only 
once and calculate 
midrange of row and 
column offsets. Use 
these offsets to get the 
exact column and row 
position in Hi-C file, 
open Hi-C file and 
extract the score for x-
row and y-cloumn. 
Only Hi-C scores with 
Pearson’s probability 
correlation greater than 
zero printed to output 
Sub Open Hi-C file{ 
 Concatenates Hi-C filepath variable to dynamically 
created current Hi-C filename and open 
corresponding file. 
Puts entire file into @filearray; 
} 
 
Opens Hi-C file bases 
on chromosome1 and 
chromosome2 values 
and their offsets. Puts 
the entire file into file 
array which is scanned 
in the GetHi-CScore 
function for getting 
score. 
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Each Hi-C file is opened 
only once since ‘chr’ file 
is sorted by 
chromosomes and 
therefore all 
corresponding Hi-C 
scores for each 
combination of row and 
column offset values 
can be obtained in one 
open file function call. 
  
Sub CalcMidPosition { 
  chrspan=1000; 
end = (column_offset * $chrspan)-1; 
   start = end - (chrspan-1); 
   cpos = (end+start)/2; 
return cpos; 
} 
Calcuate mid position of 
Offset. Offsets are in 
the range of 1000 
basepairs. Start and 
end values for offsets 
are calculated and a 
midpoint for the offset 
is obtained and 
returned as function 
value. 
 
Sub GetFilePosition { 
   readpos=Offset midpoint of chr1/chr2 
   colspan =1000000;   #hi-c file span by million 
 pos = 0; 
 if (readpos < colspan) 
 { 
  pos = 1; 
 } 
 else 
 { 
  pos = (readpos/colspan) + 1; 
   
 } 
 return pos ; 
} 
Hi-C files are in 1million 
basepair range. Get 
corresponding Hi-C file 
positions based on 
Offset midpoints 
(CalcMidPosition 
function) and return the 
corresponding 
row/column position for 
Hi-C file  
Sub GetHi-CScore { 
  @cline= Split @filearray on rowpos ; 
   Score=cline[colpo]; 
   Return score; 
} 
Scans the @filearray 
(the entire Hi-C file for 
a chromosome row-
column combination) to 
get the exact row and 
column position for Hi-
C score and return 
score 
Sub CalcRange 
{ 
 chrspan = 1000;   
 r1end = (r1col * chrspan)-1; 
 r1start = (r1end-(chrspan-1); 
 r2end = (r2col * chrspan)-1; 
Calculates start and 
end positions of offset1 
and offset2 
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 r2start = r2end-(chrspan-1); 
 
} 
The output from this program is as represented in Table 4.15 that is presented as 
the final output to the user. Further, the algorithm filtered out any Hi-C scores below 
zero and only reported translocations with positive Hi-C probability scores.  
Table 4.15: Example ‘score’ file from get_HiC-score algorithm 
Chromo 
some1 
Start End Chromo 
some2 
Start End No. 
of 
reads 
Hi-C 
Score 
chrX 0 999 chrX 1000 1999 2 1 
chrX 4000 4999 chrX 9000 9999 3 1 
chr1 5170000 5170999 chrX 4620000 4620999 2 0.050044 
chr1 5193000 5193999 chrX 17311000 17311999 2 0.018999 
chr1 5236000 5236999 chrX 2850000 2850999 8 0.061457 
chr1 16000 16999 chr20 45680000 45680999 3 0.089301 
chr1 23000 23999 chr20 63000 63999 2 0.359193 
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4.8 Proof of Concept  
BLAT provides various input options to the user that can change the output 
significantly based on the user requirements. In our case, since we were looking for 
regions which share 95% sequence identity and can therefore give more than one 
significant hit, we wanted to keep the minIdentity option as 95%. As a proof of 
concept we created a single translocation in chromosomes 4 and 8 
(t4;8)(p16.3;p23.1) with breakpoint of chromosome 4 at chr4: 4086365 and on 
chromosome 8 at chr8: 6973436 (Figure 4.8).  
Figure 4.8: Translocation (4;8); derivative chromosomes created using (Hiller, 
Bradtke, Balz, & Rieder, 2005).  
The simulation data had derivative chromosomes 4 and 8 as well as normal 
chromosome 4 and 8. This was created using the perl script provided by Dr Hayes for 
inserting manufactured translocations in the normal human genome. This mini 
FASTA file containing normal chromosome 4 and 8 and the derivative chromosome 4 
and 8 was mapped to reference genome hg19 (UCSC) using BWA-0.5.9. The BAM file 
from this alignment was used as input for extraction of anomalous reads (Section 
4.1). Since this simulated data only had chromosomes 4 and 8, the database file for 
Chr4 
Chr8 
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BLAT was also only created for chromosome 4 and 8. BLAT was run on FASTA output 
file obtained from the extraction algorithm applied to the BWA-alignment BAM file. 
There were 2,441,572 anomalous reads identified from the extraction step. We used 
two BLAT parameters, minMatch and minIdentity to test for BLAT output. These are 
defined in the BLAT manual (Appendix B) as below: 
-tileSize=N sets the size of match that triggers an alignment, usually between 8 and 
12. Default is 11 for DNA and 5 for protein. 
-minMatch=N Sets the number of tile matches. Usually set from 2 to 4.  Default 
is 2 for nucleotide, 1 for protein. 
-minIdentity=N Sets minimum sequence identity (in percent).Default is 90 for 
nucleotide searches, 25 for protein or translated protein searches. 
We kept the default tile size of 11 for this analysis and adjusted the other two 
parameters. The output from BLAT is summarized in Table 4.16.  
Table 4.16: BLAT parameter adjustment results 
Parameter Number of 
alignments 
Number of 
translocation 
reported 
Number of 
reads 
supporting 
Defaults: 
minIdentity=90 
minMatch=2 
15111989 339887 3 
minIdentity=95 
minMatch=2 
7482820 141527 2 
minIdentity=99 
minMatch=2 
1073276 8733 0 
minIdentity=95 
minMatch=4 
6620511 118282 0 
minIdentity=99 
minMatch=4 
934711 8166 0 
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Testing the algorithm with a simulated single translocation (t(4;8)) dataset showed 
that adjusting BLAT parameters to 95% identity and minimum tile match of two, 
captured the positive translocations while reducing false positive by almost a third 
(Table 4.16). Therefore these BLAT options were used in the final simulated dataset 
analysis. When tightening the alignment option to report 99% identity many false 
positives are reduced though at the cost of true positives. Since the aim was to 
detect these events which are most likely to be missed by BWA alignment tool and 
since 95% identity is the criteria for a non-allelic homologous recombination 
substrate, we used this option at the cost of reporting many false positives.   
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5. SIMULATED DATA ANALYSIS 
5.1 Creating Simulated Dataset 
The idea for creating a simulated dataset was to include known documented 
translocations that were biologically plausible and be able to test the algorithm on 
this dataset. An attempt to define drivers of translocation based on genomic 
architecture was done by Ou et al., (Ou et al., 2011) whereby they demonstrated 
recurrent translocation driven by non-allelic homologous recombination in unrelated 
families. They also mapped the regions which could be involved in potential 
translocation computationally using low-copy repeat regions in the genome which 
shares >94% sequence identity and more than 5kb in length. They were able to 
experimentally verify the computationally predicted translocations for the three 
regions identified in Table 5.1.  
Burrow et al. analyzed recurrent translocation in cancers from various databases and 
tried to define the characteristics of these translocations. They found that over 50% 
of the recurrent translocations mapped to fragile sites, defined as regions on the 
genome that show multiple gaps (Burrow, Williams, Pierce, & Wang, 2009). We tried 
to derive our list of translocations from this comprehensive list (Appendix C) that 
could be near NAHR regions and found seven listed in Table 5.1. This list of 
translocation breakpoints was used to create derivative chromosomes using the 
translocation perl script mentioned in section 4.8.  
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Table 5.1: Translocation list used in creating simulated dataset 
Translocation from Burrow et 
al paper 
Breakpoint  
First chr. 
Breakpoint  
Second chr. 
 
Gene  
First chr 
Gene  
Second 
chr. 
t(1;22)(1q21;22q11) 142749690 19819306 BCL9 IGL@ 
t(12;13)(12q14;13q13) 50787223 40914700 HMGA2 LHFP 
t(19;22)(19q13;22q11) 63789868 49571663 IGL@ BCL3 
t(12;16)(12p13;16p13) 8270437 5069858 LAG3 MYH11 
t(16;21)(16q24.3;21q22.12) 88815835 46924874 RUNX1 CBFA2T3 
t(9;14)(9p21;14q11) 27286005 42868270 TRA@ CDKN2A 
t(7;11)(7q34;11p15) 128044540 124564 TRB@ LMO1 
Translocation from Ou et al. 
paper (Ou et al., 2011) 
Breakpoint  
First chr. 
Breakpoint  
Second chr. 
 
Gene  
First chr 
Gene  
Second 
chr. 
t(4;8)(4p16.3;8p23.1) 4088911 6992273 NA NA 
t(4:11)(4p16.2;11p15.4) 3852863 3569449 NA NA 
t(8;12)(8p23.1;12p13.31) 6992273 8367384 NA NA 
This simulated dataset included normal chromosomes and the derivative translocated 
chromosomes. The FASTA file was used to create simulated data using wgsim 
program that is a part of SAMTOOLS suite. A description of the options used for this 
program is presented in Table 1.1. 
Table 5.2: Simulation read creating program-‘wgsim’ options 
Options Type  Description 
e FLOAT base error rate [0.020] 
d INT outer distance between the two ends [500] 
s INT standard deviation [50] 
N INT number of read pairs [1000000] 
1 INT length of the first read [70] 
2 INT length of the second read [70] 
r FLOAT rate of mutations [0.0010] 
R FLOAT fraction of indels [0.10] 
X FLOAT probability an indel is extended [0.30] 
c NA generate reads in color space (SOLiD read 
C NA show mismatch info in comment rather than 
h NA haplotype mode 
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At the very least, it requires input FASTA file (translocation FASTA file) and length of 
the reads. In order to get 30X coverage of the genome we needed to define the 
number of read pairs needed (-N, Table 1.1). Coverage is calculated using equation 
1 below: 
(1) 𝐶𝑜𝑣𝑒𝑟𝑎𝑔𝑒 =  𝐿𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑟𝑒𝑎𝑑 × 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠
𝐻𝑎𝑝𝑙𝑜𝑖𝑑 𝐺𝑒𝑛𝑜𝑚𝑒 𝐿𝑒𝑛𝑔𝑡ℎ  
Thus for 30X coverage and read length of 100 basepairs, we calculated the number 
of read required for the haploid genome of length 3x109 to be 900 million reads. 
Output from this program gives two FASTQ files, one each for a paired end library. 
Further, a random subsample of this dataset was produced to simulate 15X 
coverage. BWA mapping tool was used to produce the alignment BAM files. The BAM 
file was then run against current tools, namely SVDetect-0.7f and BreakDancer-1.1.  
The process flow for our algorithm was as described in Figure 5.1.
Figure 5.1. Process flow of novel algorithm 
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5.2 Simulated Data Analysis Results 
SVDetect could correctly identify four out of the ten translocations created (4/10) 
and BreakDancer detected six out of ten (6/10) briefly summarized in Table 5.3. 
Table 5.3: Comparison of current tools with novel algorithm 
Translocation from Burrow et 
al paper 
SVDetect BreakDancer 
 
Novel 
Algorithm 
t(1;22)(1q21;22q11) Detected No Detected 
t(12;13)(12q14;13q13) Detected Detected Detected 
t(19;22)(19q13;22q11) No No Detected 
t(12;16)(12p13;16p13) Detected Detected Detected 
t(16;21)(16q24.3;21q22.12) No No Detected 
t(9;14)(9p21;14q11) Detected Detected Detected 
t(7;11)(7q34;11p15) No No Detected 
Translocation from Ou et al. 
paper (Ou et al., 2011) 
SVDetect BreakDancer 
 
Novel 
Algorithm 
t(4;8)(4p16.3;8p23.1) No Detected Detected 
t(4:11)(4p16.2;11p15.4) No Detected Detected 
t(8;12)(8p23.1;12p13.31) No Detected Detected 
The novel algorithm was able to detect all the translocations at a 1000 base pair 
resolution. The number of reads supporting a translocation varied from 3 to 50. The 
three translocations that were not detected by either SVDetect or BreakDancer, 
t(19;22), t(16;21) and t(7;11), all had less than 10 reads supporting the 
translocation in the novel algorithm output. The score file output is represented in 
Table 5.4.  
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Table 5.4: Final score file output of novel algorithm 30X coverage 
Chr_1 Start End Chr_2 Start End No_ 
 of 
reads 
Pearsons 
Corr- 
elation 
coeff 
icient 
chr1 142749000 142749999 chr22 19819000 19819999 3 0.01779 
chr12 50786000 50786999 chr13 40914000 40914999 3 0.00739 
chr12 50787000 50787999 chr13 40914000 40914999 17 0.00739 
chr19 63789000 63789999 chr22 49571000 49571999 4 0.30154 
chr12 8270000 8270999 chr16 5069000 5069999 29 0.28795 
chr16 88815000 88815999 chr21 46924000 46924999 9 0.42250 
chr9 42867000 42867999 chr14 27285000 27285999 15 0.25198 
chr9 42868000 42868999 chr14 27285000 27285999 23 0.25198 
chr9 42868000 42868999 chr14 27286000 27286999 23 0.25198 
chr7 128044000 128044999 chr11 124000 124999 6 0.25539 
chr4 4088000 4088999 chr8 6991000 6991999 2 0.21970 
chr4 4088000 4088999 chr8 6992000 6992999 15 0.21970 
chr4 3852000 3852999 chr11 3569000 3569999 23 0.1985 
chr8 6991000 6991999 chr12 8367000 8367999 7 0.24114 
chr8 6992000 6992999 chr12 8367000 8367999 51 0.24114 
SVDetect, although correctly identified chromosome 1 breakpoint for translocation 
t(1;22) did not identify chromosome 2 breakpoint as precisely and had very few 
reads supporting this translocation (Table 5.5). BreakDancer did a very good job at 
breakpoint resolution but could only detect six out of ten (Table 5.6) while SVDetect 
picked four (Table 5.5).  
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Table 5.5: SVDetect output (trimmed): simulated data 30X coverage 
SV_type BAL_ 
type 
chrom
o 
some1 
chrom
o 
some2 
no 
_pai
rs 
final 
_sco
re 
break 
point1 
break 
point2 
INV_ 
TRANSLOC 
UNBAL chr1 chr22 3 1 14274984-
142750363 
19960253-
19960750 
INV_ 
TRANSLOC 
UNBAL chr1 chr22 1 1 14274900-
142749572 
19958766-
19959329 
TRANSLOC UNBAL chr1 chr22 1 1 14274981-
142750378 
22001986-
22002549 
INV_ 
TRANSLOC 
UNBAL chr12 chr13 1 1 50786416-
50786979 
40903686-
40904249 
TRANSLOC UNBAL chr12 chr16 24 0.83 8270917-
8271106 
5069215-
5069396 
INV_ 
TRANSLOC 
UNBAL chr9 chr14 36 0.88 42867615-
42867796 
27285344-
27285586 
 
Table 5.6: BreakDancer output: simulated data 30X coverage 
Chrom 
osome1 
Pos1 Chrom 
osome2 
Pos2 Type Size Score Number 
of Reads 
chr4 3852787 chr11 3569702 CTX -499 99 4 
chr4 3853180 chr11 3569260 CTX -499 99 6 
chr4 4088565 chr8 6992324 CTX -499 99 2 
chr4 4088649 chr8 6992415 CTX -499 99 2 
chr8 6992535 chr12 8367239 CTX -499 99 2 
chr8 6992629 chr12 8367239 CTX -499 99 3 
chr8 6991970 chr12 8367520 CTX -499 99 3 
chr8 6992195 chr12 8367520 CTX -499 99 3 
chr8 6992195 chr12 8367640 CTX -499 99 5 
chr9 42868057 chr14 27285682 CTX -499 99 19 
chr12 8270277 chr16 5069881 CTX -499 99 3 
chr12 8270277 chr16 5069996 CTX -499 99 5 
chr12 8270277 chr16 5070133 CTX -499 95 2 
chr12 8270357 chr16 5070133 CTX -499 99 3 
chr12 8270471 chr16 5069481 CTX -499 99 3 
chr12 8270742 chr16 5069481 CTX -499 98 2 
chr12 8270742 chr16 5069585 CTX -499 99 11 
chr12 50787289 chr13 40914358 CTX -499 99 3 
chr12 50787452 chr13 40914358 CTX -499 99 8 
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As described, cancer genome complexity is overburdened further by factors like 
sample collection, tumor heterogeneity (Ulahannan, Kovac, Mulholland, Cazier, & 
Tomlinson, 2013), and platform specific issues like AT-rich and GC-rich bias in the 
Illumina platform (Metzker, 2010). Even with a 30X coverage of the genome and a 
100% representation of the alternative allele, the tools did not detect 40% to 60% of 
the simulated translocations. For the next step the dataset was randomly sampled so 
that 50% of the reads were picked to do analysis on a 15X coverage dataset.  This is 
more realistic for current whole-genome sequencing strategies of cancer.  30X or 
greater coverage is usually reserved for exome-sequencing mainly due to cost 
constraints.  Even if a cancer genome is sequenced at 30X or greater, the inherent 
intercellular heterogeneity coupled with the aneuploidy that typifies most tumors 
means that a given translocation may be represented by even fewer supporting 
reads for the regions of interest.   
Even with 15X coverage, our novel algorithm tool was able to detect all ten 
simulated translocations (Table 5.7) albeit with fewer reads supporting the 
translocations (compare with Table 5.4).  
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Table 5.7: Final score file output of novel algorithm 15X coverage 
Chr_1 Start End Chr_2 Start End No_ 
 of 
reads 
Pearsons 
Corr- 
elation 
coeff 
icient 
chr1 142749000 142749999 chr22 19819000 19819999 2 0.01779 
chr12 50786000 50786999 chr13 40914000 40914999 2 0.00739 
chr12 50787000 50787999 chr13 40914000 40914999 7 0.00739 
chr19 63789000 63789999 chr22 49571000 49571999 3 0.30154 
chr12 8270000 8270999 chr16 5069000 5069999 14 0.28795 
chr16 88815000 88815999 chr21 46924000 46924999 5 0.42250 
chr9 42867000 42867999 chr14 27285000 27285999 10 0.25198 
chr9 42868000 42868999 chr14 27285000 27285999 8 0.25198 
chr9 42868000 42868999 chr14 27286000 27286999 14 0.25198 
chr7 128044000 128044999 chr11 124000 124999 3 0.25539 
chr4 4088000 4088999 chr8 6992000 6992999 11 0.21970 
chr4 3852000 3852999 chr11 3569000 3569999 9 0.1985 
chr8 6991000 6991999 chr12 8367000 8367999 4 0.24114 
chr8 6992000 6992999 chr12 8367000 8367999 28 0.24114 
BreakDancer was only able to detect four (4/10) translocations with 15X coverage 
(Table 5.8).   
Table 5.8: BreakDancer output: simulated data 15X coverage 
Chrom 
osome1 
Pos1 Chrom 
osome2 
Pos2 Type Size Score Number 
of Reads 
chr4 3852745 chr11 3569702 CTX -499 99 3 
chr4 3853180 chr11 3569294 CTX -499 99 4 
chr8 6992049 chr12 8367520 CTX -499 99 2 
chr9 42867966 chr14 27285748 CTX -499 99 5 
chr9 42868047 chr14 27285748 CTX -499 99 2 
chr12 8270471 chr16 5069481 CTX -499 99 2 
chr12 8270566 chr16 5069585 CTX -499 99 2 
 
SVDetect was only able to detect two (2/10) variants (Table 5.9). 
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Table 5.9: SVDetect output (trimmed): simulated data 15X coverage 
SV_type BAL_type Chr_1 Chr_
2 
nb 
_pair
s 
final 
_sco
re 
break 
point1 
break 
point2 
INV_ 
TRANSLOC 
UNBAL chr1 chr22 1 1 142749572-
142749671 
19959329-
19959428 
TRANSLOC UNBAL chr12 chr13 4 0.8 50786565 
-50786795 
40915026-
40915369 
TRANSLOC UNBAL chr12 chr13 4 0.8 50787552 
-50788028 
40913925-
40914365 
One of the major issues with the novel algorithm is that it gives large number of 
false positives despite filtering out variants with negative Hi-C scores. Therefore 
distribution-based filtering is another approach to reduce false positives. Frequency 
distribution of Hi-C data for chromosome 1 and chromosome 22 showed most of the 
regions (1 Mbps windows) with Pearson’s correlation coefficient between 0.03 and 
0.09 (Figure 5.2).   
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Figure 5.2: Hi-C score frequency distribution for chromosome 1 and 22 
 
Setting the filtering cutoff at 0.09 would make the tool miss this translocation while 
setting it at the tail end at 0.249 will capture it (Table 5.4).  
Frequency distribution of chromosome 12 and chromosome 13 (Figure 5.3) with 
cutoff above zero will include the translocation (Table 5.4).  
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Figure 5.3: Hi-C score frequency distribution for chromosome 12 and 13 
Similarly to capture t(12;16), t(19;22), t(16;21), t(9;14), t(7;11), t(4;8), t(4;11), 
and t(8;12) we need to include the far right end of the distribution (Figure 5.4, 
Figure 5.5, Figure 5.6, Figure 5.7, Figure 5.8, Figure 5.9, Figure 5.10, Figure 5.11). 
Thus, although these translocations had a strong Pearson’s correlation value, filtering 
based on distribution will lose these translocations. A filtering method to filter out 
variants which are one standard deviation away from the mean in the positive 
direction will be a better approach to capture these events.    
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Figure 5.4: Hi-C score frequency distribution for chromosome 12 and 16 
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Figure 5.5: Hi-C score frequency distribution for chromosome 19 and 22 
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Figure 5.6: Hi-C score frequency distribution for chromosome 16 and 21 
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Figure 5.7: Hi-C score frequency distribution for chromosome 9 and 14 
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Figure 5.8: Hi-C score frequency distribution for chromosome 7 and 11 
 
0
2000
4000
6000
8000
10000
12000
-0
.2
64
06
34
91
-0
.1
79
56
13
89
-0
.0
95
05
92
88
-0
.0
10
55
71
86
0.
07
39
44
91
5
0.
15
84
47
01
7
0.
24
29
49
11
8
0.
32
74
51
22
0.
41
19
53
32
1
0.
49
64
55
42
3
0.
58
09
57
52
5
0.
66
54
59
62
6
M
or
e
Fr
eq
ue
nc
y 
Hi-C score Bin 
Hi-C  score frequency distribution  
Chr7_Chr11 
Frequency
  92 
 
Figure 5.9: Hi-C score frequency distribution for chromosome 4 and 8 
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Figure 5.10: Hi-C score frequency distribution for chromosome 4 and 11 
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Figure 5.11: Hi-C score frequency distribution for chromosome 8 and 12 
Thus in order to reduce noise, filtering variants with negative correlation coefficients 
is an essential first step. Further, arriving at a cutoff by looking at the distribution of 
Hi-C scores to filter variants with strong positive correlation can further reduce noise 
and fine-tune the tool.  
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6.  DISCUSSION 
The aim of this study was to understand if characteristics of the structural variant 
made it more or less conducive to detection by current computational methods in 
use. We wanted to understand the structural variant in relation to its position in the 
genome and determine if this genomic context made some variants more difficult to 
be detected by current tools. The human genome is made up of approximately 
20,000-25,0000 genes and targeted sequencing of only these known coding regions 
covers about 1% of the 3 billion bases of the human genome, i.e. approximately 30 
million (Brunham & Hayden, 2013). Applying genome linkage analysis to single-gene 
Mendelian disease has met with considerable success as in cystic fibrosis (Kerem et 
al., 1989; Rommens et al., 1988) and Huntington’s disease (Fox, Bloch, Fahy, & 
Hayden, 1989). Application of next generation sequencing efforts to Mendelian 
disorders has led to discovery of more than 3000 genes associated with a 
phenotypically visible trait and more than 5000 phenotypic traits with known 
molecular basis as recorded to date in the Online Mendelian Inheritance in Man 
(OMIM database) (McKusick, 2014). Discovery of these specific genes has 
tremendous value in the predictive capability of genetic diagnosis through 
biomarkers as in Alzheimer as well as targeted gene therapy as in cystic fibrosis with 
the mean survival rate of cystic fibrosis going from 6 months in 1930’s to 40 years in 
1990’s (Ikpa, Bijvelds, & de Jonge, 2014) due to novel therapy. The impact of 
genotype-to-phenotype translation, while more obvious in Mendelian diseases, are 
not so easily translated in complex disease with possible multi-gene etiology. 
Translational bioinformatics tries to fill up this gap using high throughput data 
analysis techniques. Cancers are even more complicated due to presence of somatic 
variants that are not inherited and therefore more difficult to define. Further, tumors 
are highly heterogeneous, and therefore the presence of a variant will be highly 
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dependent on sample extraction and preparation. Thus, the aim is to identify the 
best approach to detect novel variants in a heterogeneous sample with highly 
mutated genome.  The currently available tools were designed around the normal 
genome architecture assuming 100% allele frequency. Cancer genome does not 
conform to this assumption. 
6.1 Repeat Analysis 
The study analysis started with the hypothesis that the tools were failing to detect 
variants due to presence of these variants in repeat regions. If the mapping tools are 
unable to map reads uniquely, the tools will not be able to pick these variants. The 
first analysis for this study tried to define the characteristics of the validated variants 
in 1000 genomes trio dataset using current variant detection algorithms. The 
purpose was to understand the reason these tools were missing to detect the 
validated variants.  SVDetect was chosen for this analysis due to its high false 
positive rate and thus be highly sensitive. Since the idea was to define context, true 
positive was defined as those variants detected by SVDetect with at least 10% of 
insert size overlap with variants in the 1000-genome validated file. Although less 
than 50% of the true variants had some overlap with the variants detected by the 
tools, their representation in the repeat regions was not as hypothesized. The 
hypothesis that structural variants missed by the tools were more likely to be in 
repeat regions was rejected by the analysis. A greater percent of the variants 
detected by the tools had repeats compared to variants not detected by the tools. 
This was consistent across all four variant types, deletion, mobile element insertion, 
tandem duplication, and novel sequences classified in the 1000-Genomes dataset. 
Repeat structure was not driving the tool’s inability to pick less than 50% of true 
variants. Since 50% of the human genome is made up of repeats, this very broad 
classification of context did not prove very useful. Since the study was trying to 
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design a tool specific for translocation, the context was now focused towards 
mechanisms driving translocation which can be captured informatically.  
6.2 Algorithm Development and Simulated Data Analysis 
Translocations lead to genetic imbalances and are a precursor to cancers. Detection 
of the same recurrent translocation in four unrelated families by Ou et al. (Ou et al., 
2011) led to implication of non-allelic homologous recombination (NAHR) as the 
driver for these variants in all these subjects. NAHR occurs due to aberrant DNA 
repair mechanism between regions that share considerable homology, also known as 
low copy repeat regions (LCRs). Unlike repeat elements, these LCRs are several 
thousand basepairs long and share greater than 95% identity. Using these 
characteristics, Ou et al. computationally mapped the NAHR regions on the human 
genome and predicted validated translocations in their database. This mapping was 
based on the segmental duplication map created using comparative genomic 
hybridization which identified novel structural variants in these regions of LCRs by 
Sharp et al. (Sharp et al., 2006). Segmental duplications as possible hotspots for 
structural variation events were first hypothesized and mapped by Bailey et al. 
(Bailey et al., 2002) identifying 169 such regions in the human genome. However, 
the physical co-location of these LCR regions in cell is also an important contributing 
factor to the actual interaction between these regions. Regions of chromosomes that 
are physically close to each other in 3-dimensional space are more likely to interact 
with each other as proved by chromosomal conformation capture experiments known 
as (3C or Hi-C) which reveal three-dimensional architecture of genome packing in 
the cell (Wijchers, 2011). The mobility of different regions in the genome is limited 
by the location of these regions in the genome (Chubb, Boyle, Perry, & Bickmore, 
2002). While accounting for these two types of important contextual based 
information about translocation etiology, the study was able to design and test the 
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algorithm based on this context and proved to do better than current methodologies 
for translocation detection.  
The algorithm was designed to capture all reads that would be ambiguously aligned 
by the mapping tool. The most popular mapping tool currently in use, namely BWA 
(Li & Durbin, 2009), was used for generating initial mapping. BWA’s popularity is due 
to its speed in mapping billions of shorts reads in hours, achieved by its effective use 
of cache memory in indexing the reads and also wide acceptance in the 
bioinformatics community as a preferred mapping tool. The output from BWA is also 
in the SAM/BAM format (Li et al., 2009) accepted as the standard output format for 
alignment. BWA randomly assigns reads which map to more than one region on the 
genome. In their simulated read alignment, BWA mapped 11/1,569,108 incorrectly 
(Li & Durbin, 2009), which still is a very low error rate but in a sequencing 
experiment with for example 50 million reads, approximately 500 reads would be 
wrongly assigned. While this may be sufficient for a normal genome, in a cancer 
genome sequencing project aimed at finding novel variants and showing 
heterogeneity, this number might make a difference. Analysis in this study showed 
that even with 100% allele frequency, which is not the case in tumors; the tools 
were missing variants in the simulated dataset. The tools pick up anomalous reads 
based on these reads mapping at greater/shorter distance than the normal 
distribution of insert size or incorrect orientation.  Our novel algorithm does not use 
the probability distribution of insert size to pick reads. This is because reads with 
NAHR characteristics, i.e. reads which share greater than 95% identity, could have 
been placed at a location selected randomly by the mapping tool since these regions 
are so similar, and thus their imputed insert size is suspect. The algorithm accounted 
for this information by extracting reads which could have multiple mappings on the 
genome while extracting the partner paired read irrespective of its mapping score. 
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Re-mapping of these ambiguous reads with a local alignment tool like BLAT (W. J. 
Kent, 2002) further helps define context, since all possible genomic regions of 
identity are now reported. Further, instead of using read distribution of the data and 
number of reads supporting a type of variant to assign probability of calling a true 
variant, the algorithm again used context to define the probability of two regions 
being involved in translocation based on their known proximity to each other in 3-D 
cellular space and therefore the probability of interacting regions (Lieberman-Aiden 
et al., 2009). Even with 15X coverage, the novel tool was able to detect all ten 
simulated translocations.   
6.3 Conclusion 
Designing a novel context based approach to detect translocations, the study 
showed a very effective way to detect these variants using a biologically derived 
context-based approach which has not been used so far to effectively mine structural 
variants. The study also rejected the hypothesis that repeat structure within the 
variant was driving the inability of current tools to detect true positive events.  
The output from this novel algorithm could help discover many de-novo variants in 
cancers and provide a starting point for mining variant information from sequencing 
data. The purpose of this tool was not to define a few variants, but to give as many 
possible variants that could then be teased out by the user through experimental 
validation. Bioinformatics data analysis of such big volume data does suffer from 
copious output of false positives, but at the same time is the first step in moving 
towards more comprehensive follow-up using laboratory tools. Providing the user 
with biological context-based algorithm instills more confidence in the output, which 
was the purpose of this analysis. 
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6.4 Limitations 
The major limitation of this study is the number of false positive reported in output. 
Ideally the user would like to see only the most relevant information that is currently 
embedded in a lot of noise. Noise can be reduced by narrowing BLAT’s extraction 
parameters for stricter re-alignment. How this would play out in a real dataset was 
not explored in this analysis.  
Since re-alignment with BLAT is a computationally intensive process, the access to 
high performance computing environment is a pre-requisite. Without high-
throughput computing the analysis can get prohibitively time consuming. Running 
BLAT alignments in parallel greatly reduces the time, and we assume that users 
would have access to parallel, high performance computing resources.  
The tool was also specifically designed for detecting translocations, and users would 
prefer getting the entire spectrum of structural variation in a single tool, which is 
another limitation for this study. 
6.5 Future Direction and Research 
The tool was specifically designed to obtain as much information from mapping as 
possible to be able to derive de-novo variants that it achieved at the cost of 
reporting a lot of noise. I would like to explore new methods to reduce noise in the 
data without compromising on the mining ability of the tool. Noise reduction 
parameters could also include evolutionary information of conserved versus non-
conserved regions to remove implausible variants. I would also like to expand the 
tool capability to detect all type of other structural variants including deletion, 
insertion and inversion. 
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This is the first context-based tool designed to date and can prove useful for 
helping lay the framework for further algorithm development along these lines which 
take other biological context into account while designing bioinformatics tools.  
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APPENDIX A 
[LIST OF 1000-GENOMES FILES USED IN ANALYSIS]   
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 NA19238   NA19238   
FASTQ_FILE MD5 
data/NA19238/sequence_read/SRR005192_1.filt.fastq
 
3110d6d61bdcc620c9a179b93c0f
 data/NA19238/sequence_read/SRR005192_2.filt.fastq
 
e7bda40a41048d14827fb0cc4f38
 data/NA19238/sequence_read/SRR005193_1.filt.fastq
 
c8798ad272b04ec4048c78ce85b1
 data/NA19238/sequence_read/SRR005193_2.filt.fastq
 
7bf0c21b54862ed57a1657a43c6d
 data/NA19238/sequence_read/SRR005194_1.filt.fastq
 
ec8fe3d8289f22c8baacbd43e16c5
 data/NA19238/sequence_read/SRR005194_2.filt.fastq
 
077f9e9e8921f966c3b659fc02c8e
 data/NA19238/sequence_read/SRR005195_1.filt.fastq
 
8966bbc2201e0632e609193bf66
 data/NA19238/sequence_read/SRR005195_2.filt.fastq
 
5c37e56b89e025904ddc5d7cebcb
 data/NA19238/sequence_read/SRR005196_1.filt.fastq
 
e8b748413e193c88b89307200ef
 data/NA19238/sequence_read/SRR005196_2.filt.fastq
 
c8222dcc6a8a598be80d5847aa84
 data/NA19238/sequence_read/SRR005197_1.filt.fastq
 
a973556332823824b53fd22e438
 data/NA19238/sequence_read/SRR005197_2.filt.fastq
 
8f1c57c94b08cb6ce7f2c2bdd553b
 data/NA19238/sequence_read/SRR005198_1.filt.fastq
 
8a9d339a0eaa86a693fc6112e4a9
 data/NA19238/sequence_read/SRR005198_2.filt.fastq
 
571be24092fd1461fc603c24fca88
 data/NA19238/sequence_read/SRR005207_1.filt.fastq
 
b58c47719b1fd3978bb66c13cf21
 data/NA19238/sequence_read/SRR005207_2.filt.fastq
 
ac1b7529997dff1a66caa91f7c7a0
 data/NA19238/sequence_read/SRR005208_1.filt.fastq
 
c9be0f679ddb17d80c939b4310b7
 data/NA19238/sequence_read/SRR005208_2.filt.fastq
 
e4ec92a85bbc5bb67b224b9af827
 data/NA19238/sequence_read/SRR005209_1.filt.fastq
 
863bae9c44ce63c6e6bc05157a6e
 data/NA19238/sequence_read/SRR005209_2.filt.fastq
 
78a0b36d85660647acb9de113ca
 data/NA19238/sequence_read/SRR005210_1.filt.fastq
 
bc0be085804c2516b49c7a36a899
 data/NA19238/sequence_read/SRR005210_2.filt.fastq
 
8476cad371e344af09e05b5cea38
 data/NA19238/sequence_read/SRR005211_1.filt.fastq
 
54adf7a8bae6c62a5461c400f99e
 data/NA19238/sequence_read/SRR005211_2.filt.fastq
 
2522236016de36b57a53bd109ab
 data/NA19238/sequence_read/SRR005212_1.filt.fastq
 
6ba1954e295bda218a2118fc8aa2
 data/NA19238/sequence_read/SRR005212_2.filt.fastq
 
b445a0cfc600db40e0b691418333
 data/NA19238/sequence_read/SRR005213_1.filt.fastq
 
fd4ae153f97419fcde27757202adf
 data/NA19238/sequence_read/SRR005213_2.filt.fastq
 
9445853a49d0bf79210427ed0f3f
 data/NA19238/sequence_read/SRR005214_1.filt.fastq
 
e30e3fe5bef08ff7426972e513d22
 data/NA19238/sequence_read/SRR005214_2.filt.fastq
 
0539bd41f8e05fc48a5725130e5b
 data/NA19238/sequence_read/SRR005234_1.filt.fastq
 
ac5ab344453144ac814e4a641d1
 data/NA19238/sequence_read/SRR005234_2.filt.fastq
 
537dcfd662bb446057a33aec0d15
  NA19239   NA19239   
FASTQ_FILE MD5 
data/NA19239/sequence_read/SRR002955_1.filt.fastq
 
d2ba15c23b0ea4d141091e29498
 data/NA19239/sequence_read/SRR002955_2.filt.fastq
 
89d1488783426bc5bee1f6486d2
 data/NA19239/sequence_read/SRR002956_1.filt.fastq
 
f6a17acc125140972b1d0e1658d7
 data/NA19239/sequence_read/SRR002956_2.filt.fastq
 
84c5ee8d297a472d2bd98bedd9c
 data/NA19239/sequence_read/SRR002957_1.filt.fastq
 
494845e8f8c23228eff7a51371fe7
 data/NA19239/sequence_read/SRR002957_2.filt.fastq
 
942fc8cbdc1ca14850d436381d6c
 data/NA19239/sequence_read/SRR002958_1.filt.fastq
 
f2ba138f5b4e3d2c22e24ef007e5
 data/NA19239/sequence_read/SRR002958_2.filt.fastq
 
8da0f35e82f3d892ab0af3278192
 data/NA19239/sequence_read/SRR002959_1.filt.fastq
 
ae73beeba370de5bf7e0a3979795
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data/NA19239/sequence_read/SRR002959_2.filt.fastq
 
e074b4e1ac1385f64f8d567f6c648
 data/NA19239/sequence_read/SRR002960_1.filt.fastq
 
8b25fee1184f5637cf16ccbb0d729
b91 data/NA19239/sequence_read/SRR002960_2.filt.fastq
 
b279a5a991b49db48a5639e5fb9f
 data/NA19239/sequence_read/SRR002961_1.filt.fastq
 
09578c8ecb4d08fe105d9c01e4ce
 data/NA19239/sequence_read/SRR002961_2.filt.fastq
 
af805552162f41cdd043f72c06add
 data/NA19239/sequence_read/SRR002962_1.filt.fastq
 
236fa73d55de2cd976342993bf21
 data/NA19239/sequence_read/SRR002962_2.filt.fastq
 
98ea38969923270d3336af8a2d0
 data/NA19239/sequence_read/SRR002963_1.filt.fastq
 
02ff2466baf9bd74f619305194058
 data/NA19239/sequence_read/SRR002963_2.filt.fastq
 
aa7ee92f6393097d52016b8b151c
 data/NA19239/sequence_read/SRR002964_1.filt.fastq
 
b25bccafd54edd86abf4e389eda1
 data/NA19239/sequence_read/SRR002964_2.filt.fastq
 
872db6265531d791f22027046c6
 data/NA19239/sequence_read/SRR002965_1.filt.fastq
 
88a0503c066051cc88b962882c0c
 data/NA19239/sequence_read/SRR002965_2.filt.fastq
 
bce9ac30781e5ec8fd19cbc70e50
 data/NA19239/sequence_read/SRR002966_1.filt.fastq
 
ae76268b7ad710dfd46aa2df8579
 data/NA19239/sequence_read/SRR002966_2.filt.fastq
 
46f7b4b1b7296fe89f39700d5132
 data/NA19239/sequence_read/SRR002967_1.filt.fastq
 
d6c6ad9f92cb457db2087e6ce363
 data/NA19239/sequence_read/SRR002967_2.filt.fastq
 
503e515dde2f13a78f0e629eba99
 data/NA19239/sequence_read/SRR003029_1.filt.fastq
 
d4c1a8c8c5acb90146499d58d603
 data/NA19239/sequence_read/SRR003029_2.filt.fastq
 
45111b5330c104a73017defcf87c
 data/NA19239/sequence_read/SRR007422_1.filt.fastq
 
250b5c091fe1c11cf1710f445e2db
 data/NA19239/sequence_read/SRR007422_2.filt.fastq
 
8ec2e99eddab5810d66d1ae3c99
  NA19240   NA19240   
FASTQ_FILE MD5 
data/NA19240/sequence_read/SRR004483_1.filt.fastq
 
b7ce1dcb4a62c3382f86143ced4b
 data/NA19240/sequence_read/SRR004483_2.filt.fastq
 
2d0d9b8c156939e516282f3ea9c0
 data/NA19240/sequence_read/SRR004484_1.filt.fastq
 
0b4cf789a716c1235c31fc574b14
 data/NA19240/sequence_read/SRR004484_2.filt.fastq
 
071c8e38659b21bcfc2e726abfe9
 data/NA19240/sequence_read/SRR004485_1.filt.fastq
 
1b615fb8d04788c413ce5424f7b6
 data/NA19240/sequence_read/SRR004485_2.filt.fastq
 
c666b912d12e3e738a550ac12acb
 data/NA19240/sequence_read/SRR004783_1.filt.fastq
 
19f0db03a8f822b7a3df27f21e1b8
 data/NA19240/sequence_read/SRR004783_2.filt.fastq
 
350412ab18793c4240ef2296d61a
 data/NA19240/sequence_read/SRR004784_1.filt.fastq
 
be46222998b027213cfafa5d9a8d
 data/NA19240/sequence_read/SRR004784_2.filt.fastq
 
77dabc7efefea2c062af0c8fda476
 data/NA19240/sequence_read/SRR004785_1.filt.fastq
 
7aef2b68952f07ceb5a4e3834103
 data/NA19240/sequence_read/SRR004785_2.filt.fastq
 
6df41a7a5290e164adc95642358d
 data/NA19240/sequence_read/SRR004786_1.filt.fastq
 
828c0a376a745e64009b0e2ecc79
 data/NA19240/sequence_read/SRR004786_2.filt.fastq
 
0c3f85ad38d3ad4e8df5d21924e9
 data/NA19240/sequence_read/SRR004788_1.filt.fastq
 
c59b50bd44ad5d3f7f7782e1316f
 data/NA19240/sequence_read/SRR004788_2.filt.fastq
 
a37b8ff65efe7fce535fd6ad7fa73a
70 
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 NA19238   NA19238   NA19238   NA19238   NA19238   
RUN_ID STUDY_ID STUDY_NAME CENTER_NAME SUBMISSION_ID 
SRR005192 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002880 
SRR005192 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002880 
SRR005193 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002881 
SRR005193 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002881 
SRR005194 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002882 
SRR005194 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002882 
SRR005195 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002883 
SRR005195 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002883 
SRR005196 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002884 
SRR005196 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002884 
SRR005197 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002885 
SRR005197 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002885 
SRR005198 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002886 
SRR005198 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002886 
SRR005207 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002895 
SRR005207 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002895 
SRR005208 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002896 
SRR005208 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002896 
SRR005209 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002897 
SRR005209 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002897 
SRR005210 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002898 
SRR005210 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002898 
SRR005211 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002899 
SRR005211 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002899 
SRR005212 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002900 
SRR005212 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002900 
SRR005213 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002901 
SRR005213 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002901 
SRR005214 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002902 
SRR005214 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002902 
SRR005234 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002922 
SRR005234 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002922 
 NA19239   NA19239   NA19239   NA19239   NA19239   
RUN_ID STUDY_ID STUDY_NAME CENTER_NAME SUBMISSION_ID 
SRR002955 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001427 
SRR002955 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001427 
SRR002956 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001428 
SRR002956 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001428 
SRR002957 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001429 
SRR002957 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001429 
SRR002958 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001430 
SRR002958 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001430 
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SRR002959 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001431 
SRR002959 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001431 
SRR002960 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001432 
SRR002960 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001432 
SRR002961 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001433 
SRR002961 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001433 
SRR002962 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001434 
SRR002962 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001434 
SRR002963 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001435 
SRR002963 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001435 
SRR002964 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001436 
SRR002964 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001436 
SRR002965 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001437 
SRR002965 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001437 
SRR002966 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001438 
SRR002966 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001438 
SRR002967 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001439 
SRR002967 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001439 
SRR003029 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001500 
SRR003029 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA001500 
SRR007422 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA004284 
SRR007422 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA004284 
 NA19240   NA19240   NA19240   NA19240   NA19240   
RUN_ID STUDY_ID STUDY_NAME CENTER_NAME SUBMISSION_ID 
SRR004483 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002351 
SRR004483 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002351 
SRR004484 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002352 
SRR004484 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002352 
SRR004485 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002353 
SRR004485 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002353 
SRR004783 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002629 
SRR004783 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002629 
SRR004784 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002630 
SRR004784 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002630 
SRR004785 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002631 
SRR004785 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002631 
SRR004786 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002632 
SRR004786 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002632 
SRR004788 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002636 
SRR004788 SRP000032 1000Genomes Project Pilot 2 WUGSC SRA002636 
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 NA19238   NA19238   NA19238   NA19238   NA19238   
SUBMISSION_DATE SAMPLE_ID SAMPLE_NAME POPULATION EXPERIMENT_ID 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/24/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/26/2008 0:00 SRS000212 NA19238 YRI SRX001106 
9/26/2008 0:00 SRS000212 NA19238 YRI SRX001106 
 NA19239   NA19239   NA19239   NA19239   NA19239   
SUBMISSION_DATE SAMPLE_ID SAMPLE_NAME POPULATION EXPERIMENT_ID 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
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8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/15/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/17/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/17/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/21/2008 0:00 SRS000213 NA19239 YRI SRX000654 
8/21/2008 0:00 SRS000213 NA19239 YRI SRX000654 
 NA19240   NA19240   NA19240   NA19240   NA19240   
SUBMISSION_DATE SAMPLE_ID SAMPLE_NAME POPULATION EXPERIMENT_ID 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/23/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
9/24/2008 0:00 SRS000214 NA19240 YRI SRX001102 
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 NA19238   NA19238   NA19238   NA19238   NA19238 
  INSTRUMENT INSTRUMENT_MODEL LIBRARY_NAME RUN_NAME  INSERT_SIZE 
_PLATFORM     
ILLUMINA Illumina Genome Analyzer II 2675169269 7592 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7592 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7593 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7593 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7594 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7594 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7595 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7595 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7596 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7596 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7597 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7597 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7598 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7598 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7607 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7607 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7608 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7608 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7609 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7609 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7610 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7610 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7611 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7611 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7612 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7612 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7613 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7613 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7614 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7614 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7646 260 
ILLUMINA Illumina Genome Analyzer II 2675169269 7646 260 
 NA19239   NA19239   NA19239   NA19239   NA19239 
  INSTRUMENT_P
 
INSTRUMENT_MODEL LIBRARY_NAME RUN_NAME INSERT_SIZE 
ILLUMINA Illumina Genome Analyzer 2485443314 5685 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5685 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5686 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5686 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5687 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5687 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5688 260 
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ILLUMINA Illumina Genome Analyzer 2485443314 5688 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5689 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5689 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5690 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5690 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5691 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5691 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5692 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5692 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5693 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5693 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5694 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5694 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5695 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5695 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5696 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5696 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5697 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5697 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5895 260 
ILLUMINA Illumina Genome Analyzer 2485443314 5895 260 
ILLUMINA Illumina Genome Analyzer 2485443314 6430 260 
ILLUMINA Illumina Genome Analyzer 2485443314 6430 260 
 NA19240   NA19240   NA19240   NA19240   NA19240 
  INSTRUMENT_L
 
INSTRUMENT_MODEL LIBRARY_NAME RUN_NAME INSERT_SIZE 
ILLUMINA Illumina Genome Analyzer II 2675080346 7223 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7223 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7224 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7224 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7225 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7225 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7522 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7522 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7523 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7523 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7524 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7524 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7525 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7525 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7526 260 
ILLUMINA Illumina Genome Analyzer II 2675080346 7526 260 
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NA19238   NA19238   NA19238 
LIBRARY PAIRED_FASTQ READ 
_LAYOUT  _COUNT 
PAIRED data/NA19238/sequence_read/SRR005192_2.filt.fastq.gz 11270293 
PAIRED data/NA19238/sequence_read/SRR005192_1.filt.fastq.gz 11270293 
PAIRED data/NA19238/sequence_read/SRR005193_2.filt.fastq.gz 11173375 
PAIRED data/NA19238/sequence_read/SRR005193_1.filt.fastq.gz 11173375 
PAIRED data/NA19238/sequence_read/SRR005194_2.filt.fastq.gz 10300764 
PAIRED data/NA19238/sequence_read/SRR005194_1.filt.fastq.gz 10300764 
PAIRED data/NA19238/sequence_read/SRR005195_2.filt.fastq.gz 8931016 
PAIRED data/NA19238/sequence_read/SRR005195_1.filt.fastq.gz 8931016 
PAIRED data/NA19238/sequence_read/SRR005196_2.filt.fastq.gz 8075975 
PAIRED data/NA19238/sequence_read/SRR005196_1.filt.fastq.gz 8075975 
PAIRED data/NA19238/sequence_read/SRR005197_2.filt.fastq.gz 7380429 
PAIRED data/NA19238/sequence_read/SRR005197_1.filt.fastq.gz 7380429 
PAIRED data/NA19238/sequence_read/SRR005198_2.filt.fastq.gz 8413304 
PAIRED data/NA19238/sequence_read/SRR005198_1.filt.fastq.gz 8413304 
PAIRED data/NA19238/sequence_read/SRR005207_2.filt.fastq.gz 5792641 
PAIRED data/NA19238/sequence_read/SRR005207_1.filt.fastq.gz 5792641 
PAIRED data/NA19238/sequence_read/SRR005208_2.filt.fastq.gz 5388572 
PAIRED data/NA19238/sequence_read/SRR005208_1.filt.fastq.gz 5388572 
PAIRED data/NA19238/sequence_read/SRR005209_2.filt.fastq.gz 4034189 
PAIRED data/NA19238/sequence_read/SRR005209_1.filt.fastq.gz 4034189 
PAIRED data/NA19238/sequence_read/SRR005210_2.filt.fastq.gz 4510010 
PAIRED data/NA19238/sequence_read/SRR005210_1.filt.fastq.gz 4510010 
PAIRED data/NA19238/sequence_read/SRR005211_2.filt.fastq.gz 4060395 
PAIRED data/NA19238/sequence_read/SRR005211_1.filt.fastq.gz 4060395 
PAIRED data/NA19238/sequence_read/SRR005212_2.filt.fastq.gz 4397559 
PAIRED data/NA19238/sequence_read/SRR005212_1.filt.fastq.gz 4397559 
PAIRED data/NA19238/sequence_read/SRR005213_2.filt.fastq.gz 4996197 
PAIRED data/NA19238/sequence_read/SRR005213_1.filt.fastq.gz 4996197 
PAIRED data/NA19238/sequence_read/SRR005214_2.filt.fastq.gz 6422603 
PAIRED data/NA19238/sequence_read/SRR005214_1.filt.fastq.gz 6422603 
PAIRED data/NA19238/sequence_read/SRR005234_2.filt.fastq.gz 8418918 
PAIRED data/NA19238/sequence_read/SRR005234_1.filt.fastq.gz 8418918 
 NA19239   NA19239   NA19239 
LIBRARY_
 
PAIRED_FASTQ READ_COU
 PAIRED data/NA19239/sequence_read/SRR002955_2.filt.fastq.gz 7258052 
PAIRED data/NA19239/sequence_read/SRR002955_1.filt.fastq.gz 7258052 
PAIRED data/NA19239/sequence_read/SRR002956_2.filt.fastq.gz 7170493 
PAIRED data/NA19239/sequence_read/SRR002956_1.filt.fastq.gz 7170493 
PAIRED data/NA19239/sequence_read/SRR002957_2.filt.fastq.gz 7245012 
PAIRED data/NA19239/sequence_read/SRR002957_1.filt.fastq.gz 7245012 
PAIRED data/NA19239/sequence_read/SRR002958_2.filt.fastq.gz 7414026 
PAIRED data/NA19239/sequence_read/SRR002958_1.filt.fastq.gz 7414026 
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PAIRED data/NA19239/sequence_read/SRR002959_2.filt.fastq.gz 8114993 
PAIRED data/NA19239/sequence_read/SRR002959_1.filt.fastq.gz 8114993 
PAIRED data/NA19239/sequence_read/SRR002960_2.filt.fastq.gz 8079331 
PAIRED data/NA19239/sequence_read/SRR002960_1.filt.fastq.gz 8079331 
PAIRED data/NA19239/sequence_read/SRR002961_2.filt.fastq.gz 7959676 
PAIRED data/NA19239/sequence_read/SRR002961_1.filt.fastq.gz 7959676 
PAIRED data/NA19239/sequence_read/SRR002962_2.filt.fastq.gz 5187607 
PAIRED data/NA19239/sequence_read/SRR002962_1.filt.fastq.gz 5187607 
PAIRED data/NA19239/sequence_read/SRR002963_2.filt.fastq.gz 6173753 
PAIRED data/NA19239/sequence_read/SRR002963_1.filt.fastq.gz 6173753 
PAIRED data/NA19239/sequence_read/SRR002964_2.filt.fastq.gz 6055820 
PAIRED data/NA19239/sequence_read/SRR002964_1.filt.fastq.gz 6055820 
PAIRED data/NA19239/sequence_read/SRR002965_2.filt.fastq.gz 6745735 
PAIRED data/NA19239/sequence_read/SRR002965_1.filt.fastq.gz 6745735 
PAIRED data/NA19239/sequence_read/SRR002966_2.filt.fastq.gz 6621194 
PAIRED data/NA19239/sequence_read/SRR002966_1.filt.fastq.gz 6621194 
PAIRED data/NA19239/sequence_read/SRR002967_2.filt.fastq.gz 6706504 
PAIRED data/NA19239/sequence_read/SRR002967_1.filt.fastq.gz 6706504 
PAIRED data/NA19239/sequence_read/SRR003029_2.filt.fastq.gz 5826974 
PAIRED data/NA19239/sequence_read/SRR003029_1.filt.fastq.gz 5826974 
PAIRED data/NA19239/sequence_read/SRR007422_2.filt.fastq.gz 6497852 
PAIRED data/NA19239/sequence_read/SRR007422_1.filt.fastq.gz 6497852 
 NA19240   NA19240   NA19240 
LIBRARY_
 
PAIRED_FASTQ READ_COU
 PAIRED data/NA19240/sequence_read/SRR004483_2.filt.fastq.gz 10553597 
PAIRED data/NA19240/sequence_read/SRR004483_1.filt.fastq.gz 10553597 
PAIRED data/NA19240/sequence_read/SRR004484_2.filt.fastq.gz 11564301 
PAIRED data/NA19240/sequence_read/SRR004484_1.filt.fastq.gz 11564301 
PAIRED data/NA19240/sequence_read/SRR004485_2.filt.fastq.gz 10252162 
PAIRED data/NA19240/sequence_read/SRR004485_1.filt.fastq.gz 10252162 
PAIRED data/NA19240/sequence_read/SRR004783_2.filt.fastq.gz 9921824 
PAIRED data/NA19240/sequence_read/SRR004783_1.filt.fastq.gz 9921824 
PAIRED data/NA19240/sequence_read/SRR004784_2.filt.fastq.gz 11020784 
PAIRED data/NA19240/sequence_read/SRR004784_1.filt.fastq.gz 11020784 
PAIRED data/NA19240/sequence_read/SRR004785_2.filt.fastq.gz 11378879 
PAIRED data/NA19240/sequence_read/SRR004785_1.filt.fastq.gz 11378879 
PAIRED data/NA19240/sequence_read/SRR004786_2.filt.fastq.gz 11581025 
PAIRED data/NA19240/sequence_read/SRR004786_1.filt.fastq.gz 11581025 
PAIRED data/NA19240/sequence_read/SRR004788_2.filt.fastq.gz 11172997 
PAIRED data/NA19240/sequence_read/SRR004788_1.filt.fastq.gz 11172997 
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 NA19238   NA19238   
BASE_COUNT ANALYSIS_GROUP 
405730548 high coverage 
405730548 high coverage 
402241500 high coverage 
402241500 high coverage 
370827504 high coverage 
370827504 high coverage 
321516576 high coverage 
321516576 high coverage 
290735100 high coverage 
290735100 high coverage 
265695444 high coverage 
265695444 high coverage 
302878944 high coverage 
302878944 high coverage 
208535076 high coverage 
208535076 high coverage 
193988592 high coverage 
193988592 high coverage 
145230804 high coverage 
145230804 high coverage 
162360360 high coverage 
162360360 high coverage 
146174220 high coverage 
146174220 high coverage 
158312124 high coverage 
158312124 high coverage 
179863092 high coverage 
179863092 high coverage 
231213708 high coverage 
231213708 high coverage 
303081048 high coverage 
303081048 high coverage 
 NA19239   NA19239   
BASE_COUNT ANALYSIS_GROUP 
261289872 high coverage 
261289872 high coverage 
258137748 high coverage 
258137748 high coverage 
260820432 high coverage 
260820432 high coverage 
266904936 high coverage 
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266904936 high coverage 
292139748 high coverage 
292139748 high coverage 
290855916 high coverage 
290855916 high coverage 
286548336 high coverage 
286548336 high coverage 
186753852 high coverage 
186753852 high coverage 
222255108 high coverage 
222255108 high coverage 
218009520 high coverage 
218009520 high coverage 
242846460 high coverage 
242846460 high coverage 
238362984 high coverage 
238362984 high coverage 
241434144 high coverage 
241434144 high coverage 
209771064 high coverage 
209771064 high coverage 
233922672 high coverage 
233922672 high coverage 
 NA19240   NA19240   
BASE_COUNT ANALYSIS_GROUP 
369375895 high coverage 
369375895 high coverage 
404750535 high coverage 
404750535 high coverage 
358825670 high coverage 
358825670 high coverage 
347263840 high coverage 
347263840 high coverage 
385727440 high coverage 
385727440 high coverage 
398260765 high coverage 
398260765 high coverage 
405335875 high coverage 
405335875 high coverage 
391054895 high coverage 
391054895 high coverage 
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APPENDIX B  
[BLAT SUITE PROGRAM SPECIFICATIONS AND USER'S GUIDE]  
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BLAT Suite Program Specifications and User Guide 
 
General: 
 
Blat produces two major classes of alignments: at the DNA level between two 
sequences that are of 95% or greater identity, but which may include large inserts, 
and at the protein or translated DNA level between sequences that are of 80% or 
greater identity and may also include large inserts.  The output of BLAT is 
flexible.  By default it is a simple tab-delimited file which describes the alignment, 
but which does not include the sequence of the alignment itself. Optionally it can 
produce BLAST and WU-BLAST compatable output as well as a number of other 
formats. 
 
 
 
 
The main programs in the blat suite are: 
 
• gfServer – a server that maintains an index of the genome in memory and 
uses the index to quickly find regions with high levels of sequence 
similarity to a query sequence. 
• gfClient – a program that queries gfServer over the network, and then 
does a detailed alignment of the query sequence with regions found by 
gfServer. 
• blat –combines client and server into a single program, first building the 
index, then using the index, and then exiting. 
• webBlat – a web based version of gfClient that presents the alignments in 
an interactive fashion. 
 
Building an index of the genome typically takes 10 or 15 minutes.  Typically for 
interactive applications one uses gfServer to build a whole genome index.  At that 
point gfClient or webBlat can align a single query within few seconds.  If one is 
aligning a lot of sequences in a batch 
mode then blat can be more efficient, particularly if run on a cluster of computers.  
Each blat run is typically done against a single chromosome, but with a large 
number of query sequences. 
 
 
 
 
Other programs in the blat suite are: 
 
• pslSort – combines and sorts the output of multiple blat runs.  (The blat 
default output format is .psl). 
• pslReps – selects the best alignments for a particular query sequence, using 
a ‘near best in genome’ approach. 
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• pslPretty – converts alignments from the psl format, which is tab-
delimited format and does not include the bases themselves, to a more 
readable alignment format. 
• faToTwoBit – convert Fasta format sequence files to a dense randomly-
accessable  .2bit format that gfClient can use. 
• twoBitToFa – convert from the .2bit 
format back to fasta 
• faToNib – convert from Fasta to a somewhat less dense randomly 
accessible format that predates .2bit.  Note each .nib file can only contain 
a single sequence. 
 
• nibFrag – convert portions of a nib file back to fasta. 
 
 
 
 
In addition you may be interested in the following programs which are not part of 
the BLAT 
suite: 
 
• In Silico PCR –  given two primers quickly find the sequence between 
them.  Available from Kent Informatics. This includes webPCR, an 
interface similar to webBlat. 
• The Genome Browser – display annotations as a series of tracks on top of 
the genome. 
Available from the University of California 
Santa Cruz.  See 
http://genome.ucsc.edu/license/. 
 
 
 
 
Running the Programs: 
 
The command line options of each of the programs is described below. Similar 
summaries of usage are printed when a command is run with no arguments.  See 
the next section for info on installing webBlat. 
 
 
 
 
blat 
 
 
 
 
blat - Standalone BLAT sequence search 
command line tool usage: 
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blat database query [-ooc=11.ooc] 
output.psl where: 
database and query are each either a .fa , .nib or .2bit file, 
 
or a list these files one file name per line. 
 
-ooc=11.ooc tells the program to load over-occurring 
11-mers from and external file. This 
will increase the speed 
by a factor of 40 in many cases, but is 
not required output.psl is where to put the output. 
Subranges of nib and .2bit files may specified using the syntax: 
 
/path/file.nib:seqid:start-end 
 
or 
 
/path/file.2bit:seqid:start-end 
 
or 
 
/path/file.nib:start-end 
 
With the second form, a sequence id of file:start-end will 
be used. options: 
-t=type Database type. Type is one of: 
 
dna - DNA sequence 
 
prot - protein sequence 
 
dnax - DNA sequence translated in six frames to protein 
 
The default is dna 
 
-q=type Query type. Type is one of: 
 
dna - DNA 
sequence 
rna - RNA 
sequence 
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prot - protein sequence 
 
dnax - DNA sequence translated in six frames to 
protein rnax - DNA sequence translated in three 
frames to protein 
The default is dna 
 
-prot Synonymous with -t=prot -q=prot 
 
-ooc=N.ooc Use overused tile file N.ooc. N should 
correspond to the tileSize 
-tileSize=N sets the size of match that triggers an alignment. 
 
Usually between 8 and 12 
 
Default is 11 for DNA and 5 for protein. 
 
-stepSize=N spacing between tiles. Default is tileSize. 
 
-oneOff=N If set to 1 this allows one mismatch in tile and still 
 
triggers an alignments.  Default 
is 0. 
 
-minMatch=N sets the number of tile matches. Usually set from 2 to 4 
 
Default is 2 for nucleotide, 1 for 
protein. 
 
-minScore=N sets minimum score. This is the matches minus the 
mismatches minus some sort of gap penalty. Default 
is 30 
-minIdentity=N Sets minimum sequence identity (in percent). Default is 
 
90 for nucleotide searches, 25 for protein or 
translated protein searches. 
-maxGap=N sets the size of maximum gap between tiles in a clump.
 Usually set from 0 to 3.
 Default is 2. Only relevent for 
minMatch > 1. 
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-noHead suppress .psl header (so it's just a tab-separated file) 
 
-makeOoc=N.ooc Make overused tile file. Target needs to be complete 
genome. 
 
-repMatch=N sets the number of repetitions of a tile allowed before 
 
it is marked as overused.  Typically this is 256 for 
tileSize 
 
12, 1024 for tile size 11, 4096 for tile 
size 10. 
 
Default is 1024.  Typically only comes into play with 
makeOoc. Also affected by stepSize. When stepSize is 
halved repMatch is doubled to compensate. 
-mask=type Mask out repeats. Alignments won't be started in masked region 
 
but may extend through it in nucleotide searches. Masked 
areas are ignored entirely in protein or translated 
searches. Types are 
lower - mask out lower cased sequence 
 
upper - mask out upper cased sequence 
 
out - mask according to database.out RepeatMasker 
.out file file.out - mask database according to 
RepeatMasker file.out 
-qMask=type Mask out repeats in query sequence. Similar to -mask 
above but for query rather than target sequence. 
 
-repeats=type Type is same as mask types above. Repeat bases will 
not be masked in any way, but matches in repeat areas 
will be reported separately from matches in other areas 
in the psl output. 
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-minRepDivergence=NN - minimum percent divergence of repeats to 
allow them to be unmasked. Default is 15. Only 
relevant for masking using RepeatMasker .out files. 
-dots=N Output dot every N sequences to show program's progress 
 
-trimT Trim leading poly-T 
 
-noTrimA Don't trim trailing poly-A 
 
-trimHardA Remove poly-A tail from qSize as well as 
alignments in psl output 
-fastMap Run for fast DNA/DNA remapping - not allowing 
introns, requiring high %ID 
-out=type Controls output file format. Type is one of: 
 
psl - Default. Tab separated format, no 
sequence pslx - Tab separated format with 
sequence 
axt - blastz-associated axt 
format maf - multiz-
associated maf format sim4 - 
similar to sim4 format 
wublast - similar to wublast 
format 
blast - similar to NCBI blast 
format blast8- NCBI blast 
tabular format 
blast9 - NCBI blast tabular format with comments 
 
-fine For high quality mRNAs look harder for small 
initial and terminal exons. Not recommended for 
ESTs 
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-maxIntron=N Sets maximum intron size. Default is 750000 
 
-extendThroughN - Allows extension of alignment through large blocks of 
N's 
 
 
Here are some blat settings for common usage scenarios: 
 
 
1) Mapping ESTs to the genome within the same species 
 
-ooc=11.ooc 
 
2) Mapping full length mRNAs to the genome in the same species 
 
-ooc=11.ooc -fine -q=rna 
 
3) Mapping ESTs to the genome across species 
 
-q=dnax -t=dnax 
 
4) Mapping mRNA to the genome across species 
 
-q=rnax -t=dnax 
 
5) Mapping proteins to the genome 
 
-q=prot -t=dnax 
 
6) Mapping DNA to DNA in the same species 
 
-ooc=11.ooc -fastMap 
 
7) Mapping DNA from one species to another species 
 
-q=dnax -t=dnax 
 
When mapping DNA from one species to another the 
 
query side of the alignment should be cut up 
into chunks of 25kb or less for best 
performance. 
 
gfServer 
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gfServer - Make a server to quickly find where DNA occurs 
in genome. To set up a server: 
gfServer start host port file(s) 
 
Where the files are in .nib or .2bit format 
 
To remove a server: 
 
gfServer stop host port 
 
To query a server with DNA sequence: 
 
gfServer query host port probe.fa 
 
To query a server with protein sequence: 
 
gfServer protQuery host port probe.fa 
 
To query a server with translated dna sequence: 
 
gfServer transQuery host port probe.fa 
 
To process one probe fa file against a .nib format genome (not starting 
server): 
 
gfServer direct probe.fa file(s).nib 
 
To figure out usage 
level gfServer 
status host port 
To get input file 
list gfServer 
files host port 
Options: 
 
-tileSize=N size of n-mers to index. Default is 11 for 
nucleotides, 4 for proteins (or translated 
nucleotides). 
-stepSize=N spacing between tiles. Default is tileSize. 
 
-minMatch=N Number of n-mer matches that trigger detailed alignment 
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Default is 2 for nucleotides, 3 for 
protiens. 
 
-maxGap=N Number of insertions or deletions allowed between n-mers. 
 
Default is 2 for nucleotides, 0 for 
protiens. 
 
-trans Translate database to protein in 6 frames. Note: 
it is best to run this on RepeatMasked data in this 
case. 
-log=logFile keep a log file that records server requests. 
 
-seqLog Include sequences in log file (not logged with -syslog) 
 
-syslog Log to syslog 
 
-logFacility=facility log to the specified syslog facility - default 
local0. 
 
-mask Use masking from nib file. 
 
-repMatch=N Number of occurrences of a tile (nmer) 
that trigger repeat masking the tile. 
Default is 1024. 
-maxDnaHits=N Maximum number of hits for a dna query that are sent from 
the 
 
server. Default is 100. 
 
-maxTransHits=N Maximum number of hits for a translated query 
that are sent from the server. Default is 200. 
-maxNtSize=N Maximum size of untranslated DNA query sequence 
 
Default is 40000 
 
-maxAsSize=N Maximum size of protein or translated DNA queries 
 
Default is 8000 
 
-canStop If set then a quit message will actually take 
down the server 
gfClient 
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gfClient - A client for the genomic 
finding program usage: 
gfClient host port nibDir in.fa out.psl 
 
where 
 
host is the name of the machine running the 
gfServer port is the same as you started 
the gfServer with 
nibDir is the path of the nib files relative to the current dir 
 
(note these are needed by the client as well as the server) 
 
in.fa a fasta format file. May contain 
multiple records out.psl where to put the 
output 
options: 
 
-t=type Database type. Type is one of: 
 
dna - DNA sequence 
 
prot - protein sequence 
 
dnax - DNA sequence translated in six frames to protein 
 
The 
default 
is dna 
 
-q=type Query type. Type is one of: 
 
dna - DNA 
sequence 
rna - RNA 
sequence 
prot - protein sequence 
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dnax - DNA sequence translated in six frames to 
protein rnax - DNA sequence translated in three 
frames to protein 
-dots=N Output a dot every N query sequences 
 
-nohead Suppresses psl five line header 
 
-minScore=N sets minimum score. This is twice the matches 
minus the mismatches minus some sort of gap 
penalty. Default is 30 
-minIdentity=N Sets minimum sequence identity (in percent). Default is 
 
90 for nucleotide searches, 25 for protein or 
translated protein searches. 
 
 
-out=type Controls output file format. Type is one of: 
 
psl - Default. Tab separated format without actual 
sequence pslx - Tab separated format with sequence 
axt - blastz-associated axt 
format maf - multiz-
associated maf format 
wublast - similar to 
wublast format blast - 
similar to NCBI blast 
format 
-maxIntron=N Sets maximum intron size. Default is 750000 
 
 
 
webBlat 
 
webBlat generally is not run from the command line. See ‘Setting 
Up webBlat instructions below` for information on this program. 
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faToTwoBit 
 
faToTwoBit - Convert DNA from fasta to 
2bit format usage: 
faToTwoBit in.fa [in2.fa in3.fa ...] 
out.2bit options: 
-noMask - Ignore lower-case masking in fa file. 
 
 
 
 
twoBitToFa 
 
twoBitToFa - Convert all or part of .2bit file 
to fasta usage: 
twoBitToFa input.2bit 
output.fa options: 
-seq=name - restrict this to just one sequence 
 
-start=X - start at given position in sequence (zero-based) 
 
-end=X - end at given position in sequence (non-inclusive) 
 
faToNib 
 
faToNib - Convert from .fa 
to .nib format usage: 
faToNib in.fa out.nib 
 
 
nibFrag 
 
nibFrag - Extract part of a 
nib file as .fa usage: 
nibFrag file.nib start end strand out.fa 
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pslPretty 
 
pslPretty - Convert PSL to human 
readable output usage: 
pslPretty in.psl target.lst 
query.lst pretty.out options: 
-axt - save in Scott Schwartz's axt format 
 
-dot=N Put out a dot every N records 
 
-long - Don't abbreviate long inserts 
 
 
 
 
It's a really good idea if the psl file is sorted by target if it contains multiple targets.  
Otherwise this will be very very slow.   The target and query lists can either be 
fasta files, nib files, or a list of fasta and/or nib files one per line.  Currently this 
only handles nucleotide based psl files. 
 
 
 
 
pslSort 
 
pslSort - merge and sort psCluster 
.psl output files usage: 
pslSort dirs[1|2] outFile 
tempDir inDir(s) 
 
This will sort all of the .psl files in the 
directories inDirs in two stages - first into 
temporary files in tempDir and second into outFile.
 The device on tempDir 
needs to have 
enough space (typically 15-20 gigabytes if processing whole genome) 
 
pslSort g2g[1|2] outFile tempDir inDir(s) 
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This will sort a genome to genome alignment, 
reflecting the alignments across the diagonal. 
 
 
Adding 1 or 2 after the dirs or g2g will limit the 
program to only the first or second pass repectively 
of the sort 
Options: 
 
-verbose=N Set verbosity level, higher for more output. Default 1 
 
 
 
 
Note for huge files pslSort will run out of memory. The unix 
sort command sort –k 10 *.psl > sorted.psl 
may be preferable in these situations, though the psl header 
lines should be removed or avoided with the –noHead option to 
blat. 
 
 
pslReps 
 
pslReps - analyse repeats and generate genome 
wide best alignments from a sorted set of 
local alignments 
usage: 
 
pslReps in.psl out.psl out.psr 
 
where in.psl is an alignment file generated by 
psLayout and sorted by pslSort, out.psl is the 
best alignment output 
and out.psr contains repeat info 
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options: 
 
-nohead don't add PSL header 
 
-ignoreSize Will not weigh in favor of larger alignments so much 
 
-noIntrons Will not penalize for not having introns when 
calculating size factor 
-singleHit Takes single best hit, not splitting into parts 
 
-minCover=0.N minimum coverage to output. Default is 0. 
 
-ignoreNs Ignore 'N's when calculating minCover. 
 
-minAli=0.N minimum 
alignment ratio 
default is 0.93 
-nearTop=0.N how much can deviate from top and be taken 
 
default is 0.01 
 
-minNearTopSize=N Minimum size of alignment that is 
near top for aligmnent to be kept.
 Default 30. 
-coverQSizes=file Tab-separate file with effective query sizes. 
 
When used with -minCover, this 
allows polyAs to be excluded from 
the coverage calculation 
 
 
 
Setting Up webBlat 
 
INSTALLING WEBBLAT 
Installing A Web-Based Blat Server involves four major steps: 
 
1) Creating sequence databases. 
 
2) Running the gfServer program to create in-memory indexes of the databases. 
 
3) Editing the webBlat.cfg file to tell it what machine and port the gfServer(s) 
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are running on, and optionally customizing the webBlat appearance to users. 
 
4) Copying the webBlat executable and webBlat.cfg to a directory where the web 
server can execute webBlat as a CGI. 
 
 
 
CREATING SEQUENCE DATABASES 
 
 
 
 
You create databases with the program faToTwoBit. Typically you'll create a 
separate database for each genome you are indexing.  Each database can 
contain up to four billion bases of sequence in an unlimited number of records.  
The databases for webPcr and webBlat are identical. 
 
 
 
The input to faToTwoBit is one or more fasta format files each of which can 
contain multiple records.  If the sequence contains repeat sequences, as is the 
case with vertebrates and many plants, the repeat sequences can 
be represented in lower case and the other sequence in upper case.  The 
gfServer program can be configured to ignore the repeat sequences.  The output 
of faToTwoBit is a file which is designed for fast random access and efficient 
storage.  The output files store four bases per byte.  They use a small amount 
of additional space to store the case of the DNA and to keep track of runs of 
 
N's in the input.  Non-N ambiguity codes such as Y and U in the input sequence 
will be converted to N. 
 
 
 
Here's how a typical installation might create a mouse and a human genome 
database: 
 
cd/data/genomes mkdir twoBit 
faToTwoBit human/hg16/*.fa twoBit/hg16.2bit faToTwoBit mouse/mm4/*.fa 
twoBit/mm4.2bit 
There's no need to put all of the databases in the same directory, but it can 
simplify bookkeeping. 
 
 
 
The databases can also be in the .nib format which was used with blat and 
gfClient/gfServer until recently.  The .nib format only packed 2 bases per byte, 
and could only handle one record per nib file.  Recent versions of blat and 
related programs can use .2bit files as well. 
 
 
 
  139 
CREATING IN-MEMORY INDICES WITH GFSERVER 
 
The gfServer program creates an in-memory index of a nucleotide sequence 
database. The index can either be for translated or untranslated searches.  
Translated indexes enable protein-based blat queries and use approximately two 
bytes per unmasked base in the database.  Untranslated indexes are used 
nucleotide-based blat queries as well 
as for In-silico PCR.  An index for normal blat uses approximately 1/4 byte per 
base.  For blat on smaller (primer-sized) queries or for In-silico PCR a more 
thorough index that requires 1/2 byte per base is recommended.  The gfServer 
is memory intensive but typically doesn not require a lot of CPU power.  Memory 
permitting multiple gfServers can be run on the same machine. 
 
 
A typical installation might go: 
 
ssh bigRamMachine 
 
cd /data/genomes/twoBit 
 
gfServer start bigRamMachine 17779 hg16.2bit & 
 
gfServer -trans -mask start bigRamMachine 17778 hg16.2bit & 
 
the -trans flag makes a translated index.   It will take approximately 
 
15 minutes to build an untranslated index, and 45 minutes to build a translate 
index.  To build an untranslated index to be shared with 
In-silico PCR do 
 
gfServer -stepSize=5 bigRamMachine 17779 hg16.2bit & 
 
This index will be slightly more sensitive, noticeably so for small query 
sequences, with blat. 
 
 
EDITING THE WEBBLAT.CFG FILE 
 
 
The webBlat.cfg file tells the webBlat program where to look for gfServers and 
for sequence.  The basic format of the .cfg file is line oriented with the 
first word of the line being a command.  Blank lines and lines starting with # 
 
are ignored.  The webBlat.cfg and webPcr.cfg files are similar. The webBlat.cfg 
commands are: 
gfServer  - defines host and port a (untranslated) gfServer is running on, the 
associated sequence directory, and the name of the database to display in the 
webPcr web page. 
 
gfServerTrans - defines location of a translated server. 
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background - defines the background image if any to display on web page 
company - defines company name to display on web page 
tempDir - where to put temporary files.  This path is relative to where the 
web server executes CGI scripts.  It is good to remove files that haven't 
been accessed for 24 hours from this directory periodically, via a cron job or 
similar mechanism. 
The background and company commands are optional.  The webBlat.cfg file 
must have at least one valid gfServer or gfServerTrans line, and a tempDir line. 
.  Here is a webBlat.cfg file that you might find at a typical installation: 
 
 
 
company Awesome Research Amalgamated background /images/dnaPaper.jpg 
gfServer bigRamMachine 17778 /data/genomes/2bit/hg16.2bit Human Genome 
gfServer bigRamMachine 17779 /data/genomes/2bit/hg16.2bit Human Genome 
gfServer mouseServer 17780 /data/genomes/2bit/mm4.2bit Mouse Genome 
gfServer mouseServer 17781 /data/genomes/2bit/mm4.2bit Mouse Genome 
tempDir ../trash 
 
 
 
PUTTING WEBBLAT WHERE THE WEB SERVER CAN EXECUTE IT 
 
The details of this step vary highly from web server to web server.  On a typical 
Apache installation it might be: 
ssh webServer cd kent/webBlat 
cp webBlat webBlat.cfg /usr/local/apache/cgi-bin mkdir /usr/local/apache/trash 
chmod 777 /usr/local/apache/trash 
 
assuming that you've put the executable and config file in kent/webBlat. The 
program will create some files in the trash directory.  It is good to periodically 
clean out old files from this directory.   On Mac OS-X instead you might do: 
cp webBlat webBlat.cfg /Library/WebServer/CGI-Executables mkdir 
/Library/WebServer/trash 
chmod 777 /Library/WebServer/trash 
 
Unless you are administering your own computer you will likely need to ask your 
local system administrators for help with this part of the webBlat installation. 
 
 
File Formats 
 
.psl files 
 
A .psl file describes a series of alignments in a dense easily parsed text format.  
It begins with a five line header which describes each field.  Following this is one 
line for each alignment with a tab between each field.  The fields are describe 
below in  a format suitable for many relational databases. 
 
matches int unsigned , # Number of bases that match that aren't repeats 
 
misMatches int unsigned ,  # Number of bases that don't match 
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repMatches int unsigned ,  # Number of bases that match but are part of 
repeats nCount int unsigned , # Number of 'N' bases 
qNumInsert int unsigned ,  # Number of inserts in query  
qBaseInsert int unsigned ,  # Number of bases inserted in query  
tNumInsert int unsigned ,   # Number of inserts in target  
tBaseInsert int unsigned ,   # Number of bases inserted in target 
strand char(2) , # + or - for query strand, optionally followed by + or – for 
target strand  
qName varchar(255) , # Query sequence name 
qSize int unsigned , # Query sequence size 
 
qStart int unsigned ,           # Alignment start position in query  
qEnd int unsigned ,            # Alignment end position in query  
tName varchar(255) ,         # Target sequence name 
tSize int unsigned , # Target sequence size 
 
tStart int unsigned , # Alignment start position in target  
tEnd int unsigned , # Alignment end position in target 
blockCount int unsigned ,  # Number of blocks in alignment. A block contains 
no gaps.  
blockSizes longblob , # Size of each block in a comma separated list 
qStarts longblob , # Start of each block in query in a comma separated list 
tStarts longblob , # Start of each block in target in a comma separated list 
 
In general the coordinates in psl files are “zero based half open.” The first base 
in a sequence is numbered zero rather than one. When representing a range the 
end coordinate is not included in the range. Thus the first 100 bases of a 
sequence are represented as 0-100, and the second 100 bases are represented 
as 100-200. There is a another little unusual feature in the .psl format. It has to 
do with how coordinates are handled on the negative strand. In the qStart/qEnd 
fields the coordinates are where it matches from the point of view of the forward 
strand (even when the match is on the reverse strand). However on the 
qStarts[] list, the coordinates are reversed. 
Here's an example of a 30-mer that has 2 blocks that align on the minus strand 
and 2 blocks on the plus strand (this sort of stuff happens in real life in response 
to assembly errors sometimes). 
 
0 1 2 3 tens position in query 
0123456789012345678901234567890 ones position in query 
++++ +++++ plus strand alignment on query 
-------- ---------- minus strand alignment on query 
 
Plus strand: 
qStart 12 qEnd 31 blockSizes 4,5 qStarts 12,26 
Minus strand: 
qStart 4 qEnd 26 blockSizes 10,8 qStarts 5,19 
 
Essentially the minus strand blockSizes and qStarts are what you would get if 
you reverse complemented the query.However the qStart and qEnd are non-
reversed. To get from one to the other: 
qStart = qSize - revQEnd qEnd = qSize - revQStart 
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.2bit files 
 
A .2bit file can store multiple DNA sequence (up to 4 gig total) in a compact 
randomly accessible format.  The two  bit files contain masking information as 
well as the DNA itself. The file begins with a 16 byte header containing the 
following fields: 
 
1)  signature – the number 0x1A412743 in the architecture of the 
machine that created the file. 
 
2) version – zero for now. Readers should abort if they see a version 
number higher than 0. 
 
3) sequenceCount – the number of sequences in the file 
 
4) reserved – always zero for now. 
 
All fields are 32 bits unless noted. If the signature value is not as given, the 
reader program should byte swap the signature and see if the swapped version 
matches.  If so all multiple-byte entities in the file will need to be byte-swapped.  
This enables these binary files to be used unchanged on different architectures. 
 
 
 
 
The header is followed by a file index.  There is one entry in the index for each 
sequence.   Each index entry contains three fields: 
 
1) nameSize – a byte containing the length of the name field 
 
2)  name – this contains the sequence name itself, and is variable 
length depending on nameSize. 
 
3) offset – 32 bit offset of the sequence data relative to the start of the file 
 
 
 
 
The index is followed by the sequence records.  These contain 9 fields: 
 
1) dnaSize – number of bases of DNA in the sequence. 
 
2) nBlockCount – the number of blocks of N’s in the file (representing 
unknown 
sequence). 
 
3) nBlockStarts – a starting position for each block of N’s 
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4) nBlockSizes – the size of each block of N’s 
 
5) maskBlockCount – the number of masked (lower case) blocks 
 
6) maskBlockStarts – starting position for each masked block 
 
7) maskBlockSizes – the size of each masked block 
 
8) packedDna – the dna packed to two bits per base as so: 00 – T,  01 – C,  
10 – A, 11 – G. 
The first base is in the most significant 2 bits byte, and the last base in the least 
significant 2 bits, so that the sequence TCAG would be represented as 
00011011.  The packedDna field will be padded with 0 bits as necessary so that 
it takes an even multiple of 32 bit in the file, as this improves i/o performance 
on some machines. 
 
 
 
 
 
 
 
.nib files 
 
A .nib file describes a DNA sequence packing two bases into each byte. Each nib 
file contains only a single sequence.  A nib file begins with a 32 bit signature 
which is 0x6BE93D3A in the architecture of the machine that created the file, 
and possibly a byte-swapped version of the same number on another machine.  
This is followed by a 32 bit number in the same format which describes the 
number of bases in the file.   This is followed by the bases themselves packed 
two bases to the byte.  The first base is packed in the high order 4 bits (nibble), 
the second base in the low order four bits.  In C code: 
 
byte = (base1<<4) + base2 
 
The numerical values for the bases are: 
 
0 – T, 1 – C, 2 – A, 3 – G, 4 – N (unknown) 
 
The most significant bit in a nibble is set if the base is masked. 
 
Limits 
 
The gfServer program requires approximately 1 byte for every 3 bases in the 
genome it is indexing in DNA mode, and 1.5 bytes for each unmasked base in 
translated mode. The blat program requires approximately two bytes for each 
base in the genome in DNA mode, and three bytes for each base in translated 
mode. The other programs use relatively little memory. 
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APPENDIX C 
[SIMULATED TRANSLOCATION REFERENCE LIST]   
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Additional file 1 - Comprehensive list of gene pairs involved in cancer-specific recurrent translocations which result in fusion transcripts 
Translocation Gene Location Fragile Site Gene Location Fragile 
 t(7;12)(p22;q13) ACTB 7p22.1 FRA7B (common, apc) GLI1 12q13.3  
inv(7)(q21q34) AKAP9 7q21.2 FRA7E (common, apc) BRAF 7q34  
t(X;17)(p11;q25) ASPSCR1 17q25.3  TFE3 Xp11.23  
inv(2)(p23q35) ATIC 2q35  ALK 2p23.2-p23.1  
t(17;20)(q23;q13) BCAS4 20q13.13  BCAS3 17q23.2  
t(2;3)(p16;q26) BCL11A 2p16.1  MDS1 3q26.2  
t(5;14)(q35;q32) BCL11B 14q32.2  NKX2E 5q35.2 FRA5G (rare, folic acid) 
t(5;14)(q35;q32) BCL11B 14q32.2  TLX3 5q35.1 FRA5G (rare, folic acid) 
inv(14)(q11q32) BCL11B 14q32.2  TRD@ 14q11.2  
t(14;18)(q32;q21) BCL2 18q21.33 FRA18B (common, apc) IGH@ 14q32.33  
t(2;18)(p11;q21) BCL2 18q21.33 FRA18B (common, apc) IGK@ 2p11.2 FRA2L (rare, folic acid) 
t(18;22)(q21;q11) BCL2 18q21.33 FRA18B (common, apc) IGL@ 22q11.22  
t(8;19)(q24;q13) BCL3 19q13.31 FRA19A (common, 5-aza) MYC 8q24.21  
t(3;16)(q27;p13) BCL6 3q27.3 FRA3C (common, apc) CIITA 16p13.13  
t(3;8)(q27;q24) BCL6 3q27.3 FRA3C (common, apc) MYC 8q24.21  
t(1;14)(q21;q32) BCL9 1q21.1 FRA1F (common, apc) IGH@ 14q32.33  
t(1;22)(q21;q11) BCL9 1q21.1 FRA1F (common, apc) IGL@ 22q11.22  
t(9;22)(q34;q11) BCR 22q11.23  ABL1 9q34.12  
t(8;22)(p12;q11) BCR 22q11.23  FGFR1 8p12  
t(9;22)(p24;q11) BCR 22q11.23  JAK2 9p24.1  
t(4;22)(q12;q11) BCR 22q11.23  PDGFRA 4q12 FRA4B (common, BrdU) 
t(11;18)(q22;q21) BIRC3 11q22.2  MALT1 18q21.32 FRA18B (common, apc) 
t(X;11)(q21;q23) BRWD3 Xq21.1  ARHGAP20 11q22.3-q23.1  
t(8;12)(q21;q22) BTG1 12q21.33 FRA12B (common, apc) MYC 8q24.21  
t(7;15)(p21;q21) C15ORF21 15q21.1  ETV1 7p21.2  
t(3;3)(q21;q26) C3ORF27 3q21.3  EVI1 3q26.2  
t(2;11)(p23;p15) CARS 11p15.4  ALK 2p23.2-p23.1  
t(16;16)(p13;q22), inv(16)(p13q22) CBFB 16q22.1 FRA16B (rare, dist A), FRA16C (common, apc) MYH11 16p13.11 FRA16A (rare, folic acid) 
t(5;10)(q33;q21) CCDC6 10q21.2 FRA10C (common, BrdU) PDGFRB 5q33.1  
inv(10)(q11q21) CCDC6 10q21.2 FRA10C (common, BrdU) RET 10q11.21 FRA10G (common, apc) 
t(5;14)(q33;q32) CCDC88C 14q32.12  PDGFRB 5q33.1  
t(11;19)(q13;p13) CCND1 11q13 .2 FRA11H (common, apc) FSTL3 19p13.3 FRA19B (rare, folic acid) 
t(5;6)(q32-33;q22) CD74 5q33.1  ROS1 6q22.2  
t(16;17)(q21;p13) CDH11 16q21  USP6 17p13.2  
t(7;11)(q21;q23) CDK6 7q21.2 FRA7E (common, apc) MLL 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(5;7)(q35;q21) CDK6 7q21.2 FRA7E (common, apc) TLX3 5q35.1 FRA5G (rare, folic acid) 
t(5;11)(q12;q23) CENPK 5q12.3  MLL 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(8;9)(p12;q33) CEP110 9q33.2  FGFR1 8p12  
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t(4;12)(q12;p13) CHIC2 4q12 FRA4B (common, BrdU) ETV6 12p13.2  
t(4;19)(q35;q13) CIC 19q13.2 FRA19A (common, 5-aza) DUX4 4q35.2  
t(2;17)(p23;q23) CLTC 17q23.1 FRA17B (common, apc) ALK 2p23.2-p23.1  
t(X;17)(p11;q23) CLTC 17q23.1 FRA17B (common, apc) TFE3 Xp11.23  
t(2;22)(p23;q11) CLTCL1 22q11.21  ALK 2p23.2-p23.1  
t(3;17)(q21;p13) CNBP 3q21.3  USP6 17p13.2  
t(17;22)(q21;q13) COL1A1 17q21.33  PDGFB 22q13.1 FRA22A (rare, folic acid) 
t(17;17)(p13;q21) COL1A1 17q21.33  USP6 17p13.2  
t(7;8)(q21;q12) COL1A2 7q21.3  PLAG1 8q12.1  
t(X;6)(q22;q13-14) COL4A5 Xq22.3  COL12A1 6q13-q14.1 FRA6D (common, BrdU) 
t(1;2)(p13;q37) COL6A3 2q37.3 FRA2J (common, apc) CSF1 1p13.3  
t(8;12)(p12;q15) CPSF6 12q15  FGFR1 8p12  
t(11;19)(q21;p13) CRTC1 19p13.11 FRA19B (rare, folic acid) MAML2 11q21  
t(11;15)(q21;q26) CRTC3 15q26.1  MAML2 11q21  
t(3;8)(p22;q12) CTNNB1 3p22.1  PLAG1 8q12.1  
t(3;9)(q27;p24) DMRT1 9p24.3  BCL6 3q27.3 FRA3C (common, apc) 
t(1;1)(p36;q41) DUSP10 1q41  PRDM16 1p36.32 FRA1A (common, apc) 
t(5;12)(q33;q14) EBF1 5q33.3  LOC204010 12q14.3  
t(X;21)(q25;q22) ELF4 Xq25  ERG 21q22.2  
t(9;14)(q34;q32) EML1 14q32.2  ABL1 9q34.12  
inv(2)(p21p23), del(2)(p21p23)* EML4 2p21  ALK 2p23.2-p23.1  
t(5;12)(q33;p13) ERC1 12p13.33  PDGFRB 5q33.1  
t(10;12)(q11;p13) ERC1 12p13.33  RET 10q11.21 FRA10G (common, apc) 
t(9;12)(q34;p13) ETV6 12p13.2  ABL1 9q34.12  
t(1;12)(q25;p13) ETV6 12p13.2  ABL2 1q25.2  
t(5;12)(q31;p13) ETV6 12p13.2  ACSL6 5q31.1 FRA5C (common, apc) 
t(1;12)(q21;p13) ETV6 12p13.2  ARNT 1q21.2 FRA1F (common, apc) 
t(12;12)(p13;q13) ETV6 12p13.2  BAZ2A 12q13.3  
t(12;13)(p13;q12) ETV6 12p13.2  CDX2 13q12.2  
t(3;12)(q26;p13) ETV6 12p13.2  EVI1 3q26.2  
t(4;12)(p16;p13) ETV6 12p13.2  FGFR3 4p16.3  
t(12;13)(p13;q12) ETV6 12p13.2  FLT3 13q12.2  
t(6;12)(q22;p13) ETV6 12p13.2  FRK 6q22.1  
t(10;12)(q24;p13) ETV6 12p13.2  GOT1 10q24.2 FRA10A (rare, folic acid) 
t(9;12)(p24;p13) ETV6 12p13.2  JAK2 9p24.1  
t(3;12)(q26;p13) ETV6 12p13.2  MDS1 3q26.2  
t(1;12)(p36;p13) ETV6 12p13.2  MDS2 1p36.11 FRA1A (common, apc) 
t(12;15)(p13;q25) ETV6 12p13.2  NTRK3 15q25.3  
t(4;12)(q12;p13) ETV6 12p13.2  PDGFRA 4q12 FRA4B (common, BrdU) 
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t(5;12)(q33;p13) ETV6 12p13.2  PDGFRB 5q33.1  
t(12;17)(p13;p13) ETV6 12p13.2  PER1 17p13.1  
inv(12)(p13q15) ETV6 12p13.2  PTPRR 12q15  
t(12;21)(p13;q22) ETV6 12p13.2  RUNX1 21q22.12  
t(6;12)(q23;p13) ETV6 12p13.2  STL 6q23  
t(9;12)(q22;p13) ETV6 12p13.2  SYK 9q22.2  
t(12;22)(q13;q12) EWSR1 22q12.2 FRA22B (common, apc) ATF1 12q13.13 FRA12A (rare, folic acid) 
t(2;22)(q33;q12) EWSR1 22q12.2 FRA22B (common, apc) CREB1 2q33.3 FRA2I (common,apc) 
t(12;22)(q13;q12) EWSR1 22q12.2 FRA22B (common, apc) DDIT3 12q13.3  
t(21;22)(q22;q12) EWSR1 22q12.2 FRA22B (common, apc) ERG 21q22.2  
t(7;22)(p21;q12) EWSR1 22q12.2 FRA22B (common, apc) ETV1 7p21.2  
t(17;22)(q21;q12) EWSR1 22q12.2 FRA22B (common, apc) ETV4 17q21.31  
t(2;22)(q35;q12) EWSR1 22q12.2 FRA22B (common, apc) FEV 2q35  
t(11;22)(q24;q12) EWSR1 22q12.2 FRA22B (common, apc) FLI1 11q24.3  
t(9;22)(q31;q12) EWSR1 22q12.2 FRA22B (common, apc) NR4A3 9q31.1  
inv(22)(q12q12) EWSR1 22q12.2 FRA22B (common, apc) PATZ1 22q12.2 FRA22B (common, apc) 
t(6;22)(p21;q12) EWSR1 22q12.2 FRA22B (common, apc) POU5F1 6p21.33 FRA6H (common, apc) 
t(2;22)(q31;q12) EWSR1 22q12.2 FRA22B (common, apc) SP3 2q31.1 FRA2G (common, apc) 
t(11;22)(p13;q12) EWSR1 22q12.2 FRA22B (common, apc) WT1 11p13 FRA11E (common, apc) 
t(12;22)(p13;q12) EWSR1 22q12.2 FRA22B (common, apc) ZNF384 12p13.31  
t(5;7)(q31;q34) FCHSD1 5q31.3  BRAF 7q34  
t(6;8)(q27;p12) FGFR1OP 6q27  FGFR1 8p12  
del(4)(q12q12)* FIP1L1 4q12 FRA4B (common, BrdU) PDGFRA 4q12 FRA4B (common, BrdU) 
t(4;17)(q12;q21) FIP1L1 4q12 FRA4B (common, BrdU) RARA 17q21.2  
t(2;13)(q36;q14) FOXO1A 13q14.11  PAX3 2q36.1  
t(X;11)(q13;q23) FOXO4 Xq13.1  MLL 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(12;16)(q13;p11) FUS 16p11.2  ATF1 12q13.13 FRA12A (rare, folic acid) 
t(11;16)(p11;p11) FUS 16p11.2  CREB3L1 11p11.2  
t(7;16)(q34;p11) FUS 16p11.2  CREB3L2 7q33-q34  
t(12;16)(q13;p11) FUS 16p11.2  DDIT3 12q13.3  
t(16;21)(p11;q22) FUS 16p11.2  ERG 21q22.2  
t(2;16)(q35;p11) FUS 16p11.2  FEV 2q35  
t(3;12)(q27;p13) GAPDH 12p13.31  BCL6 3q27.3 FRA3C (common, apc) 
t(5;12)(q33;q24) GIT2 12q24.11 FRA12E (common, apc) PDGFRB 5q33.1  
t(10;14)(q11;q32) GOLGA5 14q32.12  RET 10q11.21 FRA10G (common, apc) 
del(6)(q21q22)* GOPC 6q22.2  ROS1 6q22.2  
del(8)(q12q24)* HAS2 8q24.13 FRA8C (common, apc), FRA8E (rare, dist A) PLAG1 8q12.1  
t(8;19)(p12;q13) HERV-K (LOC113386) 19q13.43 FRA19A (common, 5-aza) FGFR1 8p12  
t(5;7)(q33;q11) HIP1 7q11.23 FRA7J (common, apc) PDGFRB 5q33.1  
t(3;6)(q27;p22) HIST1H4I 6p22.1  BCL6 3q27.3 FRA3C (common, apc) 
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inv(6)(p21q21) HMGA1 6p21.31 FRA6H (common, apc) LAMA4 6q21 FRA6F (common, apc) 
t(12;14)(q14;q11) HMGA2 12q14.3  CCNB1IP1 14q11.2  
t(8;12)(q22;q14) HMGA2 12q14.3  COX6C 8q22.2  
t(2;12)(q37;q14) HMGA2 12q14.3  CXCR7 2q37.3 FRA2J (common, apc) 
t(5;12)(q33;q14) HMGA2 12q14.3  EBF1 5q33.3  
t(12;13)(q14;q13) HMGA2 12q14.3  LHFP 13q13.3  
t(3;12)(q28;q14) HMGA2 12q14.3  LPP 3q28  
t(9;12)(p23;q14) HMGA2 12q14.3  NFIB 9p23-p22.3  
t(12;14)(q14;q24) HMGA2 12q14.3  RAD51L1 14q24.1 FRA14C (common, apc) 
t(7;7)(p15;p21) HNRPA2B1 7p15.2  ETV1 7p21.2  
t(8;10)(p11;q11) HOOK3 8p11.21  RET 10q11.21 FRA10G (common, apc) 
t(6;16)(p21;q22) HP 16q22.3  MRPS10 6p21.1 FRA6H (common, apc) 
t(3;14)(q27;q32) HSP90AA1 14q32.31  BCL6 3q27.3 FRA3C (common, apc) 
t(3;6)(q27;p21) HSP90AB1 6p21.1 FRA6H (common, apc) BCL6 3q27.3 FRA3C (common, apc) 
t(1;14)(p22;q32) IGH@ 14q32.33  BCL10 1p22.3 FRA1D (common, apc) 
t(2;14)(p16;q32) IGH@ 14q32.33  BCL11A 2p16.1  
t(14;19)(q32;q13) IGH@ 14q32.33  BCL3 19q13.31 FRA19A (common, 5-aza) 
t(3;14)(q27;q32) IGH@ 14q32.33  BCL6 3q27.3 FRA3C (common, apc) 
t(14;15)(q32;q11-13) IGH@ 14q32.33  BCL8 15q11.2  
t(11;14)(q13;q32) IGH@ 14q32.33  CCND1 11q13.2 FRA11A (rare, folic acid), FRA11H (common, 
 t(12;14)(p13;q32) IGH@ 14q32.33  CCND2 12p13.32  
t(6;14)(p21;q32) IGH@ 14q32.33  CCND3 6p21.1 FRA6H (common, apc) 
t(7;14)(q21;q32) IGH@ 14q32.33  CDK6 7q21.2 FRA7E (common, apc) 
t(14;19)(q32;q13) IGH@ 14q32.33  CEBPA 19q13.11 FRA19A (common, 5-aza) 
t(14;20)(q32;q13) IGH@ 14q32.33  CEBPB 20q13.13  
t(8;14)(q11;q32) IGH@ 14q32.33  CEBPD 8q11.21  
t(14;14)(q11;q32) IGH@ 14q32.33  CEBPE 14q11.2  
t(14;19)(q32;q13) IGH@ 14q32.33  CEBPG 19q13.11 FRA19A (common, 5-aza) 
t(12;14)(q23;q32) IGH@ 14q32.33  CHST11 12q23.3  
t(11;14)(q23;q32) IGH@ 14q32.33  DDX6 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(7;14)(q21;q32) IGH@ 14q32.33  ERVWE1 7q21.2 FRA7E (common, apc) 
t(12;14)(p13;q32) IGH@ 14q32.33  ETV6 12p13.2  
t(1;14)(q23;q32) IGH@ 14q32.33  FCGR2B 1q23.3  
t(1;14)(q21;q32) IGH@ 14q32.33  FCRL4 1q23.1  
t(4;14)(p16;q32) IGH@ 14q32.33  FGFR3 4p16.3  
t(3;14)(p14;q32) IGH@ 14q32.33  FOXP1 3p14.1  
t(6;14)(p22;q32) IGH@ 14q32.33  ID4 6p22.3  
t(14;22)(q32;q11) IGH@ 14q32.33  IGL@ 22q11.22  
t(5;14)(q31;q32) IGH@ 14q32.33  IL3 5q31.1 FRA5C (common, apc) 
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t(6;14)(p25;q32) IGH@ 14q32.33  IRF4 6p25.3  
t(1;14)(p35;q32) IGH@ 14q32.33  LAPTM5 1p35.2  
t(1;14)(q25;q32) IGH@ 14q32.33  LHX4 1q25.2  
t(14;16)(q32;q23) IGH@ 14q32.33  MAF 16q23.1  
t(14;20)(q32;q12) IGH@ 14q32.33  MAFB 20q12  
t(14;18)(q32;q21) IGH@ 14q32.33  MALT1 18q21.32 FRA18B (common, apc) 
t(1;14)(q22;q32) IGH@ 14q32.33  MUC1 1q22  
t(8;14)(q24;q32) IGH@ 14q32.33  MYC 8q24.21  
t(10;14)(q24;q32) IGH@ 14q32.33  NFKB2 10q24.32  
t(11;14)(q23;q32) IGH@ 14q32.33  PAFAH1B2 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(9;14)(p13;q32) IGH@ 14q32.33  PAX5 9p13.2  
t(11;14)(q23;q32) IGH@ 14q32.33  PCSK7 11q23.3 FRA11B (rare, folic acid), FRA11G (common, 
 t(4;14)(p14;q32) IGH@ 14q32.33  RHOH 4p14  
t(14;19)(q32;q13) IGH@ 14q32.33  SPIB 19q13.33 FRA19A (common, 5-aza) 
t(14;14)(q11;q32), inv(14)(q11q32) IGH@ 14q32.33  TRA@ 14q11.2  
inv(14)(q11q32) IGH@ 14q32.33  TRD@ 14q11.2  
t(4;14)(p16;q32) IGH@ 14q32.33  WHSC1 4p16.3  
t(14;16)(q32;q23) IGH@ 14q32.33  WWOX 16q23.1 FRA16D (common, apc) 
t(1;2)(p22;p11) IGK@ 2p11.2 FRA2L (rare, folic acid) BCL10 1p22.3 FRA1D (common, apc) 
t(2;19)(p11;q13) IGK@ 2p11.2 FRA2L (rare, folic acid) BCL3 19q13.31 FRA19A (common, 5-aza) 
t(2;3)(p11;q27) IGK@ 2p11.2 FRA2L (rare, folic acid) BCL6 3q27.3 FRA3C (common, apc) 
t(2;11)(p11;q13) IGK@ 2p11.2 FRA2L (rare, folic acid) CCND1 11q13.2 FRA11A (rare, folic acid), FRA11H (common, 
 t(2;12)(p11;p13) IGK@ 2p11.2 FRA2L (rare, folic acid) CCND2 12p13.32  
t(2;7)(p11;q21) IGK@ 2p11.2 FRA2L (rare, folic acid) CDK6 7q21.2 FRA7E (common, apc) 
t(2;18)(p11;q21) IGK@ 2p11.2 FRA2L (rare, folic acid) FVT1 18q21.33 FRA18B (common, apc) 
t(2;8)(p11;q24) IGK@ 2p11.2 FRA2L (rare, folic acid) MYC 8q24.21  
t(2;8)(p11;q24) IGK@ 2p11.2 FRA2L (rare, folic acid) PVT1 8q24.21  
t(2;6)(p11;q25) IGK@ 2p11.2 FRA2L (rare, folic acid) ZC3H12D 6q25.1  
t(19;22)(q13;q11) IGL@ 22q11.22-q11.23  BCL3 19q13.31 FRA19A (common, 5-aza) 
t(3;22)(q27;q11) IGL@ 22q11.22-q11.23  BCL6 3q27.3 FRA3C (common, apc) 
t(11;22)(q13;q11) IGL@ 22q11.22-q11.23  CCND1 11q13.2 FRA11A (rare, folic acid), FRA11H (common, 
 t(12;22)(p13;q11) IGL@ 22q11.22-q11.23  CCND2 12p13.32  
t(6;22)(p21;q11) IGL@ 22q11.22-q11.23  CCND3 6p21.1 FRA6H (common, apc) 
t(7;22)(q21;q11) IGL@ 22q11.22-q11.23  CDK6 7q21.2 FRA7E (common, apc) 
t(16;22)(q23;q11) IGL@ 22q11.22-q11.23  MAF 16q23.1  
t(8;22)(q24;q11) IGL@ 22q11.22-q11.23  MYC 8q24.21  
t(8;22)(q24;q11) IGL@ 22q11.22-q11.23  PVT1 8q24.21  
t(2;22)(p16;q11) IGL@ 22q11.22-q11.23  REL 2p16.1  
t(16;22)(q23;q11) IGL@ 22q11.22-q11.23  WWOX 16q23.1 FRA16D (common, apc) 
t(4;16)(q27;p13) IL2 4q27  DEXI 16p13.13  
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t(4;16)(q27;p13) IL2 4q27  TNFRSF17 16p13.13  
t(3;16)(q27;p12) IL21R 16p12.1 FRA16E (rare, dist A) BCL6 3q27.3 FRA3C (common, apc) 
t(5;9)(q33;q22) ITK 5q33.3  SYK 9q22.2  
t(6;7)(p21;p15) JAZF1 7p15.2-p15.1  PHF1 6p21.32 FRA6H (common, apc) 
t(7;17)(p15;q11) JAZF1 7p15.2-p15.1  SUZ12 17q11.2  
t(2;17)(p23;q25) KIAA1618 17q25.3  ALK 2p23.2-p23.1  
t(4;10)(q12;p11) KIF5B 10p11.22  PDGFRA 4q12 FRA4B (common, BrdU) 
t(10;14)(q11;q22) KTN1 14q22.3  RET 10q11.21 FRA10G (common, apc) 
t(12;16)(p13;p13) LAG3 12p13.31  MYH11 16p13.11 FRA16A (rare, folic acid) 
t(1;7)(p35;q34) LCK 1p35.1  TRB@ 7q34  
t(3;13)(q27;q14) LCP1 13q14.12  BCL6 3q27.3 FRA3C (common, apc) 
t(5;8)(p13;q12) LIFR 5p13.1 FRA5A (common, BrdU) PLAG1 8q12.1  
del(3)(q27q28)* LPP 3q28  BCL6 3q27.3 FRA3C (common, apc) 
t(7;19)(q34;p13) LYL1 19p13.13 FRA19B (rare, folic acid) TRB@ 7q34  
t(11;19)(q13;q13.4) MALAT1 11q13.1 FRA11H (common, apc) MHLB1 19q13.4 FRA19A (common, 5-aza) 
t(6;11)(p21.1;q13) MALAT1 11q13.1 FRA11H (common, apc) TFEB 6p21.1 FRA6H (common, apc) 
t(3;18)(p21;q21) MALT1 18q21.32 FRA18B (common, apc) MAP4 3p21.31  
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Extraction algorithm 
#!/usr/bin/perl -w 
 
use strict; 
use warnings; 
 
my $infile_name=shift(@ARGV); 
my $outfile1_name=$infile_name; 
my $outfile2_name=$infile_name; 
# check file extension is .sam or .bam 
if($infile_name=~/.(s|b)am$/){  
    $outfile1_name=~s/.(b|s)am$/.extraction2.sam/;  # add  .extraction.sam suffix to output file 
    $outfile2_name=~s/.(b|s)am$/.extraction2.fa/; # add .extraction.fq suffix to output file 
}else{ 
    die "Error: input file needs to be in bam/sam format.\n"; # if file extension not .sam and .bam file 
then exit 
} 
 
my $isbam=($infile_name =~ /.bam$/)? 1:0; # if .bam file then return 1(true)  
 
if($isbam){ 
    open(INFILEHDL, "samtools view $infile_name |") or die "$0: can't open ".$infile_name.":$!\n"; # 
open bam file 
}else{ 
    open INFILEHDL, "<".$infile_name or die "$0: can't open ".$infile_name.":$!\n"; #open sam file 
} 
open(OUTFILEHDL1, ">$outfile1_name") or die "$0: can't write in the output: $outfile1_name :$!\n";  
# open file in overwite mode 
open(OUTFILEHDL2, ">$outfile2_name") or die "$0: can't write in the output: $outfile2_name :$!\n";  
# open file in overwite mode 
 
my $readsum = 0; 
my $readcount = 0; 
my $prevline = "";  
my $prevfld0 = ""; 
my $prevfld1 = ""; 
my $prevfld5 = ""; 
my $prevfld9 = ""; 
my $currentfld0 = ""; 
my $currentfld1 = ""; 
my $currentfld5 = ""; 
my $currentfld8 = ""; 
my $currentfld9 = ""; 
my $first = 0; 
my $pattlen =0; 
my $Ipattern=""; 
my @meanlist =('99','163','147','83'); 
my @matchlist = 
('73','133','89','121','165','181','101','117','153','185','69','137','77','141','67','131','115','179','81','161'
,'97','145','65','129','113','177'); 
while (my $LINE=<INFILEHDL>) # read line till EOF 
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{ 
   # chomp my $LINE;  # removes trailing whitespace 
    
    my @L=split(/\t+/,$LINE); # split on white space,  + will merge multiple whitespace   
    #my @L=split; 
    if ($L[0]=~/^@/) # current line first character is @ then print that line and skip that line 
    { 
        print OUTFILEHDL1 $LINE; 
        next; 
    } 
 
    $currentfld0 = ""; 
    $currentfld1 = ""; 
    $currentfld5 = ""; 
    $currentfld8 = ""; 
    $currentfld9 = ""; 
 
    if ( scalar(@L)>= 11) # array length is atleast 11 
    { 
        $currentfld0 = $L[0]; #Identifier 
        $currentfld1 = $L[1]; #FLAG 
        $currentfld5 = $L[5]; #CIGAR 
        $currentfld8 = $L[8]; #TLEN 
        $currentfld9 = $L[9]; #SEQUENCE 
   
  if ($first == 0) # build search pattern only once 
  { 
   $pattlen = int(length($currentfld9)*.30);  #30% or less based on decimal 
point of identifier length  
   $Ipattern = "N" x $pattlen; 
   $first = 1; 
   print $Ipattern."\n" ; # for testing purpose 
  } 
 
        if  (grep{$currentfld1 eq $_} @meanlist)  
        { 
           $readsum = $readsum + $currentfld8 ; 
           $readcount = $readcount + 1 ; 
        } 
 
        if ( ($currentfld0 eq $prevfld0) and ( (grep{$currentfld1 eq $_} @matchlist) || (grep{$prevfld1 eq 
$_} @matchlist) || ($currentfld5=~/S/ || $prevfld5=~/S/))  )  
        { 
 
            print OUTFILEHDL1 $prevline."\n"; 
            print OUTFILEHDL1 $LINE."\n"; 
     
   if (index($prevfld9,$Ipattern)==-1 and index($currentfld9,$Ipattern)==-1 )  
# if N Pattern not found in Read 1 & Read 2 then write to FA file 
   { 
    print OUTFILEHDL2 ">".$prevfld0."<RID>1"."\n"; 
    print OUTFILEHDL2 $prevfld9."\n"; 
  165 
    print OUTFILEHDL2 ">".$currentfld0."<RID>2"."\n"; 
    print OUTFILEHDL2 $currentfld9."\n"; 
   } 
        } 
 
    }  # if scalar 
 
    $prevline = $LINE ;  
    $prevfld0 = $currentfld0; 
    $prevfld1 = $currentfld1; 
    $prevfld9 = $currentfld9; 
 
} # while 
 
close OUTFILEHDL1; 
close OUTFILEHDL2; 
close INFILEHDL; 
 
De-duplication algorithm 
#!/usr/bin/perl -w 
 
# Assumptions 
# psl file needs to be sorted by identifier,chromosome,start position 
 
use strict; 
use warnings; 
 
my $infile_name=shift(@ARGV); 
my $outfile1_name=$infile_name; 
if (not defined $infile_name) 
{ 
   die "Error: .psl filename missing \n";  
} 
# check file extension is psl 
if($infile_name=~/.(p)sl$/){  
    $outfile1_name=~s/.(p)sl$/.sml/;  # add  .sml suffix to output file 
}else{ 
    die "Error: input file needs to be in psl format.\n"; # if file extension not .psl then exit 
} 
open(OUTFILEHDL1, ">$outfile1_name") or die "$0: can't write in the output: $outfile1_name :$!\n";  
# open file in overwite mode 
open INFILEHDL, "<".$infile_name or die "$0: can't open ".$infile_name.":$!\n"; #open sam file 
my @read1; 
my @read2; 
my $prevline = "";  
my $prevfld9 = ""; 
my $prevfld13 = ""; 
my $prevfld15 = ""; 
my $prevfld16 = ""; 
my $prevfld17 = ""; 
my $prevrange = 0; 
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my $currentfld9 = ""; 
my $currentfld13 = ""; 
my $currentfld15 = ""; 
my $currentfld16 = ""; 
my $currentfld17 = ""; 
my $currrange = 0; 
 
 
my $iline = 1; 
my $processline = 0; 
my $i=0; 
my $j=0; 
my $lastmaxrange = 0;  
my @cid; 
my @pid; 
while (my $LINE=<INFILEHDL>) # read line till EOF 
{  
   my @L=split(/\t/,$LINE); # split on tab space     
    $processline += 1; 
    if (scalar(@L)>= 18) # array length is at least 17 
    { 
  $currentfld9  = $L[9];  # Identifier 
  if(substr($L[13],0,3) eq "chr") 
  { 
   $currentfld13 = substr($L[13],3); # Chromosome 
  } 
  else 
  { 
   $currentfld13 = $L[13]; #Chromosome 
  }  
  $currentfld15 = $L[15]; # Start 
  $currentfld16 = $L[16]; # End 
  $currentfld17 = $L[17]; # Blockcount 
  #$currrange = GetRange$currentfld15,$currentfld16(); 
                $currrange = GetRange($currentfld15,$currentfld16); 
  @cid = split("<RID>",$currentfld9); 
  @pid = split("<RID>",$prevfld9); 
 
 
  if ( (scalar(@cid) >1)   ) 
  { 
   if ($currentfld9 ne $prevfld9) # identifier not match then save 
   { 
     $lastmaxrange = 0; # if identifier changes then reset last 
max range 
    if ($currentfld17 eq "1") # blockcount = 1 then add to array 
    {  
     InsertRead();   
                                        
    } 
   } 
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   else # if same identifier then check chr range and blockcount 
   { 
    if ( $currentfld13 ne $prevfld13 ) # chromsome diff then save 
    { 
      $lastmaxrange = 0; # if chromosome changes then reset 
last max range 
     if ($currentfld17 eq "1") # blockcount = 1 then add to 
array 
     {  
      InsertRead();   
      
     } 
     else # if chromosome same then check range 
     { 
      if ( $currrange != $prevrange) # if range diff then 
save 
      { 
       if ($currentfld17 eq "1") # blockcount = 
1 then add to array 
       {  
        InsertRead();   
        
       } 
      } 
     } 
    }  
                        } 
  } 
 } #scalar L 
 
} # eof 
 
close OUTFILEHDL1; 
close INFILEHDL; 
 
sub GetRange 
{ 
 my $rangespan = 1000; 
 my $grange = 0; 
 my $st = 0; 
 my $ed = 0; 
 $st = $_[0]; 
 $ed = $_[1]; 
 my $midpoint = int(($ed+$st)/2);  
 
 if ($midpoint < $rangespan) 
 { 
  $grange = 1; 
 } 
 else 
 { 
     $grange = int($midpoint/$rangespan) + 1; 
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 } 
 return $grange ; 
} 
 
sub InsertRead 
{ 
 if ($currrange >$lastmaxrange) 
 { 
  print OUTFILEHDL1 
$currentfld9."\t".$currentfld13."\t".$currentfld15."\t".$currentfld16."\t".$currrange."\n" ; 
  $lastmaxrange = $currrange ; 
 
  $prevline  = my $LINE; 
  $prevfld9  = $currentfld9; 
  $prevfld13 = $currentfld13; 
  $prevfld15 = $currentfld15; 
  $prevfld16 = $currentfld16; 
  $prevfld17 = $currentfld17; 
  $prevrange = $currrange; 
 } 
} 
 
 
Create_matrix algorithm  
#!/usr/bin/perl -w 
 
 
# Assumption 
# sml file is ordered  by Idenitifier,chromosome 
 
use strict; 
use warnings; 
 
my $infile_name=shift(@ARGV); 
my $outfile1_name=$infile_name; 
if (not defined $infile_name) 
{ 
   die "Error: .sml filename missing \n";  
} 
# check file extension is sml 
if($infile_name=~/.(s)ml$/){  
    $outfile1_name=~s/.(s)ml$/.unsort/;  # add  .unsort suffix to output file 
}else{ 
    die "Error: input file needs to be in sml format.\n"; # if file extension not .sml then exit 
} 
open(OUTFILEHDL1, ">$outfile1_name") or die "$0: can't write in the output: $outfile1_name :$!\n";  
# open file in overwite mode 
open INFILEHDL, "<".$infile_name or die "$0: can't open ".$infile_name.":$!\n"; #open sml file 
my @read1; 
my @read2; 
my $prevline = "";  
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my $prevfld1 = ""; 
my $prevfld2 = ""; 
my $prevfld3 = ""; 
my $prevfld4 = ""; 
my $prevfld5 = ""; 
my $currentfld1 = ""; 
my $currentfld2 = ""; 
my $currentfld3 = ""; 
my $currentfld4 = ""; 
my $currentfld5 = ""; 
my $matfilename = $outfile1_name; 
 
my $processline = 0; 
my $i=0; 
my $j=0; 
my @cid; 
my @pid; 
$matfilename =~s/.(u)nsort$/.mat/; 
while (my $LINE=<INFILEHDL>) # read line till EOF 
{ 
    chomp($LINE) ; 
    my @L=split(/\t/,$LINE); # split on tab space     
    $processline += 1; 
    if (scalar(@L)>= 5) # array length is at least 5 
 
    { 
  $currentfld1  = $L[0];  # Identifier 
  $currentfld2 = $L[1]; # Chromosome 
  $currentfld3 = $L[2]; # Start 
  $currentfld4 = $L[3]; # End 
  $currentfld5 = $L[4]; # range 
 
  @cid = split("<RID>",$currentfld1); 
  @pid = split("<RID>",$prevfld1); 
  if ( (scalar(@cid) >1) and (scalar(@pid) >1)  ) 
  { 
   if ($pid[0] eq $cid[0]) # identifier match 
   { 
     InsertRead();   
   } 
   else # if different match then save array to file 
   { 
    CreateMatrix(); 
    @read1 =(); #   $#read1 = -1 # clear array 
    @read2 =(); # clear array 
                                
    InsertRead();  
                        } 
  } 
  if (($processline == 1) and (scalar(@cid) >1) ) # save first line to array 
  { 
   InsertRead();  
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  } 
 } #scalar L 
 $prevline  = $LINE; 
 $prevfld1  = $currentfld1; 
 $prevfld2 = $currentfld2; 
 $prevfld3 = $currentfld3; 
 $prevfld4 = $currentfld4; 
 $prevfld5 = $currentfld5; 
} # eof 
 
CreateMatrix(); #save array to file remaining ones 
close OUTFILEHDL1; 
close INFILEHDL; 
 
# do unix sort for field 1,Field3,Field2,Field4  here on the mat file 
 system ("sort -k1n,1 -k3n,3 -k2n,2 -k4n,4 $outfile1_name > $matfilename");  
  
 
 
sub CreateMatrix 
{ 
  my @ln1; 
 my @ln2; 
 
 my $cnt = 1; 
 foreach my $r1(@read1) # r1 and r2 combination 
 { 
  foreach my $r2(@read2) 
  { 
            @ln1 = split(/\t/,$r1); 
   @ln2 = split(/\t/,$r2);  
   if ($ln1[0] eq $ln2[0] and $ln1[1] eq $ln2[1]) # if chromosome and offset is 
same then do not print  
   { 
    # do not print 
   } 
   else 
   { 
     if (PivotFile($ln1[0],$ln2[0],$ln1[1],$ln2[1]) == 2) 
                                { 
                                        print OUTFILEHDL1 $r1."\t".$r2."\n"; 
                                } 
                                else 
                                { 
                                        print OUTFILEHDL1 $r2."\t".$r1."\n"; 
                                }            
   } 
  }  
 
 } 
 
 for(my $x=0; $x < scalar(@read1); $x++) # r1 unique combination 
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 { 
  for(my $j=$cnt; $j < scalar(@read1); $j++) 
  { 
                        @ln1 = split(/\t/,$read1[$x]); 
                        @ln2 = split(/\t/,$read1[$j]); 
                        if ($ln1[0] eq $ln2[0] and $ln1[1] eq $ln2[1]) # if chromosome and offset is same then do 
not print 
                        { 
                                # do not print 
                        } 
                        else 
                        { 
                          if (PivotFile($ln1[0],$ln2[0],$ln1[1],$ln2[1]) == 2) 
    { 
     print OUTFILEHDL1 $read1[$x]."\t".$read1[$j]."\n"; 
    } 
    else 
    { 
      print OUTFILEHDL1 $read1[$j]."\t".$read1[$x]."\n"; 
    } 
                        } 
   
  } 
  $cnt++; 
 } 
 $cnt = 1; 
        for(my $x=0; $x < scalar(@read2); $x++) # r2 unique combination 
        { 
                for(my $j=$cnt; $j < scalar(@read2); $j++) 
                { 
                        @ln1 = split(/\t/,$read2[$x]); 
                        @ln2 = split(/\t/,$read2[$j]); 
                        if ($ln1[0] eq $ln2[0] and $ln1[1] eq $ln2[1]) # if chromosome and offset is same then do 
not print 
                        { 
                                # do not print 
                        } 
                        else 
                        { 
     if (PivotFile($ln1[0],$ln2[0],$ln1[1],$ln2[1]) == 2) 
                                { 
                                        print OUTFILEHDL1 $read2[$x]."\t".$read2[$j]."\n"; 
                                } 
                                else 
                                { 
                                        print OUTFILEHDL1 $read2[$j]."\t".$read2[$x]."\n"; 
                                } 
                        } 
 
                } 
                $cnt++; 
        } 
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} 
 
sub InsertRead 
{ 
             if($cid[1] eq "1") # read 1 
             { 
                 push @read1,  $currentfld2."\t".$currentfld5; 
             } 
             if($cid[1] eq "2") # read 2 
             { 
                 push @read2,  $currentfld2."\t".$currentfld5; 
             } 
} 
 
sub PivotFile 
{ 
        my $arg1 =""; 
        my $arg2 =""; 
 my $arg3 =""; 
 my $arg4 =""; 
        $arg1 = $_[0];  # chr1 
        $arg2 = $_[1];  # chr2 
 $arg3 = $_[2];  #  offset1 
 $arg4 = $_[3];  #  offset2 
        my $rw; 
        my $co; 
        if (uc($arg1) eq 'X' or uc($arg1) eq 'Y') 
        { 
                $rw=0; 
        } 
        else 
        { 
                $rw = int($arg1); 
        } 
        if (uc($arg2) eq 'X' or uc($arg2) eq 'Y') 
        { 
                $co=0; 
        } 
        else 
        { 
                $co = int($arg2); 
        } 
 
        my $pvot = 2;  # default 2 = no 1 = yes 
 
        if ($rw == 0 and $co == 0) # both row and col are x or y 
        { 
                if ($arg1 gt $arg2) # row greater than col then pivot 
                { 
                        $pvot = 1; 
                } 
        } 
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        else 
        { 
                if ($rw == 0 and $co > 0)  # row is x or y , col is number then  pivot 
                { 
                        $pvot = 1; 
                } 
        } 
 
        if ($rw > 0 and $co > 0)        # row and col both are numbers 
        { 
 
                if ($rw > $co)  # row is greater than col then pivot 
                { 
                        $pvot = 1; 
 
                } 
        } 
  
 if ($arg1 eq $arg2)  # if and row and col is same  
 { 
 
  if (int($arg3) > int($arg4)) # if row offset is greater than col offset 
  { 
   $pvot = 1;  
  } 
 
 } 
 
 return $pvot; 
} 
 
Write_count algorithm 
 
#!/usr/bin/perl -w 
# Assumption 
# mat file is ordered by field1,field3,field2,field4 
use strict; 
use warnings; 
 
my $infile_name=shift(@ARGV); 
my $outfile1_name=$infile_name; 
if (not defined $infile_name) 
{ 
   die "Error: .sml filename missing \n";  
} 
# check file extension is mat 
if($infile_name=~/.(m)at$/){  
    $outfile1_name=~s/.(m)at$/.chr/;  # add  .chr suffix to output file 
}else{ 
    die "Error: input file needs to be in mat format.\n"; # if file extension not .mat then exit 
} 
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open(OUTFILEHDL1, ">$outfile1_name") or die "$0: can't write in the output: $outfile1_name :$!\n";  
# open file in overwite mode 
open INFILEHDL, "<".$infile_name or die "$0: can't open ".$infile_name.":$!\n"; #open mat file 
my $prevline = "";  
 
my $iline = 1; 
my $cnt = 0; 
my $first = 1; 
while (my $LINE=<INFILEHDL>) # read line till EOF 
{ 
        chomp($LINE); 
 if ($first == 1) 
 { 
     $prevline = $LINE; 
     $first = 0; 
 } 
 if ($prevline eq $LINE) 
 { 
  $cnt = $cnt + 1; 
        } 
 else 
 {  
  WriteCount(); 
  $cnt = 1; 
 } 
 $prevline  = $LINE; 
} # eof 
 
WriteCount(); #save  remaining ones 
close OUTFILEHDL1; 
close INFILEHDL; 
 
sub WriteCount 
{ 
            print OUTFILEHDL1 $prevline."\t".$cnt."\n"; 
} 
 
Get Hi-C Score algorithm 
#!/usr/bin/perl -w 
use strict; 
use warnings; 
 
# Assumptions chr file is sorted by field1,field3,field2,field4 
# Hi -c file  range is 1000000 and they are tab delimited 
 
 
my $infile_name = shift(@ARGV); 
my $hicfile_path = shift(@ARGV); 
 
my $outfile1_name = $infile_name; 
# check file extension is chr 
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if($infile_name=~/.(c)hr$/){  
    $outfile1_name=~s/.(c)hr$/.score/;  # add  .score suffix to output file 
}else{ 
    die "Error: input file needs to be in chr format.\n"; # if file extension not .chr then exit 
} 
 
if (not defined $hicfile_path ) 
{ 
   die "Error: HIC file path not found.\n";  
}  
 
open(OUTFILEHDL1, ">$outfile1_name") or die "$0: can't write in the output: $outfile1_name :$!\n";  
# open file in overwite mode 
open INFILEHDL, "<".$infile_name or die "$0: can't open ".$infile_name.":$!\n"; #open MAT file 
my $currR1fld9 = ""; 
my $currR1fld13 = ""; 
my $currR1fld15 = ""; 
my $currR1fld16 = ""; 
my $currR2fld9 = ""; 
my $currR2fld13 = ""; 
my $currR2fld15 = ""; 
my $currR2fld16 = ""; 
my $prevR1fld13 = ""; 
my $prevR2fld13 = ""; 
 
my $currhicfile = ""; 
my $prevhicfile = ""; 
my $hicfile = ""; 
my @filearray ; 
my $colmidrange = 0; 
my $rowmidrange = 0; 
my $rowpos = 0; 
my $colpos = 0; 
my $r1start =0; 
my $r1end =0; 
my $r2start =0; 
my $r2end =0; 
my $currCount=""; 
my $score = ""; 
my $pivot = 2; 
while (my $LINE=<INFILEHDL>) # read line till EOF 
{ 
 chomp($LINE); 
 my @L=split(/\t/,$LINE); # split on tab space     
 $currR1fld9 = ""; 
 $currR1fld13 = ""; 
 $currR1fld15 = ""; 
 $currR1fld16 = ""; 
 $currR2fld9 = ""; 
 $currR2fld13 = ""; 
 $currR2fld15 = ""; 
 $currR2fld16 = ""; 
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 $currCount = ""; 
 $r1start=0; 
 $r1end=0; 
 $r2start=0; 
 $r2end=0; 
 $score = "" ; 
 $pivot = 2;  
 
 if (scalar(@L)>= 5) # array length is at least 7 
    { 
  $currR1fld9  = $L[0]; # Chromosome 
  $currR1fld13 = $L[1]; # Column Offset 
               $currR2fld9  = $L[2]; # Chromosome 
  $currR2fld13 = $L[3]; # Column Offset 
  $currCount = $L[4];  # Chromosome Count  
                            
 
  if ($pivot == 1) # if row chr greater than col chr then swap chr position  
HIC_gm06690_chr2_chr18_1000000_pearson.txt 
  { 
   $currhicfile = 
"HIC_gm06690_chr".uc($currR2fld9)."_"."chr".uc($currR1fld9)."_1000000_pearson.txt";  # file name 
will chr21_chr22.hic 
  } 
  else 
  { 
   $currhicfile = 
"HIC_gm06690_chr".uc($currR1fld9)."_"."chr".uc($currR2fld9)."_1000000_pearson.txt";  # file name 
will chr21_chr22.hic 
  } 
   
  if ($currhicfile ne $prevhicfile)  # if previous file not same as current file open file 
  { 
   openHiCFile(); #open file 
  } 
  $rowpos = 0; 
  $colpos = 0; 
  $rowmidrange = CalcMidPosition($currR1fld13); 
  $colmidrange = CalcMidPosition($currR2fld13) ; 
 
 
  if ($pivot == 1)  
  { 
   $rowpos = GetFilePosition($colmidrange); 
   $colpos = GetFilePosition($rowmidrange);  
  } 
  else 
  { 
                        $rowpos = GetFilePosition($rowmidrange); 
                        $colpos = GetFilePosition($colmidrange); 
  } 
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  $score = GetHiCScore(); # get hic score 
  CalcRange($currR1fld13,$currR2fld13); 
 
  if ($score gt 0 )  # score greater than 0 then print 
  { 
   if ($currCount > 1) # count is greater than 1 then print 
   { 
    print OUTFILEHDL1 
"chr".$currR1fld9."\t".$r1start."\t".$r1end."\t"."chr".$currR2fld9."\t".$r2start."\t".$r2end."\t".$curr
Count."\t".$score."\n";  
   } 
  } 
   
 }  
  
 $prevR1fld13 = $currR1fld13; 
 $prevR2fld13 = $currR2fld13; 
 $prevhicfile = $currhicfile; 
}  
 
close OUTFILEHDL1 ; 
close INFILEHDL ; 
 
 
# open file and load into array 
sub openHiCFile   
{ 
 $hicfile =  $hicfile_path.$currhicfile; 
 @filearray = ();  
 open INFILEHIC, "<".$hicfile or die "$0: can't open ".$hicfile.":$!\n"; #open hi-c file 
 @filearray = <INFILEHIC>; 
 shift(@filearray); 
 close INFILEHIC; 
} 
 
# get HI-C Score base on row and col position 
sub GetHiCScore 
{ 
 my @cline; 
 my $scr = "Not found"; 
 if (scalar(@filearray) > $rowpos) # check if that range exists or not 
 { 
  @cline = split(/\t/,$filearray[$rowpos]); 
 
#print "score col 0  ".$cline[0]." col 1 ".$cline[1]."\n"; 
 
  if (scalar(@cline) > $colpos) # check if range exist or not 
  { 
   $scr = $cline[$colpos]; 
  } 
  else 
  { 
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    print "column offset not found 
".$currhicfile."\t".$rowpos."\t".$colpos."\n"; 
  } 
 } 
 else 
 { 
  print "row offset not found ".$currhicfile."\t".$rowpos."\t".$colpos."\n";  
 } 
 return $scr; 
} 
 
# Calculate Position based on range (not used) 
sub GetPosition 
{ 
 my $readpos = $_[0]; 
 my $start = 0; 
 my $end = 999999; 
 my $rfactor = 1000000;  # hi-c file range span by million 
 my $pos = 0; 
 for (my $i = 0; $i < 1000; $i++) 
 { 
  if (($readpos >= $start) and ($readpos <= $end)) 
  { 
   $pos = $i ; 
   last; 
  } 
  $start += $rfactor; 
  $end += $rfactor 
 } 
 return $pos; 
} 
 
 
sub GetFilePosition 
{ 
 my $readpos = $_[0]; 
 my $colspan =1000000;   #hi-c file span by million 
 my $pos = 0; 
 if ($readpos < $colspan) 
 { 
  $pos = 1; 
 } 
 else 
 { 
  $pos = int($readpos/$colspan) + 1; 
   
 } 
 return $pos ; 
} 
 
sub CalcMidPosition 
{ 
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 my $coloff = $_[0]; 
 my $chrspan = 1000;   # assuming chr file column offset span is 1000 , change this if needed 
 my $cpos = 0; 
 my $mend = ($coloff * $chrspan)-1; 
 my $mstart = $mend - ($chrspan-1); 
  
 $cpos = int(($mend+$mstart)/2); 
  
 return $cpos; 
} 
 
sub CalcRange 
{ 
 my $r1col = $_[0]; 
 my $r2col = $_[1]; 
 my $chrspan = 1000;  # assuming chr file column offset span is 1000, change this if needed 
  
 $r1end = ($r1col * $chrspan)-1; 
 $r1start = $r1end-($chrspan-1); 
 $r2end = ($r2col * $chrspan)-1; 
 $r2start = $r2end-($chrspan-1); 
 
} 
 
sub PivotFile 
{ 
 my $arg1 =""; 
 my $arg2 =""; 
 $arg1 = $_[0];  # row 
 $arg2 = $_[1];  # col 
 my $rw; 
 my $co; 
 if (uc($arg1) eq 'X' or uc($arg1) eq 'Y') 
 { 
  $rw=0; 
 } 
 else 
 { 
  $rw = int($arg1); 
 } 
 if (uc($arg2) eq 'X' or uc($arg2) eq 'Y') 
        { 
                $co=0; 
        } 
 else 
 { 
  $co = int($arg2); 
 } 
  
 my $pvot = 2;  # default 2 = no 1 = yes  
 
 if ($rw == 0 and $co == 0) # both row and col are x or y 
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 { 
  if ($arg1 gt $arg2) # row greater than col then pivot 
  { 
   $pvot = 1;   
  } 
 } 
 else 
 { 
  if ($rw == 0 and $co > 0)  # row is x or y , col is number then  pivot 
  { 
   $pvot = 1;     
  } 
 } 
 
 if ($rw > 0 and $co > 0)   # row and col both are numbers 
 { 
 
  if ($rw > $co)  # row is greater than col then pivot 
  { 
   $pvot = 1; 
 
  } 
 } 
 return $pvot; 
} 
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